data_2ll1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ll1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.901 0.382 . . . . 73.219999999999999 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.91 29.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 75.209999999999994 112.492 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.61 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 74.450000000000003 110.826 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.29 -50.0 30.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.510000000000005 110.958 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.54 23.69 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.010000000000005 110.845 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.18 155.43 57.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.561 0.696 . . . . 71.349999999999994 110.894 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 159.79 52.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.252 . . . . 75.409999999999997 112.351 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.5 65.67 10.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 71.420000000000002 110.888 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -32.8 17.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 74.239999999999995 112.363 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -95.19 31.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 71.209999999999994 110.881 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.55 117.93 10.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 70.140000000000001 110.888 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -136.35 159.55 70.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 75.319999999999993 110.892 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 105.61 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.716 2.278 . . . . 64.200000000000003 112.257 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.0 29.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.715 -0.755 . . . . 73.109999999999999 112.477 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -158.21 84.55 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 75.420000000000002 110.847 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.2 mtm-85 -96.18 162.6 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.409999999999997 110.848 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.4 21.73 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 61.509999999999998 111.145 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -113.17 145.22 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.899 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -175.63 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.848 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 tt -62.45 142.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 73.200000000000003 111.117 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.41 70.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 63.25 112.471 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.5 mt -133.28 169.65 16.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 72.540000000000006 110.873 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.63 145.78 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 63.539999999999999 110.93 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.82 111.76 24.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -149.16 147.84 28.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.109999999999999 110.875 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.51 35.77 11.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 110.923 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.76 56.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 43.340000000000003 112.517 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -143.89 167.52 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 73.340000000000003 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.95 145.95 25.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.887 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.72 176.45 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 71.219999999999999 110.875 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.98 116.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 111.136 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.310000000000002 110.931 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.886 0.374 . . . . 71.150000000000006 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.86 29.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 75.019999999999996 112.566 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.24 -176.6 5.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 74.310000000000002 110.842 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.29 -50.14 29.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.9 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.5 23.76 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.11 155.29 57.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 75.420000000000002 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.76 52.2 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.654 2.236 . . . . 64.329999999999998 112.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -146.6 65.64 10.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.592 0.711 . . . . 64.5 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.72 17.75 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 74.230000000000004 112.301 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -95.14 31.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 75.219999999999999 110.875 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.57 117.96 10.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.885 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.58 159.49 71.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 73.5 110.886 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 75.340000000000003 112.347 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.52 29.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 63.119999999999997 112.508 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -158.05 84.52 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 72.319999999999993 110.866 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -96.13 162.49 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 75.450000000000003 110.898 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -94.48 22.11 6.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.019999999999996 111.136 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.5 m -113.15 145.6 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.854 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -175.88 3.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 62.119999999999997 110.902 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.19 142.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 72.129999999999995 111.158 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.61 70.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 73.329999999999998 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.5 mt -133.62 169.56 16.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.746 0.308 . . . . 75.510000000000005 110.937 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.62 145.82 26.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 110.904 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.77 111.69 23.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 110.877 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -149.08 147.81 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 110.885 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.53 35.78 11.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.329999999999998 110.89 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.74 56.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.761 -0.733 . . . . 54.329999999999998 112.498 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 167.39 22.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 75.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.89 145.86 26.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 110.862 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 176.46 10.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 75.129999999999995 110.865 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.96 116.46 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 70.239999999999995 111.16 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 75.310000000000002 110.863 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.895 0.379 . . . . 70.310000000000002 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.4 -167.39 28.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 74.239999999999995 112.464 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.78 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 73.310000000000002 110.832 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp -72.31 -49.92 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 73.400000000000006 110.927 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.56 23.69 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.897 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.07 155.29 58.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 65.299999999999997 110.833 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 159.14 54.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.666 2.244 . . . . 75.239999999999995 112.33 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.91 65.64 11.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.664 0.745 . . . . 74.120000000000005 110.915 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.79 17.89 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 71.439999999999998 112.363 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -95.2 31.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.42 117.92 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.914 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -135.75 159.55 70.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.701 . . . . 74.450000000000003 110.841 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 105.31 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.664 2.242 . . . . 74.409999999999997 112.344 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.56 29.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 65.230000000000004 112.424 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -158.05 84.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 74.430000000000007 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -96.21 162.48 13.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.209999999999994 110.842 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -94.4 21.77 6.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 73.439999999999998 111.156 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -112.98 145.38 40.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 73.329999999999998 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -177.29 4.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 75.409999999999997 110.879 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.8 tt -61.16 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 111.087 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.94 31.36 67.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 71.439999999999998 112.481 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.92 169.74 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 70.040000000000006 110.877 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.6 145.79 26.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 75.040000000000006 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.76 111.72 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.882 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -149.05 147.74 28.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 74.530000000000001 110.902 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.51 35.77 11.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 65.420000000000002 110.934 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.71 56.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.409999999999997 112.481 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.9 167.23 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 74.5 110.9 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.8 145.52 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 75.400000000000006 110.896 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.47 176.45 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.349999999999994 110.92 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.75 116.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 111.078 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.897 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.863 0.364 . . . . 62.5 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 -167.99 29.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 55.439999999999998 112.497 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.19 -176.71 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 71.219999999999999 110.87 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.24 -50.14 29.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 110.9 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.48 23.73 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 110.885 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.06 155.31 58.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 73.239999999999995 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 159.74 52.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 64.420000000000002 112.357 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.59 65.67 10.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 64.540000000000006 110.879 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.75 17.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.733 2.288 . . . . 75.450000000000003 112.319 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.21 31.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.140000000000001 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.65 117.95 11.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 71.439999999999998 110.86 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -135.73 159.49 71.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 75.209999999999994 110.909 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.244 . . . . 60.240000000000002 112.348 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.02 -8.63 29.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.399999999999999 112.487 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -158.04 84.49 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 75.439999999999998 110.881 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -96.19 162.51 13.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.239999999999995 110.886 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -94.45 21.95 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 111.139 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -113.08 145.59 40.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.420000000000002 110.92 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -175.73 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.915 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.34 142.89 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 73.129999999999995 111.139 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.67 31.56 70.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 75.310000000000002 112.519 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -133.46 169.59 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 75.129999999999995 110.886 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.6 145.81 26.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 74.230000000000004 110.9 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -100.81 111.72 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 71.299999999999997 110.857 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -149.08 147.84 28.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 110.895 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.47 35.85 11.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.935 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.07 12.73 55.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.741 -0.742 . . . . 73.430000000000007 112.553 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -143.9 167.41 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 74.230000000000004 110.893 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.92 145.95 25.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.865 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.66 176.42 10.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 74.319999999999993 110.882 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.97 116.46 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 111.127 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 110.9 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.858 0.361 . . . . 75.140000000000001 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.44 -167.36 28.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.716 -0.754 . . . . 75.129999999999995 112.487 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 75.209999999999994 110.814 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.26 -49.89 31.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 71.430000000000007 110.907 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.73 23.72 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.863 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 155.51 57.96 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.612 0.72 . . . . 74.140000000000001 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.7 56.03 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.691 2.261 . . . . 74.230000000000004 112.341 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.43 65.67 11.7 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 110.859 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.79 17.66 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 71.099999999999994 112.338 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 71.540000000000006 110.879 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.53 117.98 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 61.229999999999997 110.819 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -136.58 159.52 70.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.606 0.717 . . . . 73.129999999999995 110.883 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.66 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.646 2.231 . . . . 74.549999999999997 112.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 -9.08 29.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 51.399999999999999 112.483 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -158.17 84.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 74.230000000000004 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -96.19 162.47 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 110.862 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.35 21.39 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 111.154 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -113.02 145.28 41.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 110.912 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -177.04 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 55.32 110.902 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.32 142.46 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 111.126 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.24 68.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 62.219999999999999 112.542 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -133.68 169.6 16.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 73.030000000000001 110.951 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.58 145.7 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.129999999999995 110.932 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.63 111.77 24.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.856 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -149.05 147.51 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.310000000000002 110.851 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.58 35.74 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.928 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.83 56.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 63.420000000000002 112.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -143.84 166.8 23.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 72.340000000000003 110.908 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.37 145.38 26.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 110.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.22 176.46 9.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.931 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.89 116.34 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 74.109999999999999 111.103 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 72.120000000000005 110.899 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.0 p . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 120.905 0.383 . . . . 42.340000000000003 110.851 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.5 -167.47 28.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 61.210000000000001 112.439 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 71.010000000000005 110.865 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.26 -49.92 31.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.926 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.69 23.72 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.845 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 155.39 57.91 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.592 0.711 . . . . 62.539999999999999 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 158.72 56.01 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.236 . . . . 74.120000000000005 112.375 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.1 p -145.39 65.73 11.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 74.319999999999993 110.864 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.89 17.73 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.71 2.273 . . . . 71.319999999999993 112.329 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -95.22 31.22 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.530000000000001 110.943 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -68.43 117.94 10.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 65.120000000000005 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.59 159.49 70.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.585 0.707 . . . . 74.400000000000006 110.899 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 75.019999999999996 112.329 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.96 29.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 71.150000000000006 112.504 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -158.18 84.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.769 0.319 . . . . 71.209999999999994 110.894 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -96.14 162.46 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 110.843 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.41 21.62 6.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 63.109999999999999 111.079 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.6 m -113.21 145.26 41.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 73.409999999999997 110.885 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -177.43 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 72.349999999999994 110.915 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.19 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 71.219999999999999 111.148 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.18 31.04 66.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.736 . . . . 63.130000000000003 112.491 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -133.68 169.72 16.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 74.549999999999997 110.919 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -150.56 145.63 26.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 110.905 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.6 111.75 24.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.040000000000006 110.872 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -148.96 147.58 28.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 74.030000000000001 110.867 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.47 35.81 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.219999999999999 110.93 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.09 12.84 56.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 63.240000000000002 112.486 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -143.85 166.85 23.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.332 . . . . 74.109999999999999 110.919 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.38 145.42 26.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.875 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.26 176.46 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 71.5 110.915 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.95 116.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 111.121 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.120000000000005 110.831 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.939 0.4 . . . . 72.129999999999995 110.837 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.42 -167.48 28.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 54.530000000000001 112.479 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.15 -176.75 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 73.329999999999998 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.3 -49.93 30.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.109999999999999 110.927 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.6 23.67 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.888 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.03 155.43 58.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 72.439999999999998 110.878 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.69 2.26 . . . . 73.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -145.41 65.75 11.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 70.299999999999997 110.842 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.87 17.72 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.721 2.281 . . . . 71.530000000000001 112.312 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.27 31.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.310000000000002 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.51 117.92 10.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 54.420000000000002 110.838 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -136.57 159.48 70.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 71.420000000000002 110.893 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.261 . . . . 62.340000000000003 112.338 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.01 -8.94 29.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.74 . . . . 65.409999999999997 112.451 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -158.22 84.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 73.129999999999995 110.853 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -96.05 162.35 13.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 75.239999999999995 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.32 21.46 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.329999999999998 111.152 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -113.13 145.22 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 71.400000000000006 110.876 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -177.23 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 42.520000000000003 110.889 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 tt -61.29 142.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 111.171 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.9 31.03 67.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 61.25 112.511 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.0 mt -133.62 169.74 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.29 . . . . 75.129999999999995 110.907 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.59 145.72 26.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.905 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.68 111.73 24.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.519999999999996 110.897 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -148.97 147.59 28.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.883 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.48 35.82 11.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.953 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.78 56.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 73.120000000000005 112.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -143.86 166.97 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.794 0.331 . . . . 72.120000000000005 110.939 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.51 145.44 26.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.91 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 176.45 9.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.887 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.93 116.4 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.219999999999999 111.161 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.219999999999999 110.882 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.837 0.351 . . . . 61.439999999999998 110.863 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.99 -167.96 29.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 74.349999999999994 112.468 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.61 5.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 75.049999999999997 110.861 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.25 -50.1 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 75.510000000000005 110.915 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.52 23.69 9.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.838 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 155.39 57.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.721 . . . . 73.510000000000005 110.855 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 159.05 54.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.276 . . . . 73.340000000000003 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.76 65.62 11.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.737 . . . . 75.310000000000002 110.879 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -32.73 17.68 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 63.409999999999997 112.331 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -95.25 31.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 110.878 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 117.93 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.872 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -136.31 159.5 70.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 72.140000000000001 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 105.56 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.712 2.274 . . . . 74.329999999999998 112.396 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.01 29.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 73.530000000000001 112.507 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -158.19 84.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -96.16 162.58 13.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.876 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.44 21.73 6.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 63.310000000000002 111.186 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.2 m -113.18 145.33 41.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 110.908 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.01 -175.57 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.239999999999995 110.873 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.49 143.17 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 65.109999999999999 111.161 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 31.3 70.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 72.329999999999998 112.475 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.2 mt -133.14 169.64 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 73.349999999999994 110.921 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.68 145.77 26.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.901 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.8 111.77 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 73.239999999999995 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -149.0 147.65 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 75.129999999999995 110.867 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.47 35.79 11.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 70.319999999999993 110.933 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.76 56.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 33.119999999999997 112.489 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -143.79 167.0 23.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.150000000000006 110.882 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.54 145.84 25.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.319999999999993 110.857 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.53 176.45 10.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.892 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -76.12 116.39 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.299999999999997 111.142 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.040000000000006 110.894 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.6 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.909 0.385 . . . . 71.010000000000005 110.867 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.24 -167.47 29.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 54.049999999999997 112.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.81 5.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 64.310000000000002 110.856 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.25 -49.86 31.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.917 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.71 23.68 9.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.200000000000003 110.837 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.97 155.25 58.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.56 0.695 . . . . 75.109999999999999 110.879 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 158.55 56.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 75.299999999999997 112.325 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.27 65.63 11.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.573 0.702 . . . . 72.439999999999998 110.866 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.8 17.87 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.634 2.223 . . . . 73.25 112.36 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -95.3 31.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.51 117.96 10.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 61.240000000000002 110.828 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -135.76 159.5 71.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.57 0.7 . . . . 74.409999999999997 110.896 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.622 2.215 . . . . 70.420000000000002 112.339 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.5 29.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 72.450000000000003 112.503 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.09 84.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 75.329999999999998 110.869 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -96.1 162.5 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 p -94.41 21.69 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.149 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.5 m -113.14 145.86 40.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 110.858 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.8 -175.52 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 73.519999999999996 110.858 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.0 143.66 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 65.530000000000001 111.149 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.83 31.77 73.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.728 . . . . 64.310000000000002 112.432 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.7 mt -133.78 169.14 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.746 0.308 . . . . 73.140000000000001 110.907 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.57 145.93 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 110.937 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -100.6 111.74 24.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -148.95 147.44 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 74.299999999999997 110.837 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 63.53 35.81 11.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.904 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.85 56.44 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 73.150000000000006 112.45 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -143.85 166.7 24.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 74.400000000000006 110.867 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 t -97.25 145.34 26.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 74.299999999999997 110.916 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 176.5 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 74.450000000000003 110.939 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.91 116.33 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 71.150000000000006 111.14 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.893 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.882 0.372 . . . . 73.450000000000003 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.45 -167.46 28.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 70.109999999999999 112.506 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.3 -176.76 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 72.109999999999999 110.853 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.35 -49.76 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.916 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -99.67 23.7 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.319999999999993 110.878 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.2 155.55 57.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.577 0.703 . . . . 75.239999999999995 110.915 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 159.79 52.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.681 2.254 . . . . 73.409999999999997 112.328 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.82 65.65 10.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 64.230000000000004 110.863 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.9 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.71 2.274 . . . . 61.299999999999997 112.374 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.32 31.24 2.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 110.929 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.39 117.95 10.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.853 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.08 159.37 72.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.732 . . . . 71.299999999999997 110.842 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 105.49 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.737 2.291 . . . . 65.299999999999997 112.32 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.33 29.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.694 -0.765 . . . . 71.540000000000006 112.483 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -157.3 84.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 74.150000000000006 110.885 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.1 mtm-85 -96.47 164.16 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 74.400000000000006 110.895 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.54 21.92 6.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 70.310000000000002 111.118 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -112.98 145.43 40.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 73.209999999999994 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -174.49 3.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 110.858 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.66 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 74.019999999999996 111.168 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 32.07 76.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 41.310000000000002 112.461 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.8 mt -133.51 169.11 17.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.754 0.311 . . . . 73.299999999999997 110.902 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.52 146.04 26.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 71.040000000000006 110.936 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.6 t -100.87 111.69 23.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.349999999999994 110.861 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -149.06 147.72 28.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 75.109999999999999 110.89 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.52 35.8 11.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 74.439999999999998 110.931 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.63 55.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 72.109999999999999 112.515 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 167.56 22.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 72.430000000000007 110.933 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.91 145.87 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 72.439999999999998 110.888 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.81 176.46 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 70.120000000000005 110.927 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -75.75 116.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 111.171 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 110.892 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.859 0.361 . . . . 63.310000000000002 110.862 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.29 -168.72 30.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 64.099999999999994 112.51 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.65 5.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 73.040000000000006 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tp -72.3 -49.99 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.873 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.26 23.67 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.833 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.92 155.93 55.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 62.240000000000002 110.816 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 163.94 36.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 74.329999999999998 112.298 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 p -151.13 64.93 6.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.73 . . . . 74.430000000000007 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.39 18.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 65.420000000000002 112.385 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -95.0 31.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 71.400000000000006 110.896 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.98 117.93 11.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 53.009999999999998 110.879 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -135.45 159.51 71.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.646 0.736 . . . . 74.010000000000005 110.858 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 105.58 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 72.019999999999996 112.31 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.02 29.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.769 . . . . 54.350000000000001 112.504 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -158.17 84.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 74.430000000000007 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -96.04 162.86 13.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 110.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.45 21.83 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.166 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.2 m -112.84 145.07 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -171.94 1.89 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 62.329999999999998 110.876 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -64.73 145.52 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.239999999999995 111.12 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.65 84.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 74.109999999999999 112.482 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.0 mt -132.64 169.62 16.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.705 0.288 . . . . 75.120000000000005 110.93 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -150.5 147.25 27.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.884 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.99 112.06 24.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 53.020000000000003 110.899 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -148.56 147.45 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 110.877 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 63.54 36.29 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.952 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.5 12.33 55.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 74.420000000000002 112.487 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.98 178.52 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 74.549999999999997 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.5 t -107.1 147.49 29.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.873 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.38 176.49 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 72.239999999999995 110.914 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.27 116.39 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 111.107 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.0 110.875 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.2 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.91 0.386 . . . . 75.120000000000005 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.56 -168.65 30.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 75.129999999999995 112.487 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.61 5.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.383 . . . . 71.430000000000007 110.817 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.3 -50.02 30.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 74.310000000000002 110.92 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -99.25 23.72 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 64.439999999999998 110.902 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.88 155.74 55.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.634 0.731 . . . . 61.299999999999997 110.823 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 164.32 34.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 75.030000000000001 112.32 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 p -152.06 64.83 5.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 73.099999999999994 110.879 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -32.31 18.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.271 . . . . 61.32 112.373 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -94.99 31.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.86 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.05 117.95 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.899 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -134.14 159.54 71.97 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 74.329999999999998 110.859 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 105.32 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 71.230000000000004 112.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.96 -8.56 29.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 75.540000000000006 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -158.09 84.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 72.209999999999994 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.06 163.06 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 73.010000000000005 110.834 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.51 22.19 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 111.117 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.9 m -112.93 145.55 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -171.93 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.310000000000002 110.876 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.64 145.51 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 111.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.14 33.0 85.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 72.129999999999995 112.487 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.03 169.57 16.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 74.349999999999994 110.917 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -150.45 147.3 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.430000000000007 110.897 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -101.07 112.1 24.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -148.54 147.5 29.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 75.310000000000002 110.848 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 63.5 36.32 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.954 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.46 12.34 55.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 63.100000000000001 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -141.87 178.54 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 74.400000000000006 110.932 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.6 t -107.21 147.5 30.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 61.350000000000001 110.895 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.35 176.39 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 110.91 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.17 116.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 74.219999999999999 111.114 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 70.209999999999994 110.872 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.906 0.384 . . . . 70.0 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.15 -168.84 30.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 71.349999999999994 112.539 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.41 -176.63 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 71.439999999999998 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.6 tp -72.2 -50.18 29.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 75.430000000000007 110.927 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.06 23.6 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.882 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.02 156.28 54.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.568 0.699 . . . . 73.209999999999994 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 164.86 33.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.644 2.229 . . . . 74.019999999999996 112.351 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.2 p -151.97 65.07 6.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.657 0.742 . . . . 62.149999999999999 110.938 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.52 18.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.723 2.282 . . . . 74.150000000000006 112.344 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -95.19 31.35 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.039999999999999 110.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 159.76 68.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.645 0.736 . . . . 72.109999999999999 110.901 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 106.53 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 72.109999999999999 112.377 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.12 29.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 53.340000000000003 112.531 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -158.21 84.76 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 73.099999999999994 110.866 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -96.6 162.62 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 110.913 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.4 21.53 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 62.350000000000001 111.086 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.3 m -112.96 144.67 42.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 63.399999999999999 110.871 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -171.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 64.409999999999997 110.867 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.07 145.89 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 74.219999999999999 111.152 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 32.78 85.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 64.540000000000006 112.43 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.7 mt -132.35 169.42 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 74.310000000000002 110.882 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -150.61 147.09 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 110.91 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -100.71 112.13 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.439999999999998 110.865 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -148.67 147.48 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 71.5 110.874 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.5 36.34 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 110.94 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.52 12.36 55.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.495 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.07 178.52 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 74.25 110.917 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.3 t -107.04 147.67 29.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 73.019999999999996 110.851 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.48 176.46 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.881 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.31 116.48 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.340000000000003 111.134 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 110.866 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.846 0.355 . . . . 65.120000000000005 110.896 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.97 -170.86 41.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 64.319999999999993 112.484 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -89.41 -172.94 3.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 71.319999999999993 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 tp -72.72 -56.07 5.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.884 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.28 23.64 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 73.310000000000002 110.893 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.97 154.43 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 73.5 110.836 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 156.31 63.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 73.430000000000007 112.343 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.64 65.57 14.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.649 0.737 . . . . 73.239999999999995 110.903 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -31.94 19.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.683 2.256 . . . . 64.430000000000007 112.324 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -94.97 31.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 71.450000000000003 110.846 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.21 117.91 11.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -134.62 159.35 72.54 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.613 0.721 . . . . 74.450000000000003 110.893 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 105.16 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 71.319999999999993 112.35 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.1 29.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 75.219999999999999 112.531 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -158.2 84.54 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 75.430000000000007 110.837 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 -93.95 162.3 13.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 110.873 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -94.73 23.18 5.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.540000000000006 111.152 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 91.0 m -113.6 148.11 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 55.030000000000001 110.892 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -178.95 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.877 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.85 139.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 65.409999999999997 111.148 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.69 32.28 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 62.549999999999997 112.48 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.5 mt -135.05 170.81 15.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 73.030000000000001 110.928 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.77 145.06 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.019999999999996 110.924 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -100.8 112.05 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.918 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -148.23 147.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.030000000000001 110.885 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 63.33 35.73 12.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 110.904 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.05 56.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 73.329999999999998 112.501 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -143.45 165.61 27.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 74.219999999999999 110.873 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 12.1 t -96.71 145.21 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.907 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.85 176.45 9.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.952 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.92 116.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 71.109999999999999 111.169 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 75.230000000000004 110.811 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.5 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.877 0.37 . . . . 72.209999999999994 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.87 -167.47 29.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 73.420000000000002 112.468 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -89.25 -176.92 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 72.200000000000003 110.843 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.9 tp -72.24 -49.82 32.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 73.099999999999994 110.927 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -99.87 23.77 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.019999999999996 110.829 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.49 154.36 59.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 158.67 56.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.229 . . . . 75.120000000000005 112.368 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -146.41 65.15 10.19 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.621 0.724 . . . . 74.230000000000004 110.87 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.647 2.231 . . . . 73.150000000000006 112.352 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -94.96 31.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.26 117.85 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.030000000000001 110.855 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 12.0 ptt180 -130.33 159.77 68.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 74.109999999999999 110.87 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 104.01 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 73.129999999999995 112.332 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -6.28 29.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 61.219999999999999 112.461 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.24 87.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 71.120000000000005 110.849 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -97.93 162.78 13.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 110.908 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 p -94.7 23.54 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.439999999999998 111.15 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.0 m -112.95 146.67 38.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.329999999999998 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -177.15 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.200000000000003 110.869 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 tp -60.87 142.48 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 111.143 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.39 31.81 68.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 60.439999999999998 112.489 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.9 mt -134.79 169.51 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 74.019999999999996 110.897 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -150.47 146.44 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 110.957 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.7 t -101.21 111.69 23.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 74.200000000000003 110.905 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.7 mmt-85 -149.17 147.84 28.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.838 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.46 35.81 11.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 73.299999999999997 110.938 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.66 55.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 62.399999999999999 112.49 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -143.78 167.56 22.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 73.329999999999998 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 t -98.12 145.19 26.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.912 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.64 176.43 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.540000000000006 110.904 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.66 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 72.409999999999997 111.106 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 110.882 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.1 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.904 0.383 . . . . 73.540000000000006 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.99 -170.05 32.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 74.530000000000001 112.525 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.57 -175.61 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 75.450000000000003 110.838 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.88 -53.98 11.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.927 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.78 23.41 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 71.420000000000002 110.832 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.8 154.96 58.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 73.310000000000002 110.862 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 161.64 45.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.709 2.273 . . . . 65.310000000000002 112.354 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.13 65.65 8.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.626 0.727 . . . . 61.100000000000001 110.9 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.69 17.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 74.310000000000002 112.347 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.2 31.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.150000000000006 110.855 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.36 117.95 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.852 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -136.71 159.43 70.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 73.430000000000007 110.904 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 105.41 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 70.329999999999998 112.351 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.27 29.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.717 . . . . 73.439999999999998 112.528 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.842 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -95.51 162.46 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.140000000000001 110.844 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.6 22.35 6.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.137 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.0 m -113.71 148.85 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -171.59 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 65.530000000000001 110.891 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 tt -64.8 145.34 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 111.128 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.8 32.93 84.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.711 -0.756 . . . . 63.119999999999997 112.481 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -133.75 168.51 18.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 72.420000000000002 110.955 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.88 146.18 26.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 63.43 110.932 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.23 112.02 24.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.869 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -148.76 148.02 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 75.129999999999995 110.835 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.33 35.84 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 73.099999999999994 110.919 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.58 55.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 71.349999999999994 112.504 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -143.32 167.61 21.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.371 . . . . 73.420000000000002 110.858 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.6 t -97.6 146.65 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 70.349999999999994 110.887 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.21 175.09 11.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.923 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.36 116.9 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 111.127 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 72.349999999999994 110.885 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.87 0.367 . . . . 72.430000000000007 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.19 -169.96 32.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 74.400000000000006 112.526 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -89.65 -175.6 4.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 73.140000000000001 110.844 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.86 -54.07 11.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 110.945 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.72 23.42 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 74.219999999999999 110.838 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 154.9 58.86 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.572 0.701 . . . . 74.25 110.898 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 161.64 45.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.693 2.262 . . . . 52.520000000000003 112.285 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.24 65.58 8.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.723 . . . . 71.040000000000006 110.909 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.75 18.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.69 2.26 . . . . 74.129999999999995 112.359 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.13 31.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 75.420000000000002 110.92 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.32 117.96 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 70.209999999999994 110.875 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -136.46 159.44 70.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 71.129999999999995 110.857 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 105.37 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 72.099999999999994 112.318 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.3 29.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 74.200000000000003 112.488 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -158.17 84.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 72.25 110.899 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -95.47 162.6 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 75.510000000000005 110.881 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -94.52 22.28 6.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 111.154 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.0 m -113.62 148.95 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 61.130000000000003 110.899 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -171.74 2.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.862 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.72 145.13 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.0 84.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 71.420000000000002 112.499 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.0 mt -133.89 168.59 18.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 74.019999999999996 110.894 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.85 146.23 26.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.947 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -100.31 112.09 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.439999999999998 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -148.72 148.09 29.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 71.129999999999995 110.891 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.35 35.79 12.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 63.399999999999999 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.51 55.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 70.340000000000003 112.474 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -143.32 167.64 21.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 74.319999999999993 110.88 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.7 t -97.6 146.62 25.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 110.861 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.22 175.14 11.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 110.916 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.4 t -72.5 116.89 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 72.150000000000006 111.151 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 75.219999999999999 110.853 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.845 0.355 . . . . 74.230000000000004 110.927 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.66 -170.18 32.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.455 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.55 -175.5 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 72.129999999999995 110.887 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.94 -54.11 10.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.911 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -95.69 23.43 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.827 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.68 154.89 59.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.562 0.696 . . . . 72.519999999999996 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.91 47.94 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.656 2.237 . . . . 74.430000000000007 112.339 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -147.32 65.54 9.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 61.109999999999999 110.882 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -32.71 17.95 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 62.310000000000002 112.332 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.886 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.57 117.99 11.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 64.200000000000003 110.85 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -136.83 159.48 70.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.635 0.731 . . . . 74.409999999999997 110.86 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 105.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.633 2.222 . . . . 74.219999999999999 112.318 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.94 -8.43 29.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 74.439999999999998 112.472 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 110.813 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -95.62 162.26 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.846 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.59 22.29 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 111.132 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.8 m -113.63 148.65 35.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.901 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -171.34 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.884 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.98 145.63 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 111.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.51 32.78 84.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 64.219999999999999 112.466 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.9 mt -133.46 168.31 18.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 75.430000000000007 110.919 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.92 146.05 26.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.923 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.3 t -99.89 112.06 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -148.62 147.9 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 71.25 110.874 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.3 35.77 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 72.329999999999998 110.925 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.66 55.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 64.140000000000001 112.444 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -143.35 167.32 22.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.35 . . . . 73.299999999999997 110.873 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.5 t -97.36 146.53 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 74.209999999999994 110.876 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.06 175.44 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 74.099999999999994 110.89 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.68 116.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 71.540000000000006 111.099 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.310000000000002 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.852 0.358 . . . . 53.210000000000001 110.91 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.38 -171.23 37.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 74.510000000000005 112.49 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.23 -172.89 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 74.099999999999994 110.838 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.8 tp -72.62 -56.14 5.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.944 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -95.24 23.58 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 72.540000000000006 110.854 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.77 154.24 61.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.319999999999993 110.865 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 156.18 64.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.697 2.265 . . . . 74.109999999999999 112.325 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.58 65.56 14.69 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 72.25 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.1 19.16 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 75.030000000000001 112.367 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -94.93 31.3 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 74.310000000000002 110.895 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.99 117.89 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.109999999999999 110.887 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -133.23 159.3 73.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.582 0.706 . . . . 74.439999999999998 110.857 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 104.85 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.510000000000005 112.354 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.77 -7.45 29.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.788 -0.72 . . . . 61.350000000000001 112.472 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -158.14 84.7 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 75.349999999999994 110.839 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -93.21 162.29 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 110.894 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.1 p -94.83 24.31 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 73.519999999999996 111.138 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.8 m -113.42 151.26 31.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.099999999999994 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.05 -179.9 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.889 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -59.36 138.29 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 74.140000000000001 111.088 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.63 35.64 55.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 73.510000000000005 112.448 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.01 170.61 15.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.793 0.33 . . . . 74.140000000000001 110.876 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -150.85 144.12 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 71.299999999999997 110.911 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.72 112.18 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.925 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -148.06 147.74 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 75.319999999999993 110.858 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.41 35.84 11.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.923 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.14 13.05 57.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 72.109999999999999 112.486 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -143.75 165.44 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 75.310000000000002 110.884 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.0 t -96.32 145.02 25.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 71.319999999999993 110.848 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.63 176.41 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.439999999999998 110.931 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.88 116.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 110.847 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.91 0.386 . . . . 75.319999999999993 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.99 -169.88 39.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 72.310000000000002 112.482 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.47 -173.51 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 71.430000000000007 110.864 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.1 tp -72.81 -54.99 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.921 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.95 23.63 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 75.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.16 154.58 60.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.602 0.715 . . . . 74.209999999999994 110.855 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.26 63.89 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 2.23 . . . . 75.299999999999997 112.308 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -143.22 65.41 15.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 73.349999999999994 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -32.16 19.07 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.673 2.249 . . . . 73.420000000000002 112.344 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -94.93 31.38 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.864 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 63.32 110.845 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -135.28 159.34 72.16 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 74.540000000000006 110.849 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 65.349999999999994 112.346 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 -8.28 29.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 74.530000000000001 112.498 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -158.15 84.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 74.340000000000003 110.87 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -94.27 162.18 13.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 70.120000000000005 110.875 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.85 23.39 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 70.010000000000005 111.134 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.0 m -114.13 147.73 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.239999999999995 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.54 -178.56 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.230000000000004 110.888 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.2 tt -60.55 140.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 70.420000000000002 111.13 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.65 32.61 61.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.75 . . . . 72.299999999999997 112.535 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.0 mt -135.44 170.14 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 63.310000000000002 110.912 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.79 144.99 25.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.200000000000003 110.936 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -100.1 112.05 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.884 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -148.63 147.92 29.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.886 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 63.45 35.79 11.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.942 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.06 12.87 56.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 73.200000000000003 112.531 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -143.64 166.96 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 71.040000000000006 110.853 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 10.8 t -97.48 144.96 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 110.86 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 176.43 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 72.010000000000005 110.898 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.24 115.94 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 74.5 111.154 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 75.010000000000005 110.872 -179.925 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.846 0.355 . . . . 73.540000000000006 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.12 165.33 27.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 73.219999999999999 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.91 29.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 75.209999999999994 112.492 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.61 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 74.450000000000003 110.826 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.29 -50.0 30.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.510000000000005 110.958 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.54 23.69 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.010000000000005 110.845 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.18 155.43 57.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.561 0.696 . . . . 71.349999999999994 110.894 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 159.79 52.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.252 . . . . 75.409999999999997 112.351 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.5 65.67 10.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 71.420000000000002 110.888 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -32.8 17.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 74.239999999999995 112.363 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -95.19 31.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 71.209999999999994 110.881 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.55 117.93 10.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 70.140000000000001 110.888 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -136.35 159.55 70.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 75.319999999999993 110.892 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 105.61 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.716 2.278 . . . . 64.200000000000003 112.257 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.0 29.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.715 -0.755 . . . . 73.109999999999999 112.477 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -158.21 84.55 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 75.420000000000002 110.847 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.2 mtm-85 -96.18 162.6 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.409999999999997 110.848 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.4 21.73 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 61.509999999999998 111.145 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -113.17 145.22 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.899 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.85 -175.63 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.848 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 tt -62.45 142.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 73.200000000000003 111.117 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.41 70.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 63.25 112.471 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.5 mt -133.28 169.65 16.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 72.540000000000006 110.873 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.63 145.78 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 63.539999999999999 110.93 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.82 111.76 24.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -149.16 147.84 28.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.109999999999999 110.875 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.51 35.77 11.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 75.439999999999998 110.923 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.76 56.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 43.340000000000003 112.517 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -143.89 167.52 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 73.340000000000003 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.95 145.95 25.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.887 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.72 176.45 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 71.219999999999999 110.875 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.98 116.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 111.136 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 73.310000000000002 110.931 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.886 0.374 . . . . 74.230000000000004 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p -133.14 165.24 25.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.895 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.86 29.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 75.019999999999996 112.566 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.24 -176.6 5.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 74.310000000000002 110.842 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.29 -50.14 29.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.9 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.5 23.76 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.11 155.29 57.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 75.420000000000002 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.76 52.2 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.654 2.236 . . . . 64.329999999999998 112.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -146.6 65.64 10.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.592 0.711 . . . . 64.5 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.72 17.75 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 74.230000000000004 112.301 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -95.14 31.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 75.219999999999999 110.875 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.57 117.96 10.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.885 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.58 159.49 71.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 73.5 110.886 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 75.340000000000003 112.347 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.52 29.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 63.119999999999997 112.508 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -158.05 84.52 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 72.319999999999993 110.866 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -96.13 162.49 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 75.450000000000003 110.898 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -94.48 22.11 6.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.019999999999996 111.136 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.5 m -113.15 145.6 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.854 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -175.88 3.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 62.119999999999997 110.902 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.19 142.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 72.129999999999995 111.158 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.61 70.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 73.329999999999998 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.5 mt -133.62 169.56 16.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.746 0.308 . . . . 75.510000000000005 110.937 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.62 145.82 26.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.239999999999995 110.904 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.77 111.69 23.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 110.877 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -149.08 147.81 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 110.885 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.53 35.78 11.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.329999999999998 110.89 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.74 56.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.761 -0.733 . . . . 54.329999999999998 112.498 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 167.39 22.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 75.0 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.89 145.86 26.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 110.862 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.64 176.46 10.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 75.129999999999995 110.865 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.96 116.46 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 70.239999999999995 111.16 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 75.310000000000002 110.863 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 t0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.854 0.359 . . . . 72.450000000000003 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.5 p -139.78 165.21 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 70.310000000000002 110.861 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.4 -167.39 28.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 74.239999999999995 112.464 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.78 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 73.310000000000002 110.832 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tp -72.31 -49.92 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 73.400000000000006 110.927 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.56 23.69 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.897 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.07 155.29 58.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 65.299999999999997 110.833 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 159.14 54.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.666 2.244 . . . . 75.239999999999995 112.33 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.91 65.64 11.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.664 0.745 . . . . 74.120000000000005 110.915 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.79 17.89 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 71.439999999999998 112.363 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -95.2 31.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.42 117.92 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.914 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -135.75 159.55 70.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.701 . . . . 74.450000000000003 110.841 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 105.31 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.664 2.242 . . . . 74.409999999999997 112.344 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.56 29.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 65.230000000000004 112.424 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -158.05 84.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 74.430000000000007 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -96.21 162.48 13.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.209999999999994 110.842 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -94.4 21.77 6.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 73.439999999999998 111.156 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -112.98 145.38 40.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 73.329999999999998 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -177.29 4.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 75.409999999999997 110.879 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.8 tt -61.16 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 111.087 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.94 31.36 67.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 71.439999999999998 112.481 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.92 169.74 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 70.040000000000006 110.877 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.6 145.79 26.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 75.040000000000006 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.76 111.72 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.882 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -149.05 147.74 28.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 74.530000000000001 110.902 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.51 35.77 11.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 65.420000000000002 110.934 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.71 56.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.409999999999997 112.481 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.9 167.23 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 74.5 110.9 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.8 145.52 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 75.400000000000006 110.896 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.47 176.45 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.349999999999994 110.92 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.75 116.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 111.078 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.897 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 53.119999999999997 110.859 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.97 165.33 27.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 62.5 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 -167.99 29.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 55.439999999999998 112.497 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.19 -176.71 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 71.219999999999999 110.87 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.24 -50.14 29.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 110.9 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.48 23.73 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 110.885 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.06 155.31 58.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 73.239999999999995 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 159.74 52.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 64.420000000000002 112.357 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.59 65.67 10.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 64.540000000000006 110.879 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.75 17.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.733 2.288 . . . . 75.450000000000003 112.319 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.21 31.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.140000000000001 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.65 117.95 11.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 71.439999999999998 110.86 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -135.73 159.49 71.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 75.209999999999994 110.909 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.244 . . . . 60.240000000000002 112.348 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.02 -8.63 29.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.399999999999999 112.487 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -158.04 84.49 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 75.439999999999998 110.881 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -96.19 162.51 13.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.239999999999995 110.886 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -94.45 21.95 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 111.139 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -113.08 145.59 40.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.420000000000002 110.92 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -175.73 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.915 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.34 142.89 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 73.129999999999995 111.139 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.67 31.56 70.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 75.310000000000002 112.519 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -133.46 169.59 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 75.129999999999995 110.886 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.6 145.81 26.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 74.230000000000004 110.9 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -100.81 111.72 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 71.299999999999997 110.857 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -149.08 147.84 28.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 110.895 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.47 35.85 11.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.935 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.07 12.73 55.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.741 -0.742 . . . . 73.430000000000007 112.553 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -143.9 167.41 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 74.230000000000004 110.893 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.92 145.95 25.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.865 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.66 176.42 10.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 74.319999999999993 110.882 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.97 116.46 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 111.127 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 110.9 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.844 0.354 . . . . 74.430000000000007 110.865 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.2 p -140.39 165.26 27.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.896 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.44 -167.36 28.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.716 -0.754 . . . . 75.129999999999995 112.487 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 75.209999999999994 110.814 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.26 -49.89 31.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 71.430000000000007 110.907 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.73 23.72 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.863 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 155.51 57.96 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.612 0.72 . . . . 74.140000000000001 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.7 56.03 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.691 2.261 . . . . 74.230000000000004 112.341 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.43 65.67 11.7 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 110.859 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.79 17.66 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 71.099999999999994 112.338 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 71.540000000000006 110.879 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.53 117.98 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 61.229999999999997 110.819 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -136.58 159.52 70.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.606 0.717 . . . . 73.129999999999995 110.883 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.66 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.646 2.231 . . . . 74.549999999999997 112.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 -9.08 29.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 51.399999999999999 112.483 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -158.17 84.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 74.230000000000004 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -96.19 162.47 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 110.862 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.35 21.39 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 111.154 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -113.02 145.28 41.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 110.912 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -177.04 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 55.32 110.902 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.32 142.46 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 111.126 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.24 68.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 62.219999999999999 112.542 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.4 mt -133.68 169.6 16.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 73.030000000000001 110.951 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.58 145.7 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.129999999999995 110.932 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.63 111.77 24.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.856 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -149.05 147.51 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 75.310000000000002 110.851 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.58 35.74 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.928 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.83 56.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 63.420000000000002 112.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -143.84 166.8 23.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 72.340000000000003 110.908 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.37 145.38 26.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 110.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.22 176.46 9.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.931 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.89 116.34 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 74.109999999999999 111.103 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 72.120000000000005 110.899 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.837 0.351 . . . . 63.43 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.82 165.25 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 42.340000000000003 110.851 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.5 -167.47 28.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 61.210000000000001 112.439 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 71.010000000000005 110.865 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.26 -49.92 31.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.926 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.69 23.72 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.845 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 155.39 57.91 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.592 0.711 . . . . 62.539999999999999 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 158.72 56.01 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.236 . . . . 74.120000000000005 112.375 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.1 p -145.39 65.73 11.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 74.319999999999993 110.864 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.89 17.73 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.71 2.273 . . . . 71.319999999999993 112.329 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -95.22 31.22 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.530000000000001 110.943 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -68.43 117.94 10.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 65.120000000000005 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.59 159.49 70.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.585 0.707 . . . . 74.400000000000006 110.899 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 75.019999999999996 112.329 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.96 29.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 71.150000000000006 112.504 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -158.18 84.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.769 0.319 . . . . 71.209999999999994 110.894 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -96.14 162.46 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 110.843 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.41 21.62 6.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 63.109999999999999 111.079 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.6 m -113.21 145.26 41.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 73.409999999999997 110.885 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -177.43 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 72.349999999999994 110.915 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.19 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 71.219999999999999 111.148 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.18 31.04 66.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.736 . . . . 63.130000000000003 112.491 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.8 mt -133.68 169.72 16.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 74.549999999999997 110.919 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -150.56 145.63 26.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 110.905 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.6 111.75 24.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.040000000000006 110.872 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -148.96 147.58 28.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 74.030000000000001 110.867 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.47 35.81 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.219999999999999 110.93 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.09 12.84 56.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 63.240000000000002 112.486 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -143.85 166.85 23.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.332 . . . . 74.109999999999999 110.919 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.38 145.42 26.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.875 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.26 176.46 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 71.5 110.915 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.95 116.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 111.121 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.120000000000005 110.831 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.888 0.375 . . . . 74.439999999999998 110.905 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p -139.81 165.21 27.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 72.129999999999995 110.837 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.42 -167.48 28.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 54.530000000000001 112.479 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.15 -176.75 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 73.329999999999998 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.3 -49.93 30.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.109999999999999 110.927 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.6 23.67 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.888 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.03 155.43 58.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 72.439999999999998 110.878 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.69 2.26 . . . . 73.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -145.41 65.75 11.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 70.299999999999997 110.842 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.87 17.72 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.721 2.281 . . . . 71.530000000000001 112.312 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.27 31.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.310000000000002 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.51 117.92 10.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 54.420000000000002 110.838 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -136.57 159.48 70.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 71.420000000000002 110.893 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.261 . . . . 62.340000000000003 112.338 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.01 -8.94 29.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.74 . . . . 65.409999999999997 112.451 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -158.22 84.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 73.129999999999995 110.853 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -96.05 162.35 13.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 75.239999999999995 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.32 21.46 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.329999999999998 111.152 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -113.13 145.22 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 71.400000000000006 110.876 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 -177.23 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 42.520000000000003 110.889 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 tt -61.29 142.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 111.171 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.9 31.03 67.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 61.25 112.511 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.0 mt -133.62 169.74 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.29 . . . . 75.129999999999995 110.907 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.59 145.72 26.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.905 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.68 111.73 24.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.519999999999996 110.897 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -148.97 147.59 28.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.883 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.48 35.82 11.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.953 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.78 56.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 73.120000000000005 112.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -143.86 166.97 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.794 0.331 . . . . 72.120000000000005 110.939 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.51 145.44 26.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.91 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 176.45 9.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.887 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.93 116.4 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.219999999999999 111.161 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.219999999999999 110.882 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.826 0.346 . . . . 74.200000000000003 110.885 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.51 165.31 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 61.439999999999998 110.863 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.99 -167.96 29.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 74.349999999999994 112.468 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.61 5.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 75.049999999999997 110.861 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.25 -50.1 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 75.510000000000005 110.915 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.52 23.69 9.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.838 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 155.39 57.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.721 . . . . 73.510000000000005 110.855 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 159.05 54.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.276 . . . . 73.340000000000003 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.76 65.62 11.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.737 . . . . 75.310000000000002 110.879 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -32.73 17.68 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 63.409999999999997 112.331 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -95.25 31.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 110.878 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 117.93 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.872 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -136.31 159.5 70.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 72.140000000000001 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 105.56 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.712 2.274 . . . . 74.329999999999998 112.396 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.01 29.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 73.530000000000001 112.507 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -158.19 84.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -96.16 162.58 13.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.876 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.44 21.73 6.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 63.310000000000002 111.186 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.2 m -113.18 145.33 41.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 110.908 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.01 -175.57 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.239999999999995 110.873 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.49 143.17 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 65.109999999999999 111.161 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 31.3 70.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 72.329999999999998 112.475 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.2 mt -133.14 169.64 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 73.349999999999994 110.921 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.68 145.77 26.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.901 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.8 111.77 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 73.239999999999995 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -149.0 147.65 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 75.129999999999995 110.867 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.47 35.79 11.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 70.319999999999993 110.933 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.76 56.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 33.119999999999997 112.489 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -143.79 167.0 23.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.150000000000006 110.882 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.54 145.84 25.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.319999999999993 110.857 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.53 176.45 10.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.892 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -76.12 116.39 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.299999999999997 111.142 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.040000000000006 110.894 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.82 0.343 . . . . 64.129999999999995 110.872 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.6 p -139.87 165.1 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 110.867 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.24 -167.47 29.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 54.049999999999997 112.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.81 5.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 64.310000000000002 110.856 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.25 -49.86 31.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.917 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.71 23.68 9.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.200000000000003 110.837 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.97 155.25 58.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.56 0.695 . . . . 75.109999999999999 110.879 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 158.55 56.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 75.299999999999997 112.325 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.27 65.63 11.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.573 0.702 . . . . 72.439999999999998 110.866 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.8 17.87 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.634 2.223 . . . . 73.25 112.36 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -95.3 31.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.51 117.96 10.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 61.240000000000002 110.828 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -135.76 159.5 71.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.57 0.7 . . . . 74.409999999999997 110.896 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.622 2.215 . . . . 70.420000000000002 112.339 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.5 29.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 72.450000000000003 112.503 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.09 84.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 75.329999999999998 110.869 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -96.1 162.5 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 p -94.41 21.69 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.149 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.5 m -113.14 145.86 40.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 110.858 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.8 -175.52 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 73.519999999999996 110.858 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.0 143.66 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 65.530000000000001 111.149 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.83 31.77 73.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.728 . . . . 64.310000000000002 112.432 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.7 mt -133.78 169.14 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.746 0.308 . . . . 73.140000000000001 110.907 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.57 145.93 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 110.937 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -100.6 111.74 24.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -148.95 147.44 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 74.299999999999997 110.837 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 63.53 35.81 11.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.904 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.85 56.44 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 73.150000000000006 112.45 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -143.85 166.7 24.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 74.400000000000006 110.867 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 t -97.25 145.34 26.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 74.299999999999997 110.916 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 176.5 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 74.450000000000003 110.939 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.91 116.33 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 71.150000000000006 111.14 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.893 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.849 0.357 . . . . 74.239999999999995 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p -135.65 165.38 25.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 73.450000000000003 110.902 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.45 -167.46 28.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 70.109999999999999 112.506 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.3 -176.76 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 72.109999999999999 110.853 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.2 tp -72.35 -49.76 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.916 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -99.67 23.7 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.319999999999993 110.878 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.2 155.55 57.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.577 0.703 . . . . 75.239999999999995 110.915 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 159.79 52.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.681 2.254 . . . . 73.409999999999997 112.328 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.82 65.65 10.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 64.230000000000004 110.863 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.9 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.71 2.274 . . . . 61.299999999999997 112.374 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.32 31.24 2.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 110.929 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.39 117.95 10.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.853 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.08 159.37 72.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.732 . . . . 71.299999999999997 110.842 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 105.49 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.737 2.291 . . . . 65.299999999999997 112.32 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.33 29.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.694 -0.765 . . . . 71.540000000000006 112.483 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -157.3 84.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 74.150000000000006 110.885 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.1 mtm-85 -96.47 164.16 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 74.400000000000006 110.895 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.54 21.92 6.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 70.310000000000002 111.118 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -112.98 145.43 40.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 73.209999999999994 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -174.49 3.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 110.858 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.66 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 74.019999999999996 111.168 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 32.07 76.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 41.310000000000002 112.461 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.8 mt -133.51 169.11 17.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.754 0.311 . . . . 73.299999999999997 110.902 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.52 146.04 26.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 71.040000000000006 110.936 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.6 t -100.87 111.69 23.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.349999999999994 110.861 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -149.06 147.72 28.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 75.109999999999999 110.89 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.52 35.8 11.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 74.439999999999998 110.931 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.63 55.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 72.109999999999999 112.515 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 167.56 22.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 72.430000000000007 110.933 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.7 t -97.91 145.87 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 72.439999999999998 110.888 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.81 176.46 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 70.120000000000005 110.927 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -75.75 116.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 111.171 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 110.892 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.834 0.35 . . . . 71.040000000000006 110.898 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.25 165.5 16.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.310000000000002 110.862 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.29 -168.72 30.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 64.099999999999994 112.51 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.65 5.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 73.040000000000006 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tp -72.3 -49.99 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.873 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.26 23.67 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.833 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.92 155.93 55.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 62.240000000000002 110.816 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 163.94 36.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 74.329999999999998 112.298 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 p -151.13 64.93 6.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.73 . . . . 74.430000000000007 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.39 18.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 65.420000000000002 112.385 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -95.0 31.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 71.400000000000006 110.896 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.98 117.93 11.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 53.009999999999998 110.879 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -135.45 159.51 71.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.646 0.736 . . . . 74.010000000000005 110.858 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 105.58 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 72.019999999999996 112.31 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.02 29.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.769 . . . . 54.350000000000001 112.504 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -158.17 84.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 74.430000000000007 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -96.04 162.86 13.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 110.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.45 21.83 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.166 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.2 m -112.84 145.07 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -171.94 1.89 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 62.329999999999998 110.876 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -64.73 145.52 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.239999999999995 111.12 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.65 84.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 74.109999999999999 112.482 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 77.0 mt -132.64 169.62 16.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.705 0.288 . . . . 75.120000000000005 110.93 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -150.5 147.25 27.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.884 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.99 112.06 24.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 53.020000000000003 110.899 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -148.56 147.45 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 110.877 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 63.54 36.29 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.952 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.5 12.33 55.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 74.420000000000002 112.487 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.98 178.52 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 74.549999999999997 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.5 t -107.1 147.49 29.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.873 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.38 176.49 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 72.239999999999995 110.914 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.27 116.39 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 111.107 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.0 110.875 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.813 0.34 . . . . 72.310000000000002 110.878 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.2 p -136.47 165.61 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 75.120000000000005 110.857 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.56 -168.65 30.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 75.129999999999995 112.487 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.61 5.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.383 . . . . 71.430000000000007 110.817 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.3 -50.02 30.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 74.310000000000002 110.92 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -99.25 23.72 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 64.439999999999998 110.902 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.88 155.74 55.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.634 0.731 . . . . 61.299999999999997 110.823 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 164.32 34.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 75.030000000000001 112.32 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 p -152.06 64.83 5.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 73.099999999999994 110.879 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -32.31 18.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.271 . . . . 61.32 112.373 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -94.99 31.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.86 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.05 117.95 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.899 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt-85 -134.14 159.54 71.97 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 74.329999999999998 110.859 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 105.32 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 71.230000000000004 112.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.96 -8.56 29.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 75.540000000000006 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -158.09 84.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 72.209999999999994 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.06 163.06 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 73.010000000000005 110.834 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.51 22.19 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 111.117 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.9 m -112.93 145.55 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -171.93 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.310000000000002 110.876 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.64 145.51 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 111.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.14 33.0 85.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 72.129999999999995 112.487 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.03 169.57 16.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 74.349999999999994 110.917 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -150.45 147.3 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.430000000000007 110.897 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -101.07 112.1 24.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -148.54 147.5 29.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 75.310000000000002 110.848 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 63.5 36.32 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.954 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.46 12.34 55.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 63.100000000000001 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -141.87 178.54 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 74.400000000000006 110.932 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.6 t -107.21 147.5 30.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 61.350000000000001 110.895 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.35 176.39 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 110.91 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.17 116.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 74.219999999999999 111.114 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 70.209999999999994 110.872 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.851 0.358 . . . . 74.540000000000006 110.881 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.0 165.44 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.15 -168.84 30.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 71.349999999999994 112.539 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.41 -176.63 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 71.439999999999998 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.6 tp -72.2 -50.18 29.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 75.430000000000007 110.927 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.06 23.6 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.882 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.02 156.28 54.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.568 0.699 . . . . 73.209999999999994 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 164.86 33.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.644 2.229 . . . . 74.019999999999996 112.351 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.2 p -151.97 65.07 6.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.657 0.742 . . . . 62.149999999999999 110.938 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.52 18.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.723 2.282 . . . . 74.150000000000006 112.344 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -95.19 31.35 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.039999999999999 110.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 159.76 68.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.645 0.736 . . . . 72.109999999999999 110.901 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 106.53 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 72.109999999999999 112.377 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.12 29.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 53.340000000000003 112.531 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -158.21 84.76 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 73.099999999999994 110.866 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -96.6 162.62 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 110.913 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.4 21.53 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 62.350000000000001 111.086 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.3 m -112.96 144.67 42.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 63.399999999999999 110.871 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -171.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 64.409999999999997 110.867 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.07 145.89 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 74.219999999999999 111.152 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 32.78 85.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 64.540000000000006 112.43 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.7 mt -132.35 169.42 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 74.310000000000002 110.882 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -150.61 147.09 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.140000000000001 110.91 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -100.71 112.13 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.439999999999998 110.865 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -148.67 147.48 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 71.5 110.874 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.5 36.34 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 110.94 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.52 12.36 55.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.495 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.07 178.52 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 74.25 110.917 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.3 t -107.04 147.67 29.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 73.019999999999996 110.851 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.48 176.46 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.881 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 p -77.31 116.48 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 65.340000000000003 111.134 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 110.866 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 70.519999999999996 110.888 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 p -126.91 168.33 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 65.120000000000005 110.896 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.97 -170.86 41.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 64.319999999999993 112.484 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -89.41 -172.94 3.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 71.319999999999993 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 tp -72.72 -56.07 5.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.884 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.28 23.64 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 73.310000000000002 110.893 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.97 154.43 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 73.5 110.836 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 156.31 63.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 73.430000000000007 112.343 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.64 65.57 14.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.649 0.737 . . . . 73.239999999999995 110.903 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -31.94 19.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.683 2.256 . . . . 64.430000000000007 112.324 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -94.97 31.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 71.450000000000003 110.846 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.21 117.91 11.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -134.62 159.35 72.54 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.613 0.721 . . . . 74.450000000000003 110.893 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 105.16 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 71.319999999999993 112.35 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.1 29.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 75.219999999999999 112.531 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -158.2 84.54 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 75.430000000000007 110.837 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 -93.95 162.3 13.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 110.873 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -94.73 23.18 5.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.540000000000006 111.152 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 91.0 m -113.6 148.11 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 55.030000000000001 110.892 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -178.95 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.877 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.85 139.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 65.409999999999997 111.148 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.69 32.28 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 62.549999999999997 112.48 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.5 mt -135.05 170.81 15.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 73.030000000000001 110.928 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.77 145.06 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.019999999999996 110.924 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -100.8 112.05 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.918 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -148.23 147.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.030000000000001 110.885 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 63.33 35.73 12.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 110.904 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.05 56.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 73.329999999999998 112.501 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -143.45 165.61 27.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 74.219999999999999 110.873 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 12.1 t -96.71 145.21 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.907 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.85 176.45 9.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.010000000000005 110.952 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.92 116.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 71.109999999999999 111.169 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 75.230000000000004 110.811 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.349 . . . . 74.409999999999997 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.52 164.85 29.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 110.895 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.87 -167.47 29.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 73.420000000000002 112.468 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -89.25 -176.92 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 72.200000000000003 110.843 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.9 tp -72.24 -49.82 32.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 73.099999999999994 110.927 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -99.87 23.77 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.019999999999996 110.829 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.49 154.36 59.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 158.67 56.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.229 . . . . 75.120000000000005 112.368 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -146.41 65.15 10.19 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.621 0.724 . . . . 74.230000000000004 110.87 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.647 2.231 . . . . 73.150000000000006 112.352 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -94.96 31.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.26 117.85 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.030000000000001 110.855 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 12.0 ptt180 -130.33 159.77 68.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 74.109999999999999 110.87 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 104.01 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 73.129999999999995 112.332 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -6.28 29.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 61.219999999999999 112.461 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.24 87.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 71.120000000000005 110.849 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -97.93 162.78 13.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 110.908 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 p -94.7 23.54 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.439999999999998 111.15 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.0 m -112.95 146.67 38.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.329999999999998 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -177.15 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.200000000000003 110.869 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.6 tp -60.87 142.48 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 111.143 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.39 31.81 68.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 60.439999999999998 112.489 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 95.9 mt -134.79 169.51 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 74.019999999999996 110.897 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -150.47 146.44 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 110.957 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.7 t -101.21 111.69 23.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 74.200000000000003 110.905 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.7 mmt-85 -149.17 147.84 28.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.838 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.46 35.81 11.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 73.299999999999997 110.938 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.66 55.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 62.399999999999999 112.49 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -143.78 167.56 22.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 73.329999999999998 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 t -98.12 145.19 26.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.912 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.64 176.43 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.540000000000006 110.904 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.66 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 72.409999999999997 111.106 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 110.882 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.88 0.372 . . . . 72.219999999999999 110.917 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.65 164.82 26.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 73.540000000000006 110.879 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.99 -170.05 32.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 74.530000000000001 112.525 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.57 -175.61 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 75.450000000000003 110.838 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.88 -53.98 11.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.927 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.78 23.41 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 71.420000000000002 110.832 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.8 154.96 58.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 73.310000000000002 110.862 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 161.64 45.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.709 2.273 . . . . 65.310000000000002 112.354 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.13 65.65 8.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.626 0.727 . . . . 61.100000000000001 110.9 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.69 17.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 74.310000000000002 112.347 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.2 31.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 73.150000000000006 110.855 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.36 117.95 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.852 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -136.71 159.43 70.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 73.430000000000007 110.904 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 105.41 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 70.329999999999998 112.351 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.27 29.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.717 . . . . 73.439999999999998 112.528 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.842 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -95.51 162.46 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.140000000000001 110.844 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.6 22.35 6.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.137 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.0 m -113.71 148.85 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.140000000000001 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.65 -171.59 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 65.530000000000001 110.891 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 tt -64.8 145.34 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 111.128 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.8 32.93 84.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.711 -0.756 . . . . 63.119999999999997 112.481 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -133.75 168.51 18.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 72.420000000000002 110.955 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.88 146.18 26.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 63.43 110.932 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.23 112.02 24.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.869 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -148.76 148.02 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 75.129999999999995 110.835 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.33 35.84 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 73.099999999999994 110.919 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.58 55.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 71.349999999999994 112.504 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -143.32 167.61 21.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.371 . . . . 73.420000000000002 110.858 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.6 t -97.6 146.65 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 70.349999999999994 110.887 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.21 175.09 11.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.923 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.36 116.9 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 111.127 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 72.349999999999994 110.885 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.837 0.351 . . . . 74.219999999999999 110.873 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -123.45 164.97 17.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 110.859 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.19 -169.96 32.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 74.400000000000006 112.526 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -89.65 -175.6 4.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 73.140000000000001 110.844 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.86 -54.07 11.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 110.945 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.72 23.42 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 74.219999999999999 110.838 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 154.9 58.86 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.572 0.701 . . . . 74.25 110.898 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 161.64 45.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.693 2.262 . . . . 52.520000000000003 112.285 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.24 65.58 8.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.723 . . . . 71.040000000000006 110.909 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.75 18.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.69 2.26 . . . . 74.129999999999995 112.359 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.13 31.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 75.420000000000002 110.92 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.32 117.96 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 70.209999999999994 110.875 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -136.46 159.44 70.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 71.129999999999995 110.857 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 105.37 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 72.099999999999994 112.318 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.3 29.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 74.200000000000003 112.488 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -158.17 84.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 72.25 110.899 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -95.47 162.6 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 75.510000000000005 110.881 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -94.52 22.28 6.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 111.154 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.0 m -113.62 148.95 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 61.130000000000003 110.899 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -171.74 2.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.862 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.72 145.13 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.0 84.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 71.420000000000002 112.499 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 69.0 mt -133.89 168.59 18.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 74.019999999999996 110.894 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.85 146.23 26.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.947 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -100.31 112.09 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 75.439999999999998 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -148.72 148.09 29.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 71.129999999999995 110.891 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.35 35.79 12.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 63.399999999999999 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.51 55.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 70.340000000000003 112.474 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -143.32 167.64 21.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 74.319999999999993 110.88 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.7 t -97.6 146.62 25.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 110.861 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.22 175.14 11.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 110.916 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.4 t -72.5 116.89 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 72.150000000000006 111.151 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 75.219999999999999 110.853 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.876 0.37 . . . . 74.400000000000006 110.895 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p -125.56 164.7 19.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 74.230000000000004 110.927 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.66 -170.18 32.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.455 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.55 -175.5 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 72.129999999999995 110.887 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.94 -54.11 10.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.911 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -95.69 23.43 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.827 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.68 154.89 59.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.562 0.696 . . . . 72.519999999999996 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.91 47.94 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.656 2.237 . . . . 74.430000000000007 112.339 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -147.32 65.54 9.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 61.109999999999999 110.882 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -32.71 17.95 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 62.310000000000002 112.332 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.886 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.57 117.99 11.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 64.200000000000003 110.85 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -136.83 159.48 70.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.635 0.731 . . . . 74.409999999999997 110.86 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 105.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.633 2.222 . . . . 74.219999999999999 112.318 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.94 -8.43 29.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 74.439999999999998 112.472 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 110.813 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -95.62 162.26 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.846 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.59 22.29 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 111.132 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.8 m -113.63 148.65 35.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.901 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -171.34 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.884 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.98 145.63 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 111.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.51 32.78 84.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 64.219999999999999 112.466 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.9 mt -133.46 168.31 18.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 75.430000000000007 110.919 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.92 146.05 26.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.923 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.3 t -99.89 112.06 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -148.62 147.9 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 71.25 110.874 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.3 35.77 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 72.329999999999998 110.925 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.66 55.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 64.140000000000001 112.444 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -143.35 167.32 22.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.35 . . . . 73.299999999999997 110.873 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.5 t -97.36 146.53 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 74.209999999999994 110.876 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.06 175.44 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 74.099999999999994 110.89 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.68 116.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 71.540000000000006 111.099 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.310000000000002 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.85 0.357 . . . . 73.109999999999999 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p -135.54 170.32 16.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 53.210000000000001 110.91 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.38 -171.23 37.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 74.510000000000005 112.49 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.23 -172.89 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 74.099999999999994 110.838 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.8 tp -72.62 -56.14 5.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 110.944 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -95.24 23.58 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 72.540000000000006 110.854 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.77 154.24 61.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.319999999999993 110.865 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 156.18 64.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.697 2.265 . . . . 74.109999999999999 112.325 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.58 65.56 14.69 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 72.25 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.1 19.16 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 75.030000000000001 112.367 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -94.93 31.3 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 74.310000000000002 110.895 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.99 117.89 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.109999999999999 110.887 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -133.23 159.3 73.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.582 0.706 . . . . 74.439999999999998 110.857 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 104.85 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.510000000000005 112.354 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.77 -7.45 29.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.788 -0.72 . . . . 61.350000000000001 112.472 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -158.14 84.7 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 75.349999999999994 110.839 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -93.21 162.29 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 110.894 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.1 p -94.83 24.31 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 73.519999999999996 111.138 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.8 m -113.42 151.26 31.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.099999999999994 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.05 -179.9 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.889 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -59.36 138.29 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 74.140000000000001 111.088 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.63 35.64 55.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 73.510000000000005 112.448 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.5 mt -138.01 170.61 15.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.793 0.33 . . . . 74.140000000000001 110.876 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -150.85 144.12 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 71.299999999999997 110.911 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.72 112.18 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.925 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -148.06 147.74 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 75.319999999999993 110.858 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.41 35.84 11.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.923 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.14 13.05 57.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 72.109999999999999 112.486 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -143.75 165.44 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 75.310000000000002 110.884 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.0 t -96.32 145.02 25.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 71.319999999999993 110.848 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.63 176.41 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.439999999999998 110.931 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.88 116.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 110.847 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.88 0.372 . . . . 71.200000000000003 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p -134.31 168.87 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 75.319999999999993 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.99 -169.88 39.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 72.310000000000002 112.482 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.47 -173.51 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 71.430000000000007 110.864 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.1 tp -72.81 -54.99 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.921 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.95 23.63 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 75.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.16 154.58 60.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.602 0.715 . . . . 74.209999999999994 110.855 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.26 63.89 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 2.23 . . . . 75.299999999999997 112.308 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -143.22 65.41 15.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 73.349999999999994 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -32.16 19.07 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.673 2.249 . . . . 73.420000000000002 112.344 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -94.93 31.38 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.864 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 63.32 110.845 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -135.28 159.34 72.16 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 74.540000000000006 110.849 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 65.349999999999994 112.346 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 -8.28 29.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 74.530000000000001 112.498 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -158.15 84.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 74.340000000000003 110.87 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -94.27 162.18 13.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 70.120000000000005 110.875 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.85 23.39 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 70.010000000000005 111.134 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.0 m -114.13 147.73 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.239999999999995 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.54 -178.56 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.230000000000004 110.888 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.2 tt -60.55 140.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 70.420000000000002 111.13 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.65 32.61 61.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.75 . . . . 72.299999999999997 112.535 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.0 mt -135.44 170.14 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 63.310000000000002 110.912 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.79 144.99 25.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.200000000000003 110.936 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -100.1 112.05 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.884 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -148.63 147.92 29.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.886 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 63.45 35.79 11.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.942 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.06 12.87 56.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 73.200000000000003 112.531 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -143.64 166.96 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 71.040000000000006 110.853 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 10.8 t -97.48 144.96 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 110.86 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 176.43 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 72.010000000000005 110.898 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -77.24 115.94 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 74.5 111.154 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 75.010000000000005 110.872 -179.925 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.901 0.382 . . . . 73.219999999999999 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.91 29.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.200000000000003 112.492 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.61 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 74.450000000000003 110.826 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.2 tp -72.29 -50.0 30.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 61.310000000000002 110.958 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.54 23.69 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.010000000000005 110.845 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.18 155.43 57.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.561 0.696 . . . . 71.349999999999994 110.894 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 159.79 52.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.252 . . . . 75.049999999999997 112.351 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.5 65.67 10.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 71.420000000000002 110.888 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -32.8 17.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 74.239999999999995 112.363 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -95.19 31.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 71.209999999999994 110.881 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.55 117.93 10.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 70.140000000000001 110.888 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -136.35 159.55 70.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 75.319999999999993 110.892 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 105.61 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.716 2.278 . . . . 64.200000000000003 112.257 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.0 29.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.715 -0.755 . . . . 12.529999999999999 112.477 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -158.21 84.55 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 75.420000000000002 110.847 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.2 mtm-85 -96.18 162.6 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 61.340000000000003 110.848 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.4 21.73 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 61.509999999999998 111.145 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -113.17 145.22 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.899 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.6 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.85 -175.63 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 110.848 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 tt -62.45 142.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 72.329999999999998 111.117 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.41 70.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 34.530000000000001 112.471 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.5 mt -133.28 169.65 16.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 52.43 110.873 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.63 145.78 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 63.539999999999999 110.93 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.82 111.76 24.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' HD11 ' A' ' 31' ' ' LEU . 27.6 mmt180 -149.16 147.84 28.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 64.109999999999999 110.875 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.51 35.77 11.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 55.520000000000003 110.923 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.76 56.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 43.340000000000003 112.517 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -143.89 167.52 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 65.030000000000001 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.619 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.95 145.95 25.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.887 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.619 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.72 176.45 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 71.219999999999999 110.875 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.98 116.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 61.32 111.136 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 54.530000000000001 110.931 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.886 0.374 . . . . 71.150000000000006 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.86 29.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 74.409999999999997 112.566 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.24 -176.6 5.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 74.219999999999999 110.842 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.29 -50.14 29.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 50.539999999999999 110.9 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.5 23.76 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.11 155.29 57.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 75.420000000000002 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.76 52.2 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.654 2.236 . . . . 64.329999999999998 112.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -146.6 65.64 10.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.592 0.711 . . . . 53.399999999999999 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.72 17.75 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 64.420000000000002 112.301 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -95.14 31.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 75.219999999999999 110.875 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.57 117.96 10.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 62.130000000000003 110.885 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.58 159.49 71.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 73.5 110.886 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 73.25 112.347 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.52 29.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 32.039999999999999 112.508 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -158.05 84.52 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 72.319999999999993 110.866 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -96.13 162.49 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 75.450000000000003 110.898 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -94.48 22.11 6.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.019999999999996 111.136 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.5 m -113.15 145.6 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.854 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.606 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.26 -175.88 3.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 44.450000000000003 110.902 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.19 142.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 72.129999999999995 111.158 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.61 70.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 73.329999999999998 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.606 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.5 mt -133.62 169.56 16.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.746 0.308 . . . . 75.510000000000005 110.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.62 145.82 26.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 110.904 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.77 111.69 23.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 110.877 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' HD11 ' A' ' 31' ' ' LEU . 12.5 mmt180 -149.08 147.81 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 110.885 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.53 35.78 11.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.89 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.74 56.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.761 -0.733 . . . . 54.329999999999998 112.498 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 167.39 22.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 63.549999999999997 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.615 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.89 145.86 26.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 110.862 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.64 176.46 10.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 75.129999999999995 110.865 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.96 116.46 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 42.340000000000003 111.16 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 73.099999999999994 110.863 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.895 0.379 . . . . 60.020000000000003 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.4 -167.39 28.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 74.239999999999995 112.464 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.78 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 73.310000000000002 110.832 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.0 tp -72.31 -49.92 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.200000000000003 110.927 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.56 23.69 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.897 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.07 155.29 58.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 61.039999999999999 110.833 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 159.14 54.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.666 2.244 . . . . 73.430000000000007 112.33 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.91 65.64 11.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.664 0.745 . . . . 50.329999999999998 110.915 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.79 17.89 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 71.439999999999998 112.363 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -95.2 31.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.42 117.92 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.914 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 10.9 ptm180 -135.75 159.55 70.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.701 . . . . 72.450000000000003 110.841 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.5 Cg_endo -69.78 105.31 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.664 2.242 . . . . 74.409999999999997 112.344 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.56 29.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 65.230000000000004 112.424 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -158.05 84.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -96.21 162.48 13.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.209999999999994 110.842 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -94.4 21.77 6.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 73.439999999999998 111.156 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -112.98 145.38 40.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 72.340000000000003 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.612 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.34 -177.29 4.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 75.409999999999997 110.879 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.8 tt -61.16 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 62.030000000000001 111.087 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.94 31.36 67.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 43.219999999999999 112.481 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 20' ' ' CYS . 94.7 mt -133.92 169.74 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 70.040000000000006 110.877 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.6 145.79 26.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 70.519999999999996 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.76 111.72 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.882 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' HD11 ' A' ' 31' ' ' LEU . 39.2 mmt180 -149.05 147.74 28.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 70.019999999999996 110.902 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.51 35.77 11.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 65.420000000000002 110.934 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.71 56.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.409999999999997 112.481 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.9 167.23 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 61.119999999999997 110.9 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.607 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.8 145.52 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 75.400000000000006 110.896 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.47 176.45 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.349999999999994 110.92 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.75 116.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 63.229999999999997 111.078 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 61.409999999999997 110.897 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.863 0.364 . . . . 62.020000000000003 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 -167.99 29.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 55.439999999999998 112.497 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.19 -176.71 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 54.240000000000002 110.87 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.24 -50.14 29.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 110.9 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.48 23.73 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 72.219999999999999 110.885 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.06 155.31 58.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 73.239999999999995 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 159.74 52.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 61.25 112.357 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.59 65.67 10.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 64.129999999999995 110.879 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.75 17.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.733 2.288 . . . . 75.450000000000003 112.319 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -95.21 31.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.140000000000001 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.65 117.95 11.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 64.109999999999999 110.86 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 1.2 ptt180 -135.73 159.49 71.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 74.430000000000007 110.909 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.1 Cg_endo -69.78 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.244 . . . . 60.240000000000002 112.348 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.02 -8.63 29.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.399999999999999 112.487 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -158.04 84.49 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 65.430000000000007 110.881 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -96.19 162.51 13.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 63.530000000000001 110.886 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -94.45 21.95 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 111.139 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -113.08 145.59 40.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.420000000000002 110.92 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.17 -175.73 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.915 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.34 142.89 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 65.129999999999995 111.139 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.67 31.56 70.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 75.310000000000002 112.519 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.1 mt -133.46 169.59 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 65.209999999999994 110.886 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.6 145.81 26.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 64.409999999999997 110.9 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -100.81 111.72 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 71.299999999999997 110.857 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HB2' HD11 ' A' ' 31' ' ' LEU . 19.2 mmt180 -149.08 147.84 28.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 110.895 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.47 35.85 11.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.935 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.07 12.73 55.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.741 -0.742 . . . . 71.120000000000005 112.553 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -143.9 167.41 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 74.230000000000004 110.893 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.615 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.92 145.95 25.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.865 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.66 176.42 10.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 74.030000000000001 110.882 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.97 116.46 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 54.240000000000002 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 110.9 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.858 0.361 . . . . 75.140000000000001 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.44 -167.36 28.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.487 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 75.209999999999994 110.814 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.26 -49.89 31.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 71.430000000000007 110.907 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.73 23.72 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.099999999999994 110.863 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 155.51 57.96 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.612 0.72 . . . . 74.140000000000001 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.7 56.03 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.691 2.261 . . . . 74.230000000000004 112.341 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.43 65.67 11.7 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 110.859 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.79 17.66 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 71.099999999999994 112.338 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 60.25 110.879 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.53 117.98 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 61.229999999999997 110.819 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -136.58 159.52 70.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.606 0.717 . . . . 73.129999999999995 110.883 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.66 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.646 2.231 . . . . 74.549999999999997 112.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 -9.08 29.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 51.399999999999999 112.483 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -158.17 84.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 74.230000000000004 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -96.19 162.47 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 110.862 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.35 21.39 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.219999999999999 111.154 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -113.02 145.28 41.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 65.540000000000006 110.912 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.612 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.23 -177.04 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 53.130000000000003 110.902 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.32 142.46 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 71.310000000000002 111.126 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.24 68.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 61.530000000000001 112.542 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.4 mt -133.68 169.6 16.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 64.319999999999993 110.951 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.58 145.7 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.399999999999999 110.932 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.63 111.77 24.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.856 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HB2' HD11 ' A' ' 31' ' ' LEU . 37.5 mmt180 -149.05 147.51 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 74.099999999999994 110.851 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.58 35.74 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 64.109999999999999 110.928 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.83 56.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 63.420000000000002 112.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -143.84 166.8 23.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 70.040000000000006 110.908 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.562 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.37 145.38 26.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 110.888 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.22 176.46 9.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.931 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.89 116.34 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 65.439999999999998 111.103 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 71.109999999999999 110.899 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.0 p . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 120.905 0.383 . . . . 41.450000000000003 110.851 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.5 -167.47 28.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 61.210000000000001 112.439 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 62.5 110.865 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.26 -49.92 31.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.926 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.69 23.72 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.845 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 155.39 57.91 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.592 0.711 . . . . 62.539999999999999 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 158.72 56.01 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.236 . . . . 64.049999999999997 112.375 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.1 p -145.39 65.73 11.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 70.219999999999999 110.864 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.89 17.73 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.71 2.273 . . . . 61.229999999999997 112.329 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -95.22 31.22 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 41.439999999999998 110.943 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -68.43 117.94 10.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 65.120000000000005 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.59 159.49 70.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.585 0.707 . . . . 74.400000000000006 110.899 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 75.019999999999996 112.329 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.96 29.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 71.150000000000006 112.504 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -158.18 84.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.769 0.319 . . . . 64.200000000000003 110.894 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -96.14 162.46 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 110.843 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.41 21.62 6.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 60.140000000000001 111.079 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.6 m -113.21 145.26 41.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 73.409999999999997 110.885 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.615 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.2 -177.43 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 65.519999999999996 110.915 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.19 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 71.219999999999999 111.148 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.18 31.04 66.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.736 . . . . 30.030000000000001 112.491 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.615 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.8 mt -133.68 169.72 16.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 74.549999999999997 110.919 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -150.56 145.63 26.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 52.210000000000001 110.905 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.6 111.75 24.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.040000000000006 110.872 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' HD11 ' A' ' 31' ' ' LEU . 21.4 mmt180 -148.96 147.58 28.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 73.230000000000004 110.867 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.47 35.81 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.219999999999999 110.93 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.09 12.84 56.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 63.240000000000002 112.486 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -143.85 166.85 23.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.332 . . . . 74.109999999999999 110.919 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.565 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.38 145.42 26.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.875 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.26 176.46 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 71.5 110.915 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.95 116.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 111.121 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.120000000000005 110.831 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.939 0.4 . . . . 51.539999999999999 110.837 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.42 -167.48 28.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 54.530000000000001 112.479 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.15 -176.75 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 73.329999999999998 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.3 -49.93 30.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 63.020000000000003 110.927 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.6 23.67 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.888 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.03 155.43 58.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 72.439999999999998 110.878 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.69 2.26 . . . . 73.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -145.41 65.75 11.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 70.299999999999997 110.842 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.87 17.72 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.721 2.281 . . . . 71.530000000000001 112.312 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.27 31.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.25 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.51 117.92 10.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 45.229999999999997 110.838 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -136.57 159.48 70.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 71.420000000000002 110.893 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.261 . . . . 51.240000000000002 112.338 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.01 -8.94 29.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.74 . . . . 65.409999999999997 112.451 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -158.22 84.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 73.129999999999995 110.853 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -96.05 162.35 13.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 75.239999999999995 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.32 21.46 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.329999999999998 111.152 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -113.13 145.22 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 71.400000000000006 110.876 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.61 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.11 -177.23 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 33.5 110.889 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 tt -61.29 142.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.310000000000002 111.171 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.9 31.03 67.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 53.0 112.511 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.0 mt -133.62 169.74 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.29 . . . . 62.409999999999997 110.907 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.59 145.72 26.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.905 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.68 111.73 24.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.519999999999996 110.897 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HB2' HD11 ' A' ' 31' ' ' LEU . 26.2 mmt180 -148.97 147.59 28.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.883 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.48 35.82 11.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 110.953 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.78 56.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 63.539999999999999 112.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -143.86 166.97 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.794 0.331 . . . . 70.439999999999998 110.939 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.51 145.44 26.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.91 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.29 176.45 9.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.887 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.93 116.4 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 60.439999999999998 111.161 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.219999999999999 110.882 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.837 0.351 . . . . 61.439999999999998 110.863 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.99 -167.96 29.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 74.349999999999994 112.468 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.61 5.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 62.009999999999998 110.861 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.452 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.25 -50.1 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 53.43 110.915 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.52 23.69 9.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.838 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 155.39 57.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.721 . . . . 73.510000000000005 110.855 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 159.05 54.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.276 . . . . 64.219999999999999 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.76 65.62 11.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.737 . . . . 75.310000000000002 110.879 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -32.73 17.68 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 63.409999999999997 112.331 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -95.25 31.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 110.878 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 117.93 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.872 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -136.31 159.5 70.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 64.140000000000001 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 105.56 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.712 2.274 . . . . 61.530000000000001 112.396 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.01 29.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 73.530000000000001 112.507 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -158.19 84.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -96.16 162.58 13.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.299999999999997 110.876 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.44 21.73 6.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 62.149999999999999 111.186 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.2 m -113.18 145.33 41.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 110.908 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.605 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.01 -175.57 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 63.229999999999997 110.873 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.49 143.17 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 54.039999999999999 111.161 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 31.3 70.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 72.329999999999998 112.475 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.2 mt -133.14 169.64 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 73.349999999999994 110.921 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.68 145.77 26.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.901 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.8 111.77 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 73.239999999999995 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' HD11 ' A' ' 31' ' ' LEU . 16.0 mmt180 -149.0 147.65 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 54.130000000000003 110.867 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.47 35.79 11.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 70.319999999999993 110.933 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.76 56.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 32.210000000000001 112.489 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -143.79 167.0 23.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.150000000000006 110.882 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.54 145.84 25.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.319999999999993 110.857 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.53 176.45 10.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 70.409999999999997 110.892 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -76.12 116.39 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.299999999999997 111.142 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.040000000000006 110.894 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.6 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.909 0.385 . . . . 71.010000000000005 110.867 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.24 -167.47 29.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 54.049999999999997 112.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.81 5.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 64.310000000000002 110.856 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.25 -49.86 31.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 45.549999999999997 110.917 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.71 23.68 9.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.200000000000003 110.837 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.97 155.25 58.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.56 0.695 . . . . 75.109999999999999 110.879 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 158.55 56.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 70.510000000000005 112.325 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.27 65.63 11.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.573 0.702 . . . . 72.439999999999998 110.866 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.8 17.87 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.634 2.223 . . . . 64.120000000000005 112.36 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -95.3 31.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.51 117.96 10.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 61.240000000000002 110.828 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 8.8 ptm180 -135.76 159.5 71.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.57 0.7 . . . . 64.030000000000001 110.896 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.622 2.215 . . . . 62.149999999999999 112.339 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.5 29.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 63.219999999999999 112.503 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.09 84.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 72.540000000000006 110.869 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -96.1 162.5 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 p -94.41 21.69 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.149 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.5 m -113.14 145.86 40.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 110.858 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.627 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.8 -175.52 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 73.519999999999996 110.858 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.0 143.66 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 65.530000000000001 111.149 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.83 31.77 73.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.728 . . . . 64.310000000000002 112.432 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 20' ' ' CYS . 93.7 mt -133.78 169.14 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.746 0.308 . . . . 73.140000000000001 110.907 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.57 145.93 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 110.937 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -100.6 111.74 24.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HB2' HD11 ' A' ' 31' ' ' LEU . 10.5 mmt180 -148.95 147.44 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 110.837 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 63.53 35.81 11.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.904 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.85 56.44 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 73.150000000000006 112.45 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -143.85 166.7 24.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 73.420000000000002 110.867 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.559 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.8 t -97.25 145.34 26.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 73.209999999999994 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.08 176.5 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.939 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.91 116.33 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 62.340000000000003 111.14 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 53.43 110.893 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.882 0.372 . . . . 61.210000000000001 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.45 -167.46 28.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 70.109999999999999 112.506 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.3 -176.76 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 72.109999999999999 110.853 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.2 tp -72.35 -49.76 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.916 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -99.67 23.7 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.319999999999993 110.878 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.2 155.55 57.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.577 0.703 . . . . 73.120000000000005 110.915 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 159.79 52.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.681 2.254 . . . . 70.310000000000002 112.328 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.82 65.65 10.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 64.230000000000004 110.863 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.9 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.71 2.274 . . . . 61.030000000000001 112.374 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.32 31.24 2.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 110.929 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.39 117.95 10.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.853 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -135.08 159.37 72.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.732 . . . . 71.299999999999997 110.842 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.77 105.49 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.737 2.291 . . . . 53.240000000000002 112.32 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.33 29.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.694 -0.765 . . . . 71.540000000000006 112.483 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -157.3 84.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 74.150000000000006 110.885 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.1 mtm-85 -96.47 164.16 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 72.540000000000006 110.895 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.54 21.92 6.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 70.310000000000002 111.118 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -112.98 145.43 40.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 73.209999999999994 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.625 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.51 -174.49 3.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 110.858 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.66 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.299999999999997 111.168 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 32.07 76.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 32.039999999999999 112.461 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.625 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.8 mt -133.51 169.11 17.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.754 0.311 . . . . 62.409999999999997 110.902 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.52 146.04 26.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 71.040000000000006 110.936 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.6 t -100.87 111.69 23.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.349999999999994 110.861 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.469 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.6 mmt180 -149.06 147.72 28.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 70.310000000000002 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.52 35.8 11.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 74.439999999999998 110.931 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.63 55.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 72.109999999999999 112.515 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 167.56 22.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 72.430000000000007 110.933 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.618 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.91 145.87 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 64.349999999999994 110.888 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.81 176.46 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 70.120000000000005 110.927 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -75.75 116.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 111.171 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 110.892 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.859 0.361 . . . . 63.310000000000002 110.862 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.29 -168.72 30.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 64.099999999999994 112.51 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.65 5.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 73.040000000000006 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.5 tp -72.3 -49.99 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 62.109999999999999 110.873 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.26 23.67 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.833 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.92 155.93 55.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 62.240000000000002 110.816 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 163.94 36.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 70.140000000000001 112.298 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 p -151.13 64.93 6.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.73 . . . . 74.430000000000007 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.39 18.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 65.420000000000002 112.385 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -95.0 31.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 110.896 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.98 117.93 11.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 53.009999999999998 110.879 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -135.45 159.51 71.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.646 0.736 . . . . 74.010000000000005 110.858 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 105.58 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 60.450000000000003 112.31 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.02 29.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.769 . . . . 52.409999999999997 112.504 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -158.17 84.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 71.209999999999994 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -96.04 162.86 13.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 110.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.45 21.83 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.166 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.2 m -112.84 145.07 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.583 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.17 -171.94 1.89 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 62.329999999999998 110.876 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -64.73 145.52 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.329999999999998 111.12 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.65 84.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 72.129999999999995 112.482 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.583 HD12 ' H ' ' A' ' 20' ' ' CYS . 77.0 mt -132.64 169.62 16.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.705 0.288 . . . . 62.340000000000003 110.93 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -150.5 147.25 27.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.884 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.99 112.06 24.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 53.020000000000003 110.899 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.543 ' HB2' HD11 ' A' ' 31' ' ' LEU . 25.8 mmt180 -148.56 147.45 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 65.230000000000004 110.877 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 63.54 36.29 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 61.329999999999998 110.952 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.5 12.33 55.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 74.420000000000002 112.487 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.98 178.52 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 73.540000000000006 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.643 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.5 t -107.1 147.49 29.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.873 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.643 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.38 176.49 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 72.239999999999995 110.914 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.27 116.39 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 111.107 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 61.450000000000003 110.875 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.2 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.91 0.386 . . . . 75.120000000000005 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.56 -168.65 30.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 52.25 112.487 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.61 5.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.383 . . . . 71.430000000000007 110.817 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.4 tp -72.3 -50.02 30.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 73.319999999999993 110.92 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -99.25 23.72 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 62.350000000000001 110.902 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.88 155.74 55.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.634 0.731 . . . . 61.299999999999997 110.823 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 164.32 34.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 75.030000000000001 112.32 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 p -152.06 64.83 5.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 64.030000000000001 110.879 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -32.31 18.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.271 . . . . 61.009999999999998 112.373 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -94.99 31.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.86 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.05 117.95 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.899 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 4.5 ptt-85 -134.14 159.54 71.97 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 64.010000000000005 110.859 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.8 105.32 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 62.149999999999999 112.308 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.96 -8.56 29.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 53.32 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -158.09 84.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 72.209999999999994 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.06 163.06 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.834 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.51 22.19 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 111.117 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.9 m -112.93 145.55 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.584 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.64 -171.93 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.310000000000002 110.876 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.64 145.51 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 111.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.14 33.0 85.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 72.129999999999995 112.487 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.584 HD12 ' H ' ' A' ' 20' ' ' CYS . 76.6 mt -133.03 169.57 16.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 64.349999999999994 110.917 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -150.45 147.3 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.430000000000007 110.897 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -101.07 112.1 24.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.538 ' HB2' HD11 ' A' ' 31' ' ' LEU . 35.3 mmt180 -148.54 147.5 29.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 110.848 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 63.5 36.32 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 71.400000000000006 110.954 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.46 12.34 55.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 63.100000000000001 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -141.87 178.54 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 74.400000000000006 110.932 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.643 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.6 t -107.21 147.5 30.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 43.149999999999999 110.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.643 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.35 176.39 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 110.91 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.17 116.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 72.299999999999997 111.114 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 70.209999999999994 110.872 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.906 0.384 . . . . 70.0 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.15 -168.84 30.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 71.349999999999994 112.539 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.41 -176.63 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 54.43 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.443 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.6 tp -72.2 -50.18 29.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 74.310000000000002 110.927 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.06 23.6 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.882 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.02 156.28 54.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.568 0.699 . . . . 73.209999999999994 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 164.86 33.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.644 2.229 . . . . 74.019999999999996 112.351 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.2 p -151.97 65.07 6.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.657 0.742 . . . . 61.049999999999997 110.938 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.52 18.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.723 2.282 . . . . 74.150000000000006 112.344 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -95.19 31.35 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 65.299999999999997 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.039999999999999 110.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 159.76 68.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.645 0.736 . . . . 64.549999999999997 110.901 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 106.53 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 72.109999999999999 112.377 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.12 29.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 53.340000000000003 112.531 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -158.21 84.76 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 71.140000000000001 110.866 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -96.6 162.62 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 110.913 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.4 21.53 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 62.350000000000001 111.086 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.3 m -112.96 144.67 42.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 51.030000000000001 110.871 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.579 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.91 -171.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 64.409999999999997 110.867 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.07 145.89 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 71.319999999999993 111.152 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 32.78 85.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 64.540000000000006 112.43 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.579 HD12 ' H ' ' A' ' 20' ' ' CYS . 73.7 mt -132.35 169.42 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 74.310000000000002 110.882 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -150.61 147.09 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 110.91 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -100.71 112.13 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.439999999999998 110.865 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.548 ' HB2' HD11 ' A' ' 31' ' ' LEU . 19.4 mmt180 -148.67 147.48 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 62.329999999999998 110.874 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.5 36.34 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 110.94 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.52 12.36 55.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.495 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.07 178.52 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 73.209999999999994 110.917 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.64 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.3 t -107.04 147.67 29.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.851 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.48 176.46 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.881 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.7 p -77.31 116.48 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 62.219999999999999 111.134 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 64.439999999999998 110.866 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.846 0.355 . . . . 65.120000000000005 110.896 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.97 -170.86 41.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 43.420000000000002 112.484 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -89.41 -172.94 3.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 71.319999999999993 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 23' ' ' LEU . 7.3 tp -72.72 -56.07 5.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.884 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.28 23.64 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 60.329999999999998 110.893 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.97 154.43 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 73.5 110.836 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 156.31 63.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 62.310000000000002 112.343 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.64 65.57 14.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.649 0.737 . . . . 61.32 110.903 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -31.94 19.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.683 2.256 . . . . 64.430000000000007 112.324 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -94.97 31.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 71.450000000000003 110.846 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.21 117.91 11.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -134.62 159.35 72.54 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.613 0.721 . . . . 71.219999999999999 110.893 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 105.16 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 71.319999999999993 112.35 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.1 29.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 51.149999999999999 112.531 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -158.2 84.54 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 60.43 110.837 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 -93.95 162.3 13.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 110.873 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -94.73 23.18 5.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.540000000000006 111.152 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 91.0 m -113.6 148.11 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 55.030000000000001 110.892 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.1 -178.95 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.877 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.85 139.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 52.240000000000002 111.148 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.69 32.28 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 62.329999999999998 112.48 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.575 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.5 mt -135.05 170.81 15.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 60.229999999999997 110.928 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.77 145.06 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.019999999999996 110.924 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -100.8 112.05 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.918 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HB2' HD11 ' A' ' 31' ' ' LEU . 32.2 mmt180 -148.23 147.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.030000000000001 110.885 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 63.33 35.73 12.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 110.904 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.05 56.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 73.329999999999998 112.501 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -143.45 165.61 27.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 72.219999999999999 110.873 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.537 ' C ' HD23 ' A' ' 31' ' ' LEU . 12.1 t -96.71 145.21 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 65.230000000000004 110.907 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.85 176.45 9.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.010000000000005 110.952 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -74.92 116.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 71.109999999999999 111.169 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 71.450000000000003 110.811 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.5 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.877 0.37 . . . . 72.209999999999994 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.87 -167.47 29.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 14.02 112.468 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -89.25 -176.92 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 71.439999999999998 110.843 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.471 HD13 ' CD2' ' A' ' 23' ' ' LEU . 5.9 tp -72.24 -49.82 32.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 73.099999999999994 110.927 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -99.87 23.77 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.019999999999996 110.829 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.49 154.36 59.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 158.67 56.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.229 . . . . 71.120000000000005 112.368 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -146.41 65.15 10.19 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.621 0.724 . . . . 74.230000000000004 110.87 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.647 2.231 . . . . 72.200000000000003 112.352 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -94.96 31.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.26 117.85 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.030000000000001 110.855 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 12.0 ptt180 -130.33 159.77 68.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 72.239999999999995 110.87 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 104.01 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 70.230000000000004 112.332 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -6.28 29.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 61.219999999999999 112.461 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.24 87.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 61.219999999999999 110.849 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -97.93 162.78 13.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 110.908 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 p -94.7 23.54 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.439999999999998 111.15 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.0 m -112.95 146.67 38.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 70.420000000000002 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.614 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.36 -177.15 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.200000000000003 110.869 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 22' ' ' GLY . 6.6 tp -60.87 142.48 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.200000000000003 111.143 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' H ' HD12 ' A' ' 21' ' ' ILE . . . 70.39 31.81 68.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 60.439999999999998 112.489 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.614 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.9 mt -134.79 169.51 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 42.439999999999998 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -150.47 146.44 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 64.430000000000007 110.957 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.7 t -101.21 111.69 23.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 74.200000000000003 110.905 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.7 mmt-85 -149.17 147.84 28.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.838 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.46 35.81 11.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 73.230000000000004 110.938 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.66 55.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 62.399999999999999 112.49 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -143.78 167.56 22.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 64.219999999999999 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.621 ' C ' HD23 ' A' ' 31' ' ' LEU . 6.0 t -98.12 145.19 26.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.912 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.64 176.43 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 110.904 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -76.66 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 64.129999999999995 111.106 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 54.100000000000001 110.882 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.1 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.904 0.383 . . . . 73.540000000000006 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.99 -170.05 32.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 32.240000000000002 112.525 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.57 -175.61 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 72.340000000000003 110.838 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.88 -53.98 11.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.927 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.78 23.41 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 71.420000000000002 110.832 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.8 154.96 58.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 73.310000000000002 110.862 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 161.64 45.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.709 2.273 . . . . 65.310000000000002 112.354 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.13 65.65 8.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.626 0.727 . . . . 61.100000000000001 110.9 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.69 17.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 74.310000000000002 112.347 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.2 31.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 72.319999999999993 110.855 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.36 117.95 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.852 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -136.71 159.43 70.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 73.430000000000007 110.904 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 105.41 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 70.329999999999998 112.351 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.27 29.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.717 . . . . 73.439999999999998 112.528 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.842 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -95.51 162.46 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.140000000000001 110.844 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.6 22.35 6.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.137 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.0 m -113.71 148.85 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.109999999999999 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.567 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.65 -171.59 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 51.119999999999997 110.891 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 tt -64.8 145.34 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 71.219999999999999 111.128 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.8 32.93 84.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.711 -0.756 . . . . 60.43 112.481 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.567 HD12 ' H ' ' A' ' 20' ' ' CYS . 68.7 mt -133.75 168.51 18.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 72.209999999999994 110.955 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.8 tt0 -150.88 146.18 26.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 63.43 110.932 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.23 112.02 24.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.869 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HB2' HD11 ' A' ' 31' ' ' LEU . 20.9 mmt85 -148.76 148.02 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.439999999999998 110.835 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.33 35.84 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 71.540000000000006 110.919 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.58 55.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 53.100000000000001 112.504 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -143.32 167.61 21.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.371 . . . . 73.420000000000002 110.858 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.611 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.6 t -97.6 146.65 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 44.409999999999997 110.887 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.611 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.21 175.09 11.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.923 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.498 HG23 HD11 ' A' ' 5' ' ' LEU . 84.9 t -72.36 116.9 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 71.120000000000005 111.127 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 64.140000000000001 110.885 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.87 0.367 . . . . 72.319999999999993 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.19 -169.96 32.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 61.43 112.526 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -89.65 -175.6 4.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 72.200000000000003 110.844 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.86 -54.07 11.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 110.945 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.72 23.42 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 71.400000000000006 110.838 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 154.9 58.86 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.572 0.701 . . . . 74.25 110.898 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 161.64 45.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.693 2.262 . . . . 52.439999999999998 112.285 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.24 65.58 8.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.723 . . . . 71.040000000000006 110.909 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.75 18.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.69 2.26 . . . . 73.209999999999994 112.359 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.13 31.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.32 117.96 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 70.209999999999994 110.875 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -136.46 159.44 70.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 70.010000000000005 110.857 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 105.37 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 72.099999999999994 112.318 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.3 29.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 53.219999999999999 112.488 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -158.17 84.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 72.25 110.899 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -95.47 162.6 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 72.239999999999995 110.881 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -94.52 22.28 6.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.154 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.0 m -113.62 148.95 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 61.130000000000003 110.899 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.75 -171.74 2.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.862 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.72 145.13 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.0 84.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 71.420000000000002 112.499 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.573 HD12 ' H ' ' A' ' 20' ' ' CYS . 69.0 mt -133.89 168.59 18.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 74.019999999999996 110.894 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.9 tt0 -150.85 146.23 26.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 110.947 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -100.31 112.09 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.420000000000002 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' A' ' 31' ' ' LEU . 29.3 mmt180 -148.72 148.09 29.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 64.140000000000001 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.35 35.79 12.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 63.399999999999999 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.51 55.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 70.340000000000003 112.474 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -143.32 167.64 21.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 62.350000000000001 110.88 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.616 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.7 t -97.6 146.62 25.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 64.549999999999997 110.861 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.22 175.14 11.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 110.916 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 5' ' ' LEU . 85.4 t -72.5 116.89 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 72.150000000000006 111.151 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.853 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.845 0.355 . . . . 72.209999999999994 110.927 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.66 -170.18 32.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.455 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.55 -175.5 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 71.430000000000007 110.887 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.94 -54.11 10.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.911 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -95.69 23.43 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.827 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.68 154.89 59.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.562 0.696 . . . . 72.519999999999996 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.91 47.94 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.656 2.237 . . . . 74.430000000000007 112.339 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -147.32 65.54 9.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 61.109999999999999 110.882 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -32.71 17.95 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 62.310000000000002 112.332 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.886 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.57 117.99 11.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 64.200000000000003 110.85 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -136.83 159.48 70.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.635 0.731 . . . . 72.310000000000002 110.86 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 105.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.633 2.222 . . . . 74.219999999999999 112.318 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.94 -8.43 29.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 62.530000000000001 112.472 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 110.813 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -95.62 162.26 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.846 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.59 22.29 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 65.140000000000001 111.132 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.8 m -113.63 148.65 35.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.901 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.49 -171.34 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 72.030000000000001 110.884 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.98 145.63 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 111.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.51 32.78 84.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 35.530000000000001 112.466 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD12 ' H ' ' A' ' 20' ' ' CYS . 68.9 mt -133.46 168.31 18.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 64.030000000000001 110.919 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.8 tt0 -150.92 146.05 26.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.923 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.3 t -99.89 112.06 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HB2' HD11 ' A' ' 31' ' ' LEU . 10.8 mmt180 -148.62 147.9 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 55.240000000000002 110.874 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.3 35.77 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 71.310000000000002 110.925 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.66 55.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.130000000000003 112.444 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -143.35 167.32 22.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.35 . . . . 72.349999999999994 110.873 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.601 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.5 t -97.36 146.53 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 74.209999999999994 110.876 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.06 175.44 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 110.89 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 5' ' ' LEU . 84.9 t -72.68 116.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 71.540000000000006 111.099 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.310000000000002 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.852 0.358 . . . . 53.210000000000001 110.91 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.38 -171.23 37.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 74.510000000000005 112.49 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.23 -172.89 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 72.299999999999997 110.838 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.8 tp -72.62 -56.14 5.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.944 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -95.24 23.58 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 72.540000000000006 110.854 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.77 154.24 61.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.319999999999993 110.865 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 156.18 64.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.697 2.265 . . . . 74.109999999999999 112.325 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.58 65.56 14.69 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 63.329999999999998 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.1 19.16 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 75.030000000000001 112.367 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -94.93 31.3 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 110.895 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.99 117.89 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.109999999999999 110.887 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -133.23 159.3 73.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.582 0.706 . . . . 74.439999999999998 110.857 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 104.85 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.510000000000005 112.354 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.77 -7.45 29.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.788 -0.72 . . . . 61.350000000000001 112.472 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -158.14 84.7 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 75.349999999999994 110.839 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -93.21 162.29 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.894 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.1 p -94.83 24.31 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 51.439999999999998 111.138 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.8 m -113.42 151.26 31.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.099999999999994 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.613 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -81.05 -179.9 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.889 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -59.36 138.29 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 111.088 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.63 35.64 55.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 71.129999999999995 112.448 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 20' ' ' CYS . 92.5 mt -138.01 170.61 15.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.793 0.33 . . . . 71.340000000000003 110.876 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -150.85 144.12 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 64.109999999999999 110.911 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.72 112.18 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.409999999999997 110.925 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HB2' HD11 ' A' ' 31' ' ' LEU . 3.0 mmt180 -148.06 147.74 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 74.239999999999995 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.41 35.84 11.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.923 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.14 13.05 57.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 72.109999999999999 112.486 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -143.75 165.44 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 63.340000000000003 110.884 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.528 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.0 t -96.32 145.02 25.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 55.509999999999998 110.848 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.63 176.41 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.230000000000004 110.931 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.4 p -74.88 116.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 64.200000000000003 110.847 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.91 0.386 . . . . 71.409999999999997 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.99 -169.88 39.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 44.350000000000001 112.482 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.47 -173.51 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 65.109999999999999 110.864 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 23' ' ' LEU . 7.1 tp -72.81 -54.99 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 65.299999999999997 110.921 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.95 23.63 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 75.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.16 154.58 60.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.602 0.715 . . . . 73.129999999999995 110.855 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.26 63.89 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 2.23 . . . . 75.299999999999997 112.308 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -143.22 65.41 15.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 73.349999999999994 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -32.16 19.07 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.673 2.249 . . . . 73.420000000000002 112.344 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -94.93 31.38 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.864 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 63.32 110.845 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -135.28 159.34 72.16 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 74.540000000000006 110.849 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 54.299999999999997 112.346 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 -8.28 29.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 71.319999999999993 112.498 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -158.15 84.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 74.340000000000003 110.87 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -94.27 162.18 13.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 70.120000000000005 110.875 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.85 23.39 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 54.520000000000003 111.134 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.0 m -114.13 147.73 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.239999999999995 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.588 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.54 -178.56 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.230000000000004 110.888 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.2 tt -60.55 140.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 63.329999999999998 111.13 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.65 32.61 61.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.75 . . . . 72.299999999999997 112.535 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.0 mt -135.44 170.14 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 63.310000000000002 110.912 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.79 144.99 25.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.200000000000003 110.936 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -100.1 112.05 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.884 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.3 mmt-85 -148.63 147.92 29.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.886 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 63.45 35.79 11.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.942 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.06 12.87 56.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 51.130000000000003 112.531 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -143.64 166.96 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 71.040000000000006 110.853 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.59 ' C ' HD23 ' A' ' 31' ' ' LEU . 10.8 t -97.48 144.96 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 110.86 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.46 176.43 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 72.010000000000005 110.898 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.24 115.94 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 72.230000000000004 111.154 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.230000000000004 110.872 -179.925 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.846 0.355 . . . . 73.540000000000006 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.12 165.33 27.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 73.219999999999999 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.91 29.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.200000000000003 112.492 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.61 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 74.450000000000003 110.826 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.2 tp -72.29 -50.0 30.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 61.310000000000002 110.958 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.54 23.69 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.010000000000005 110.845 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.18 155.43 57.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.561 0.696 . . . . 71.349999999999994 110.894 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 159.79 52.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.252 . . . . 75.049999999999997 112.351 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.5 65.67 10.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 71.420000000000002 110.888 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -32.8 17.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 74.239999999999995 112.363 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -95.19 31.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 71.209999999999994 110.881 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.55 117.93 10.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 70.140000000000001 110.888 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -136.35 159.55 70.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 75.319999999999993 110.892 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 105.61 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.716 2.278 . . . . 64.200000000000003 112.257 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.0 29.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.715 -0.755 . . . . 12.529999999999999 112.477 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -158.21 84.55 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 75.420000000000002 110.847 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.2 mtm-85 -96.18 162.6 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 61.340000000000003 110.848 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.4 21.73 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 61.509999999999998 111.145 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -113.17 145.22 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.899 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.6 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.85 -175.63 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 110.848 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 tt -62.45 142.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 72.329999999999998 111.117 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.41 70.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 34.530000000000001 112.471 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.5 mt -133.28 169.65 16.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 52.43 110.873 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.63 145.78 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 63.539999999999999 110.93 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.82 111.76 24.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' HD11 ' A' ' 31' ' ' LEU . 27.6 mmt180 -149.16 147.84 28.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 64.109999999999999 110.875 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.51 35.77 11.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 55.520000000000003 110.923 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.76 56.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 43.340000000000003 112.517 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -143.89 167.52 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 65.030000000000001 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.619 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.95 145.95 25.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.887 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.619 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.72 176.45 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 71.219999999999999 110.875 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.98 116.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 61.32 111.136 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 54.530000000000001 110.931 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.886 0.374 . . . . 74.230000000000004 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p -133.14 165.24 25.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.895 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.86 29.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 74.409999999999997 112.566 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.24 -176.6 5.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 74.219999999999999 110.842 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.29 -50.14 29.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 50.539999999999999 110.9 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.5 23.76 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.11 155.29 57.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 75.420000000000002 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.76 52.2 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.654 2.236 . . . . 64.329999999999998 112.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -146.6 65.64 10.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.592 0.711 . . . . 53.399999999999999 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.72 17.75 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 64.420000000000002 112.301 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -95.14 31.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 75.219999999999999 110.875 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.57 117.96 10.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 62.130000000000003 110.885 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.58 159.49 71.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 73.5 110.886 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 73.25 112.347 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.52 29.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 32.039999999999999 112.508 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -158.05 84.52 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 72.319999999999993 110.866 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -96.13 162.49 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 75.450000000000003 110.898 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -94.48 22.11 6.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.019999999999996 111.136 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.5 m -113.15 145.6 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.854 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.606 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.26 -175.88 3.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 44.450000000000003 110.902 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.19 142.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 72.129999999999995 111.158 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.61 70.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 73.329999999999998 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.606 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.5 mt -133.62 169.56 16.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.746 0.308 . . . . 75.510000000000005 110.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.62 145.82 26.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 62.340000000000003 110.904 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.77 111.69 23.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 110.877 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' HD11 ' A' ' 31' ' ' LEU . 12.5 mmt180 -149.08 147.81 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 110.885 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.53 35.78 11.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.89 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.74 56.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.761 -0.733 . . . . 54.329999999999998 112.498 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 167.39 22.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 63.549999999999997 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.615 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.89 145.86 26.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 110.862 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.64 176.46 10.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 75.129999999999995 110.865 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.96 116.46 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 42.340000000000003 111.16 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 73.099999999999994 110.863 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 t0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.854 0.359 . . . . 71.109999999999999 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.5 p -139.78 165.21 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 60.020000000000003 110.861 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.4 -167.39 28.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 74.239999999999995 112.464 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.78 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 73.310000000000002 110.832 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.0 tp -72.31 -49.92 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.200000000000003 110.927 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.56 23.69 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.897 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.07 155.29 58.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 61.039999999999999 110.833 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 159.14 54.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.666 2.244 . . . . 73.430000000000007 112.33 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.91 65.64 11.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.664 0.745 . . . . 50.329999999999998 110.915 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.79 17.89 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 71.439999999999998 112.363 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -95.2 31.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.42 117.92 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.914 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 10.9 ptm180 -135.75 159.55 70.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.701 . . . . 72.450000000000003 110.841 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.5 Cg_endo -69.78 105.31 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.664 2.242 . . . . 74.409999999999997 112.344 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.56 29.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 65.230000000000004 112.424 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -158.05 84.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -96.21 162.48 13.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.209999999999994 110.842 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -94.4 21.77 6.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 73.439999999999998 111.156 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -112.98 145.38 40.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 72.340000000000003 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.612 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.34 -177.29 4.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 75.409999999999997 110.879 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.8 tt -61.16 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 62.030000000000001 111.087 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.94 31.36 67.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 43.219999999999999 112.481 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 20' ' ' CYS . 94.7 mt -133.92 169.74 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 70.040000000000006 110.877 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.6 145.79 26.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 70.519999999999996 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.76 111.72 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 110.882 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' HD11 ' A' ' 31' ' ' LEU . 39.2 mmt180 -149.05 147.74 28.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 70.019999999999996 110.902 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.51 35.77 11.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 65.420000000000002 110.934 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.71 56.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.409999999999997 112.481 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.9 167.23 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 61.119999999999997 110.9 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.607 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.8 145.52 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 75.400000000000006 110.896 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.47 176.45 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.349999999999994 110.92 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.75 116.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 63.229999999999997 111.078 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 61.409999999999997 110.897 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 53.119999999999997 110.859 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.97 165.33 27.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 62.020000000000003 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 -167.99 29.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 55.439999999999998 112.497 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.19 -176.71 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 54.240000000000002 110.87 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.24 -50.14 29.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 110.9 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.48 23.73 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 72.219999999999999 110.885 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.06 155.31 58.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 73.239999999999995 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 159.74 52.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 61.25 112.357 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.59 65.67 10.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 64.129999999999995 110.879 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.75 17.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.733 2.288 . . . . 75.450000000000003 112.319 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -95.21 31.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.140000000000001 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.65 117.95 11.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 64.109999999999999 110.86 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 1.2 ptt180 -135.73 159.49 71.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 74.430000000000007 110.909 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.1 Cg_endo -69.78 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.244 . . . . 60.240000000000002 112.348 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.02 -8.63 29.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.399999999999999 112.487 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -158.04 84.49 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 65.430000000000007 110.881 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -96.19 162.51 13.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 63.530000000000001 110.886 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -94.45 21.95 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 111.139 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -113.08 145.59 40.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.420000000000002 110.92 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.604 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.17 -175.73 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.915 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.34 142.89 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 65.129999999999995 111.139 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.67 31.56 70.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 75.310000000000002 112.519 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.1 mt -133.46 169.59 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 65.209999999999994 110.886 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.6 145.81 26.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 64.409999999999997 110.9 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -100.81 111.72 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 71.299999999999997 110.857 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HB2' HD11 ' A' ' 31' ' ' LEU . 19.2 mmt180 -149.08 147.84 28.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.510000000000005 110.895 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.47 35.85 11.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.935 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.07 12.73 55.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.741 -0.742 . . . . 71.120000000000005 112.553 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -143.9 167.41 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 74.230000000000004 110.893 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.615 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.92 145.95 25.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.865 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.66 176.42 10.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 74.030000000000001 110.882 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.97 116.46 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 54.240000000000002 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 110.9 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.844 0.354 . . . . 60.130000000000003 110.865 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.2 p -140.39 165.26 27.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.896 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.44 -167.36 28.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.487 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 75.209999999999994 110.814 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.26 -49.89 31.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 71.430000000000007 110.907 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.73 23.72 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.099999999999994 110.863 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 155.51 57.96 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.612 0.72 . . . . 74.140000000000001 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.7 56.03 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.691 2.261 . . . . 74.230000000000004 112.341 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.43 65.67 11.7 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 110.859 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.79 17.66 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 71.099999999999994 112.338 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 60.25 110.879 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.53 117.98 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 61.229999999999997 110.819 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -136.58 159.52 70.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.606 0.717 . . . . 73.129999999999995 110.883 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.66 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.646 2.231 . . . . 74.549999999999997 112.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 -9.08 29.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 51.399999999999999 112.483 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -158.17 84.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 74.230000000000004 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -96.19 162.47 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 110.862 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.35 21.39 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.219999999999999 111.154 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -113.02 145.28 41.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 65.540000000000006 110.912 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.612 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.23 -177.04 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 53.130000000000003 110.902 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.32 142.46 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 71.310000000000002 111.126 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.24 68.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 61.530000000000001 112.542 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.4 mt -133.68 169.6 16.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 64.319999999999993 110.951 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.58 145.7 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.399999999999999 110.932 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.63 111.77 24.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.856 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HB2' HD11 ' A' ' 31' ' ' LEU . 37.5 mmt180 -149.05 147.51 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 74.099999999999994 110.851 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.58 35.74 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 64.109999999999999 110.928 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.83 56.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 63.420000000000002 112.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -143.84 166.8 23.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 70.040000000000006 110.908 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.562 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.37 145.38 26.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 110.888 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.22 176.46 9.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.931 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.89 116.34 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 65.439999999999998 111.103 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 71.109999999999999 110.899 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.837 0.351 . . . . 63.43 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.82 165.25 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 41.450000000000003 110.851 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.5 -167.47 28.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 61.210000000000001 112.439 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 62.5 110.865 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.26 -49.92 31.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.926 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.69 23.72 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 70.140000000000001 110.845 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 155.39 57.91 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.592 0.711 . . . . 62.539999999999999 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 158.72 56.01 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.236 . . . . 64.049999999999997 112.375 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.1 p -145.39 65.73 11.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 70.219999999999999 110.864 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.89 17.73 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.71 2.273 . . . . 61.229999999999997 112.329 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -95.22 31.22 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 41.439999999999998 110.943 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -68.43 117.94 10.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 65.120000000000005 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.59 159.49 70.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.585 0.707 . . . . 74.400000000000006 110.899 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 75.019999999999996 112.329 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.96 29.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 71.150000000000006 112.504 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -158.18 84.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.769 0.319 . . . . 64.200000000000003 110.894 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -96.14 162.46 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 110.843 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.41 21.62 6.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 60.140000000000001 111.079 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.6 m -113.21 145.26 41.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 73.409999999999997 110.885 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.615 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.2 -177.43 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 65.519999999999996 110.915 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.19 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 71.219999999999999 111.148 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.18 31.04 66.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.736 . . . . 30.030000000000001 112.491 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.615 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.8 mt -133.68 169.72 16.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 74.549999999999997 110.919 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -150.56 145.63 26.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 52.210000000000001 110.905 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.6 111.75 24.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.040000000000006 110.872 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' HD11 ' A' ' 31' ' ' LEU . 21.4 mmt180 -148.96 147.58 28.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 73.230000000000004 110.867 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.47 35.81 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.219999999999999 110.93 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.09 12.84 56.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 63.240000000000002 112.486 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -143.85 166.85 23.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.332 . . . . 74.109999999999999 110.919 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.565 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.38 145.42 26.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.875 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.26 176.46 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 71.5 110.915 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.95 116.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 111.121 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.120000000000005 110.831 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.888 0.375 . . . . 64.150000000000006 110.905 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p -139.81 165.21 27.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 51.539999999999999 110.837 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.42 -167.48 28.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 54.530000000000001 112.479 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.15 -176.75 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 73.329999999999998 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.3 -49.93 30.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 63.020000000000003 110.927 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.6 23.67 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.888 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.03 155.43 58.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 72.439999999999998 110.878 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.69 2.26 . . . . 73.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -145.41 65.75 11.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 70.299999999999997 110.842 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.87 17.72 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.721 2.281 . . . . 71.530000000000001 112.312 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.27 31.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.25 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.51 117.92 10.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 45.229999999999997 110.838 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -136.57 159.48 70.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 71.420000000000002 110.893 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.261 . . . . 51.240000000000002 112.338 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.01 -8.94 29.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.74 . . . . 65.409999999999997 112.451 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -158.22 84.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 73.129999999999995 110.853 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -96.05 162.35 13.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 75.239999999999995 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.32 21.46 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.329999999999998 111.152 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -113.13 145.22 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 71.400000000000006 110.876 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.61 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.11 -177.23 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 33.5 110.889 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 tt -61.29 142.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.310000000000002 111.171 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.9 31.03 67.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 53.0 112.511 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.0 mt -133.62 169.74 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.29 . . . . 62.409999999999997 110.907 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.59 145.72 26.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.905 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.68 111.73 24.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.519999999999996 110.897 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HB2' HD11 ' A' ' 31' ' ' LEU . 26.2 mmt180 -148.97 147.59 28.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 71.439999999999998 110.883 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.48 35.82 11.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 110.953 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.78 56.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 63.539999999999999 112.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -143.86 166.97 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.794 0.331 . . . . 70.439999999999998 110.939 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.51 145.44 26.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.91 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.29 176.45 9.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.887 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.93 116.4 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 60.439999999999998 111.161 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.219999999999999 110.882 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.826 0.346 . . . . 70.209999999999994 110.885 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.51 165.31 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 61.439999999999998 110.863 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.99 -167.96 29.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 74.349999999999994 112.468 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.61 5.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 62.009999999999998 110.861 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.452 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.25 -50.1 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 53.43 110.915 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.52 23.69 9.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 110.838 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 155.39 57.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.721 . . . . 73.510000000000005 110.855 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 159.05 54.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.276 . . . . 64.219999999999999 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.76 65.62 11.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.737 . . . . 75.310000000000002 110.879 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -32.73 17.68 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 63.409999999999997 112.331 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -95.25 31.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 74.319999999999993 110.878 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 117.93 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.872 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -136.31 159.5 70.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 64.140000000000001 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 105.56 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.712 2.274 . . . . 61.530000000000001 112.396 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.01 29.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 73.530000000000001 112.507 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -158.19 84.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -96.16 162.58 13.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.299999999999997 110.876 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.44 21.73 6.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 62.149999999999999 111.186 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.2 m -113.18 145.33 41.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 110.908 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.605 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.01 -175.57 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 63.229999999999997 110.873 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.49 143.17 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 54.039999999999999 111.161 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 31.3 70.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 72.329999999999998 112.475 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.2 mt -133.14 169.64 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 73.349999999999994 110.921 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.68 145.77 26.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.901 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.8 111.77 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 73.239999999999995 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' HD11 ' A' ' 31' ' ' LEU . 16.0 mmt180 -149.0 147.65 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 54.130000000000003 110.867 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.47 35.79 11.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 70.319999999999993 110.933 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.76 56.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 32.210000000000001 112.489 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -143.79 167.0 23.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.150000000000006 110.882 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.54 145.84 25.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.319999999999993 110.857 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.53 176.45 10.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 70.409999999999997 110.892 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -76.12 116.39 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.299999999999997 111.142 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.040000000000006 110.894 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.82 0.343 . . . . 64.129999999999995 110.872 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.6 p -139.87 165.1 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 110.867 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.24 -167.47 29.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 54.049999999999997 112.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.81 5.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 64.310000000000002 110.856 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.25 -49.86 31.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 45.549999999999997 110.917 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.71 23.68 9.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.200000000000003 110.837 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.97 155.25 58.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.56 0.695 . . . . 75.109999999999999 110.879 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 158.55 56.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 70.510000000000005 112.325 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.27 65.63 11.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.573 0.702 . . . . 72.439999999999998 110.866 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.8 17.87 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.634 2.223 . . . . 64.120000000000005 112.36 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -95.3 31.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.51 117.96 10.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 61.240000000000002 110.828 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 8.8 ptm180 -135.76 159.5 71.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.57 0.7 . . . . 64.030000000000001 110.896 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.622 2.215 . . . . 62.149999999999999 112.339 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.5 29.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 63.219999999999999 112.503 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.09 84.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 72.540000000000006 110.869 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -96.1 162.5 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 p -94.41 21.69 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.149 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.5 m -113.14 145.86 40.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 63.520000000000003 110.858 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.627 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.8 -175.52 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 73.519999999999996 110.858 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.0 143.66 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 65.530000000000001 111.149 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.83 31.77 73.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.728 . . . . 64.310000000000002 112.432 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 20' ' ' CYS . 93.7 mt -133.78 169.14 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.746 0.308 . . . . 73.140000000000001 110.907 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.57 145.93 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 110.937 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -100.6 111.74 24.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HB2' HD11 ' A' ' 31' ' ' LEU . 10.5 mmt180 -148.95 147.44 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 110.837 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 63.53 35.81 11.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.904 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.85 56.44 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 73.150000000000006 112.45 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -143.85 166.7 24.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 73.420000000000002 110.867 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.559 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.8 t -97.25 145.34 26.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 73.209999999999994 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.08 176.5 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.939 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.91 116.33 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 62.340000000000003 111.14 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 53.43 110.893 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.849 0.357 . . . . 74.239999999999995 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p -135.65 165.38 25.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 61.210000000000001 110.902 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.45 -167.46 28.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 70.109999999999999 112.506 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.3 -176.76 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 72.109999999999999 110.853 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.2 tp -72.35 -49.76 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.916 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -99.67 23.7 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.319999999999993 110.878 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.2 155.55 57.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.577 0.703 . . . . 73.120000000000005 110.915 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 159.79 52.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.681 2.254 . . . . 70.310000000000002 112.328 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.82 65.65 10.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 64.230000000000004 110.863 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.9 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.71 2.274 . . . . 61.030000000000001 112.374 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.32 31.24 2.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 75.329999999999998 110.929 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.39 117.95 10.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 72.209999999999994 110.853 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -135.08 159.37 72.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.732 . . . . 71.299999999999997 110.842 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.77 105.49 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.737 2.291 . . . . 53.240000000000002 112.32 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.33 29.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.694 -0.765 . . . . 71.540000000000006 112.483 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -157.3 84.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 74.150000000000006 110.885 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.1 mtm-85 -96.47 164.16 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 72.540000000000006 110.895 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.54 21.92 6.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 70.310000000000002 111.118 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -112.98 145.43 40.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 73.209999999999994 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.625 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.51 -174.49 3.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 110.858 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.66 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.299999999999997 111.168 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 32.07 76.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 32.039999999999999 112.461 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.625 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.8 mt -133.51 169.11 17.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.754 0.311 . . . . 62.409999999999997 110.902 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.52 146.04 26.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 71.040000000000006 110.936 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.6 t -100.87 111.69 23.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.349999999999994 110.861 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.469 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.6 mmt180 -149.06 147.72 28.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 70.310000000000002 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.52 35.8 11.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 74.439999999999998 110.931 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.63 55.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 72.109999999999999 112.515 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 167.56 22.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 72.430000000000007 110.933 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.618 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.91 145.87 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 64.349999999999994 110.888 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.81 176.46 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 70.120000000000005 110.927 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -75.75 116.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 75.409999999999997 111.171 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 110.892 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.834 0.35 . . . . 62.119999999999997 110.898 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.25 165.5 16.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.310000000000002 110.862 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.29 -168.72 30.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 64.099999999999994 112.51 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.65 5.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 73.040000000000006 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.5 tp -72.3 -49.99 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 62.109999999999999 110.873 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.26 23.67 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.833 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.92 155.93 55.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 62.240000000000002 110.816 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 163.94 36.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 70.140000000000001 112.298 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 p -151.13 64.93 6.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.73 . . . . 74.430000000000007 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.39 18.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 65.420000000000002 112.385 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -95.0 31.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 110.896 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.98 117.93 11.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 53.009999999999998 110.879 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -135.45 159.51 71.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.646 0.736 . . . . 74.010000000000005 110.858 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 105.58 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 60.450000000000003 112.31 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.02 29.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.769 . . . . 52.409999999999997 112.504 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -158.17 84.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 71.209999999999994 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -96.04 162.86 13.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 64.450000000000003 110.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.45 21.83 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.166 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.2 m -112.84 145.07 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.17 -171.94 1.89 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 62.329999999999998 110.876 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -64.73 145.52 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.329999999999998 111.12 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.65 84.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 72.129999999999995 112.482 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.583 HD12 ' H ' ' A' ' 20' ' ' CYS . 77.0 mt -132.64 169.62 16.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.705 0.288 . . . . 62.340000000000003 110.93 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -150.5 147.25 27.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.884 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.99 112.06 24.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 53.020000000000003 110.899 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.543 ' HB2' HD11 ' A' ' 31' ' ' LEU . 25.8 mmt180 -148.56 147.45 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 65.230000000000004 110.877 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 63.54 36.29 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 61.329999999999998 110.952 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.5 12.33 55.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 74.420000000000002 112.487 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.98 178.52 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 73.540000000000006 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.643 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.5 t -107.1 147.49 29.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.873 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.643 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.38 176.49 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 72.239999999999995 110.914 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.27 116.39 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 111.107 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 61.450000000000003 110.875 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.813 0.34 . . . . 65.319999999999993 110.878 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.2 p -136.47 165.61 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 75.120000000000005 110.857 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.56 -168.65 30.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 52.25 112.487 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.61 5.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.383 . . . . 71.430000000000007 110.817 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.4 tp -72.3 -50.02 30.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 73.319999999999993 110.92 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -99.25 23.72 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 62.350000000000001 110.902 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.88 155.74 55.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.634 0.731 . . . . 61.299999999999997 110.823 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 164.32 34.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 75.030000000000001 112.32 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 p -152.06 64.83 5.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 64.030000000000001 110.879 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -32.31 18.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.271 . . . . 61.009999999999998 112.373 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -94.99 31.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.86 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.05 117.95 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.899 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 4.5 ptt-85 -134.14 159.54 71.97 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 64.010000000000005 110.859 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.8 105.32 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 62.149999999999999 112.308 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.96 -8.56 29.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 53.32 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -158.09 84.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 72.209999999999994 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.06 163.06 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.834 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.51 22.19 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 111.117 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.9 m -112.93 145.55 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 71.400000000000006 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.584 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.64 -171.93 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.310000000000002 110.876 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.64 145.51 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 111.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.14 33.0 85.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 72.129999999999995 112.487 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.584 HD12 ' H ' ' A' ' 20' ' ' CYS . 76.6 mt -133.03 169.57 16.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 64.349999999999994 110.917 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -150.45 147.3 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.430000000000007 110.897 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -101.07 112.1 24.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' HB2' HD11 ' A' ' 31' ' ' LEU . 35.3 mmt180 -148.54 147.5 29.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.109999999999999 110.848 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 63.5 36.32 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 71.400000000000006 110.954 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.46 12.34 55.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 63.100000000000001 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -141.87 178.54 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 74.400000000000006 110.932 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.643 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.6 t -107.21 147.5 30.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 43.149999999999999 110.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.643 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.35 176.39 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 110.91 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.17 116.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 72.299999999999997 111.114 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 70.209999999999994 110.872 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.851 0.358 . . . . 74.540000000000006 110.881 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.0 165.44 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.15 -168.84 30.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 71.349999999999994 112.539 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.41 -176.63 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 54.43 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.443 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.6 tp -72.2 -50.18 29.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 74.310000000000002 110.927 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.06 23.6 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.200000000000003 110.882 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.02 156.28 54.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.568 0.699 . . . . 73.209999999999994 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 164.86 33.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.644 2.229 . . . . 74.019999999999996 112.351 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.2 p -151.97 65.07 6.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.657 0.742 . . . . 61.049999999999997 110.938 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.52 18.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.723 2.282 . . . . 74.150000000000006 112.344 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -95.19 31.35 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 65.299999999999997 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.039999999999999 110.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 159.76 68.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.645 0.736 . . . . 64.549999999999997 110.901 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 106.53 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 72.109999999999999 112.377 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.12 29.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 53.340000000000003 112.531 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -158.21 84.76 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 71.140000000000001 110.866 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -96.6 162.62 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 110.913 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.4 21.53 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 62.350000000000001 111.086 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.3 m -112.96 144.67 42.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 51.030000000000001 110.871 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.579 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.91 -171.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 64.409999999999997 110.867 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.07 145.89 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 71.319999999999993 111.152 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 32.78 85.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 64.540000000000006 112.43 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.579 HD12 ' H ' ' A' ' 20' ' ' CYS . 73.7 mt -132.35 169.42 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 74.310000000000002 110.882 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -150.61 147.09 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 110.91 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -100.71 112.13 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.439999999999998 110.865 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.548 ' HB2' HD11 ' A' ' 31' ' ' LEU . 19.4 mmt180 -148.67 147.48 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 62.329999999999998 110.874 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.5 36.34 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 110.94 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.52 12.36 55.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.495 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.07 178.52 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 73.209999999999994 110.917 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.64 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.3 t -107.04 147.67 29.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.851 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.48 176.46 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.510000000000005 110.881 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.7 p -77.31 116.48 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 62.219999999999999 111.134 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 64.439999999999998 110.866 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 70.519999999999996 110.888 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 p -126.91 168.33 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 65.120000000000005 110.896 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.97 -170.86 41.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 43.420000000000002 112.484 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -89.41 -172.94 3.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 71.319999999999993 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 23' ' ' LEU . 7.3 tp -72.72 -56.07 5.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.884 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.28 23.64 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 60.329999999999998 110.893 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.97 154.43 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 73.5 110.836 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 156.31 63.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 62.310000000000002 112.343 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.64 65.57 14.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.649 0.737 . . . . 61.32 110.903 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -31.94 19.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.683 2.256 . . . . 64.430000000000007 112.324 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -94.97 31.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 71.450000000000003 110.846 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.21 117.91 11.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -134.62 159.35 72.54 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.613 0.721 . . . . 71.219999999999999 110.893 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 105.16 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 71.319999999999993 112.35 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.1 29.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 51.149999999999999 112.531 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -158.2 84.54 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 60.43 110.837 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 -93.95 162.3 13.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.310000000000002 110.873 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -94.73 23.18 5.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.540000000000006 111.152 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 91.0 m -113.6 148.11 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 55.030000000000001 110.892 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.1 -178.95 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.877 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.85 139.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 52.240000000000002 111.148 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.69 32.28 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 62.329999999999998 112.48 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.575 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.5 mt -135.05 170.81 15.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 60.229999999999997 110.928 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.77 145.06 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.019999999999996 110.924 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -100.8 112.05 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.918 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HB2' HD11 ' A' ' 31' ' ' LEU . 32.2 mmt180 -148.23 147.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.030000000000001 110.885 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 63.33 35.73 12.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 110.904 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.05 56.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 73.329999999999998 112.501 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -143.45 165.61 27.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 72.219999999999999 110.873 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.537 ' C ' HD23 ' A' ' 31' ' ' LEU . 12.1 t -96.71 145.21 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 65.230000000000004 110.907 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.85 176.45 9.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.010000000000005 110.952 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -74.92 116.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 71.109999999999999 111.169 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 71.450000000000003 110.811 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.349 . . . . 63.149999999999999 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.52 164.85 29.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 110.895 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.87 -167.47 29.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 14.02 112.468 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -89.25 -176.92 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 71.439999999999998 110.843 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.471 HD13 ' CD2' ' A' ' 23' ' ' LEU . 5.9 tp -72.24 -49.82 32.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 73.099999999999994 110.927 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -99.87 23.77 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.019999999999996 110.829 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.49 154.36 59.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 158.67 56.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.229 . . . . 71.120000000000005 112.368 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -146.41 65.15 10.19 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.621 0.724 . . . . 74.230000000000004 110.87 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.647 2.231 . . . . 72.200000000000003 112.352 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -94.96 31.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.26 117.85 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.030000000000001 110.855 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 12.0 ptt180 -130.33 159.77 68.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 72.239999999999995 110.87 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 104.01 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 70.230000000000004 112.332 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -6.28 29.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 61.219999999999999 112.461 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.24 87.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 61.219999999999999 110.849 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -97.93 162.78 13.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 110.908 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 p -94.7 23.54 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.439999999999998 111.15 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.0 m -112.95 146.67 38.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 70.420000000000002 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.614 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.36 -177.15 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.200000000000003 110.869 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 22' ' ' GLY . 6.6 tp -60.87 142.48 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.200000000000003 111.143 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' H ' HD12 ' A' ' 21' ' ' ILE . . . 70.39 31.81 68.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 60.439999999999998 112.489 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.614 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.9 mt -134.79 169.51 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 42.439999999999998 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -150.47 146.44 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 64.430000000000007 110.957 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.7 t -101.21 111.69 23.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 74.200000000000003 110.905 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.7 mmt-85 -149.17 147.84 28.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.838 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.46 35.81 11.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 73.230000000000004 110.938 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.66 55.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 62.399999999999999 112.49 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -143.78 167.56 22.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 64.219999999999999 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.621 ' C ' HD23 ' A' ' 31' ' ' LEU . 6.0 t -98.12 145.19 26.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.329999999999998 110.912 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.64 176.43 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 110.904 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -76.66 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 64.129999999999995 111.106 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 54.100000000000001 110.882 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.88 0.372 . . . . 63.310000000000002 110.917 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.65 164.82 26.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 73.540000000000006 110.879 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.99 -170.05 32.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 32.240000000000002 112.525 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.57 -175.61 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 72.340000000000003 110.838 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.88 -53.98 11.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.927 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.78 23.41 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 71.420000000000002 110.832 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.8 154.96 58.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 73.310000000000002 110.862 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 161.64 45.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.709 2.273 . . . . 65.310000000000002 112.354 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.13 65.65 8.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.626 0.727 . . . . 61.100000000000001 110.9 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.69 17.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 74.310000000000002 112.347 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.2 31.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 72.319999999999993 110.855 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.36 117.95 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.349999999999994 110.852 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -136.71 159.43 70.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 73.430000000000007 110.904 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 105.41 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 70.329999999999998 112.351 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.27 29.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.717 . . . . 73.439999999999998 112.528 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 72.219999999999999 110.842 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -95.51 162.46 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.140000000000001 110.844 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.6 22.35 6.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 72.310000000000002 111.137 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.0 m -113.71 148.85 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.109999999999999 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.567 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.65 -171.59 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 51.119999999999997 110.891 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 tt -64.8 145.34 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 71.219999999999999 111.128 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.8 32.93 84.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.711 -0.756 . . . . 60.43 112.481 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.567 HD12 ' H ' ' A' ' 20' ' ' CYS . 68.7 mt -133.75 168.51 18.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 72.209999999999994 110.955 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.8 tt0 -150.88 146.18 26.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 63.43 110.932 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.23 112.02 24.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.869 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HB2' HD11 ' A' ' 31' ' ' LEU . 20.9 mmt85 -148.76 148.02 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.439999999999998 110.835 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.33 35.84 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 71.540000000000006 110.919 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.58 55.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 53.100000000000001 112.504 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -143.32 167.61 21.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.371 . . . . 73.420000000000002 110.858 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.611 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.6 t -97.6 146.65 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 44.409999999999997 110.887 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.611 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.21 175.09 11.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.923 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.498 HG23 HD11 ' A' ' 5' ' ' LEU . 84.9 t -72.36 116.9 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 71.120000000000005 111.127 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 64.140000000000001 110.885 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.837 0.351 . . . . 74.219999999999999 110.873 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -123.45 164.97 17.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.319999999999993 110.859 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.19 -169.96 32.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 61.43 112.526 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -89.65 -175.6 4.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 72.200000000000003 110.844 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.86 -54.07 11.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 110.945 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.72 23.42 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 71.400000000000006 110.838 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 154.9 58.86 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.572 0.701 . . . . 74.25 110.898 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 161.64 45.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.693 2.262 . . . . 52.439999999999998 112.285 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.24 65.58 8.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.723 . . . . 71.040000000000006 110.909 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.75 18.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.69 2.26 . . . . 73.209999999999994 112.359 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.13 31.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.32 117.96 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 70.209999999999994 110.875 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -136.46 159.44 70.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 70.010000000000005 110.857 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 105.37 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 72.099999999999994 112.318 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.3 29.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 53.219999999999999 112.488 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -158.17 84.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 72.25 110.899 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -95.47 162.6 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 72.239999999999995 110.881 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -94.52 22.28 6.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.154 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.0 m -113.62 148.95 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 61.130000000000003 110.899 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.75 -171.74 2.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 110.862 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.72 145.13 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.0 84.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 71.420000000000002 112.499 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.573 HD12 ' H ' ' A' ' 20' ' ' CYS . 69.0 mt -133.89 168.59 18.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 74.019999999999996 110.894 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.9 tt0 -150.85 146.23 26.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 110.947 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -100.31 112.09 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.420000000000002 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' A' ' 31' ' ' LEU . 29.3 mmt180 -148.72 148.09 29.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 64.140000000000001 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.35 35.79 12.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 63.399999999999999 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.51 55.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 70.340000000000003 112.474 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -143.32 167.64 21.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 62.350000000000001 110.88 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.616 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.7 t -97.6 146.62 25.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 64.549999999999997 110.861 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.22 175.14 11.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 110.916 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 5' ' ' LEU . 85.4 t -72.5 116.89 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 72.150000000000006 111.151 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.853 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.876 0.37 . . . . 74.400000000000006 110.895 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p -125.56 164.7 19.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.927 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.66 -170.18 32.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.455 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.55 -175.5 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 71.430000000000007 110.887 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.94 -54.11 10.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 74.239999999999995 110.911 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -95.69 23.43 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 110.827 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.68 154.89 59.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.562 0.696 . . . . 72.519999999999996 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.91 47.94 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.656 2.237 . . . . 74.430000000000007 112.339 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -147.32 65.54 9.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 61.109999999999999 110.882 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -32.71 17.95 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 62.310000000000002 112.332 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.886 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.57 117.99 11.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 64.200000000000003 110.85 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -136.83 159.48 70.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.635 0.731 . . . . 72.310000000000002 110.86 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 105.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.633 2.222 . . . . 74.219999999999999 112.318 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.94 -8.43 29.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 62.530000000000001 112.472 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 110.813 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -95.62 162.26 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.846 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.59 22.29 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 65.140000000000001 111.132 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.8 m -113.63 148.65 35.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 110.901 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.49 -171.34 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 72.030000000000001 110.884 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.98 145.63 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 74.120000000000005 111.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.51 32.78 84.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 35.530000000000001 112.466 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD12 ' H ' ' A' ' 20' ' ' CYS . 68.9 mt -133.46 168.31 18.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 64.030000000000001 110.919 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.8 tt0 -150.92 146.05 26.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.923 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.3 t -99.89 112.06 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HB2' HD11 ' A' ' 31' ' ' LEU . 10.8 mmt180 -148.62 147.9 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 55.240000000000002 110.874 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.3 35.77 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 71.310000000000002 110.925 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.66 55.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.130000000000003 112.444 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -143.35 167.32 22.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.35 . . . . 72.349999999999994 110.873 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.601 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.5 t -97.36 146.53 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 74.209999999999994 110.876 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.06 175.44 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 110.89 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 5' ' ' LEU . 84.9 t -72.68 116.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 71.540000000000006 111.099 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.310000000000002 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.85 0.357 . . . . 72.129999999999995 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p -135.54 170.32 16.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 53.210000000000001 110.91 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.38 -171.23 37.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 74.510000000000005 112.49 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.23 -172.89 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 72.299999999999997 110.838 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.8 tp -72.62 -56.14 5.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.944 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -95.24 23.58 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 72.540000000000006 110.854 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.77 154.24 61.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.319999999999993 110.865 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 156.18 64.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.697 2.265 . . . . 74.109999999999999 112.325 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.58 65.56 14.69 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 63.329999999999998 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.1 19.16 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 75.030000000000001 112.367 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -94.93 31.3 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 110.895 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.99 117.89 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.109999999999999 110.887 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -133.23 159.3 73.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.582 0.706 . . . . 74.439999999999998 110.857 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 104.85 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.510000000000005 112.354 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.77 -7.45 29.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.788 -0.72 . . . . 61.350000000000001 112.472 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -158.14 84.7 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 75.349999999999994 110.839 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -93.21 162.29 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.894 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.1 p -94.83 24.31 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 51.439999999999998 111.138 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.8 m -113.42 151.26 31.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.099999999999994 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.613 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -81.05 -179.9 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.889 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -59.36 138.29 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 111.088 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.63 35.64 55.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 71.129999999999995 112.448 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 20' ' ' CYS . 92.5 mt -138.01 170.61 15.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.793 0.33 . . . . 71.340000000000003 110.876 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -150.85 144.12 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 64.109999999999999 110.911 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.72 112.18 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.409999999999997 110.925 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HB2' HD11 ' A' ' 31' ' ' LEU . 3.0 mmt180 -148.06 147.74 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 74.239999999999995 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.41 35.84 11.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.923 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.14 13.05 57.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 72.109999999999999 112.486 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -143.75 165.44 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 63.340000000000003 110.884 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.528 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.0 t -96.32 145.02 25.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 55.509999999999998 110.848 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.63 176.41 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.230000000000004 110.931 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.4 p -74.88 116.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 64.200000000000003 110.847 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.88 0.372 . . . . 71.200000000000003 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p -134.31 168.87 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 71.409999999999997 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.99 -169.88 39.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 44.350000000000001 112.482 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.47 -173.51 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 65.109999999999999 110.864 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 23' ' ' LEU . 7.1 tp -72.81 -54.99 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 65.299999999999997 110.921 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.95 23.63 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 75.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.16 154.58 60.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.602 0.715 . . . . 73.129999999999995 110.855 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.26 63.89 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 2.23 . . . . 75.299999999999997 112.308 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -143.22 65.41 15.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 73.349999999999994 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -32.16 19.07 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.673 2.249 . . . . 73.420000000000002 112.344 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -94.93 31.38 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.864 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 63.32 110.845 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -135.28 159.34 72.16 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 74.540000000000006 110.849 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 54.299999999999997 112.346 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 -8.28 29.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 71.319999999999993 112.498 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -158.15 84.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 74.340000000000003 110.87 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -94.27 162.18 13.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 70.120000000000005 110.875 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.85 23.39 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 54.520000000000003 111.134 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.0 m -114.13 147.73 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.239999999999995 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.588 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.54 -178.56 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.230000000000004 110.888 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.2 tt -60.55 140.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 63.329999999999998 111.13 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.65 32.61 61.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.75 . . . . 72.299999999999997 112.535 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.0 mt -135.44 170.14 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 63.310000000000002 110.912 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.79 144.99 25.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.200000000000003 110.936 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -100.1 112.05 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.884 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.3 mmt-85 -148.63 147.92 29.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.886 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 63.45 35.79 11.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 110.942 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.06 12.87 56.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 51.130000000000003 112.531 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -143.64 166.96 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 71.040000000000006 110.853 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.59 ' C ' HD23 ' A' ' 31' ' ' LEU . 10.8 t -97.48 144.96 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 110.86 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.46 176.43 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 72.010000000000005 110.898 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.24 115.94 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 72.230000000000004 111.154 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.230000000000004 110.872 -179.925 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.901 0.382 . . . . 73.22 110.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.91 29.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.2 112.492 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.61 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 74.45 110.826 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.2 tp -72.29 -50.0 30.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 61.31 110.958 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.54 23.69 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.01 110.845 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.18 155.43 57.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.561 0.696 . . . . 71.35 110.894 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 159.79 52.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.252 . . . . 75.05 112.351 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.5 65.67 10.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 71.42 110.888 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -32.8 17.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 74.24 112.363 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -95.19 31.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 71.21 110.881 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.55 117.93 10.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 70.14 110.888 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -136.35 159.55 70.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 75.32 110.892 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 105.61 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.716 2.278 . . . . 64.2 112.257 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.0 29.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.715 -0.755 . . . . 12.53 112.477 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -158.21 84.55 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 75.42 110.847 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.2 mtm-85 -96.18 162.6 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 61.34 110.848 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.4 21.73 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 61.51 111.145 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -113.17 145.22 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.899 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.6 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.85 -175.63 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.848 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 tt -62.45 142.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 72.33 111.117 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.41 70.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 34.53 112.471 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.5 mt -133.28 169.65 16.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 52.43 110.873 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.63 145.78 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 63.54 110.93 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.82 111.76 24.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.33 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' HD11 ' A' ' 31' ' ' LEU . 27.6 mmt180 -149.16 147.84 28.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 64.11 110.875 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.51 35.77 11.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 55.52 110.923 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.76 56.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 43.34 112.517 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -143.89 167.52 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 65.03 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.619 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.95 145.95 25.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 71.44 110.887 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.619 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.72 176.45 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 71.22 110.875 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.98 116.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 61.32 111.136 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 54.53 110.931 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.886 0.374 . . . . 71.15 110.895 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.86 29.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 74.41 112.566 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.24 -176.6 5.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 74.22 110.842 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.29 -50.14 29.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 50.54 110.9 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.5 23.76 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.23 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.11 155.29 57.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 75.42 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.76 52.2 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.654 2.236 . . . . 64.33 112.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -146.6 65.64 10.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.592 0.711 . . . . 53.4 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.72 17.75 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 64.42 112.301 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -95.14 31.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 75.22 110.875 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.57 117.96 10.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 62.13 110.885 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.58 159.49 71.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 73.5 110.886 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 73.25 112.347 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.52 29.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 32.04 112.508 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -158.05 84.52 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 72.32 110.866 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -96.13 162.49 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 75.45 110.898 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -94.48 22.11 6.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.02 111.136 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.5 m -113.15 145.6 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 64.32 110.854 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.606 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.26 -175.88 3.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 44.45 110.902 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.19 142.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 72.13 111.158 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.61 70.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 73.33 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.606 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.5 mt -133.62 169.56 16.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.746 0.308 . . . . 75.51 110.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.62 145.82 26.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 62.34 110.904 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.77 111.69 23.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.51 110.877 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' HD11 ' A' ' 31' ' ' LEU . 12.5 mmt180 -149.08 147.81 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 71.4 110.885 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.53 35.78 11.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.89 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.74 56.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.761 -0.733 . . . . 54.33 112.498 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 167.39 22.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 63.55 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.615 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.89 145.86 26.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 73.42 110.862 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.64 176.46 10.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 75.13 110.865 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.96 116.46 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 42.34 111.16 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.863 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.895 0.379 . . . . 60.02 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.4 -167.39 28.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 74.24 112.464 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.78 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 73.31 110.832 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.0 tp -72.31 -49.92 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.2 110.927 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.56 23.69 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.897 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.07 155.29 58.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 61.04 110.833 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 159.14 54.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.666 2.244 . . . . 73.43 112.33 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.91 65.64 11.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.664 0.745 . . . . 50.33 110.915 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.79 17.89 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 71.44 112.363 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -95.2 31.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.42 117.92 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.914 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 10.9 ptm180 -135.75 159.55 70.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.701 . . . . 72.45 110.841 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.5 Cg_endo -69.78 105.31 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.664 2.242 . . . . 74.41 112.344 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.56 29.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 65.23 112.424 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -158.05 84.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 73.11 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -96.21 162.48 13.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.21 110.842 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -94.4 21.77 6.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.156 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -112.98 145.38 40.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 72.34 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.612 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.34 -177.29 4.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 75.41 110.879 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.8 tt -61.16 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 62.03 111.087 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.94 31.36 67.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 43.22 112.481 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 20' ' ' CYS . 94.7 mt -133.92 169.74 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 70.04 110.877 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.6 145.79 26.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.76 111.72 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 65.21 110.882 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' HD11 ' A' ' 31' ' ' LEU . 39.2 mmt180 -149.05 147.74 28.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 70.02 110.902 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.51 35.77 11.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 65.42 110.934 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.71 56.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.41 112.481 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.9 167.23 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 61.12 110.9 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.607 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.8 145.52 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 75.4 110.896 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.47 176.45 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.35 110.92 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.75 116.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 63.23 111.078 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 61.41 110.897 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.863 0.364 . . . . 62.02 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 -167.99 29.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 55.44 112.497 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.19 -176.71 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 54.24 110.87 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.24 -50.14 29.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.9 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.48 23.73 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 72.22 110.885 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.06 155.31 58.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 73.24 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 159.74 52.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 61.25 112.357 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.59 65.67 10.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 64.13 110.879 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.75 17.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.733 2.288 . . . . 75.45 112.319 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.21 31.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.65 117.95 11.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 64.11 110.86 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 1.2 ptt180 -135.73 159.49 71.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 74.43 110.909 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.1 Cg_endo -69.78 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.244 . . . . 60.24 112.348 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.02 -8.63 29.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.4 112.487 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -158.04 84.49 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 65.43 110.881 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -96.19 162.51 13.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 63.53 110.886 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -94.45 21.95 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 71.41 111.139 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -113.08 145.59 40.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.42 110.92 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.17 -175.73 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.915 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.34 142.89 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 65.13 111.139 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.67 31.56 70.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 75.31 112.519 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.1 mt -133.46 169.59 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 65.21 110.886 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.6 145.81 26.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 64.41 110.9 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -100.81 111.72 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 71.3 110.857 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HB2' HD11 ' A' ' 31' ' ' LEU . 19.2 mmt180 -149.08 147.84 28.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.51 110.895 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.47 35.85 11.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.935 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.07 12.73 55.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.741 -0.742 . . . . 71.12 112.553 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -143.9 167.41 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 74.23 110.893 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.615 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.92 145.95 25.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.865 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.66 176.42 10.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 74.03 110.882 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.97 116.46 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 54.24 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.01 110.9 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.858 0.361 . . . . 75.14 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.44 -167.36 28.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.487 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 75.21 110.814 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.26 -49.89 31.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 71.43 110.907 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.73 23.72 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.1 110.863 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 155.51 57.96 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.612 0.72 . . . . 74.14 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.7 56.03 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.691 2.261 . . . . 74.23 112.341 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.43 65.67 11.7 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 74.43 110.859 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.79 17.66 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 71.1 112.338 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 60.25 110.879 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.53 117.98 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 61.23 110.819 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -136.58 159.52 70.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.606 0.717 . . . . 73.13 110.883 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.66 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.646 2.231 . . . . 74.55 112.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 -9.08 29.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 51.4 112.483 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -158.17 84.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 74.23 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -96.19 162.47 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 73.35 110.862 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.35 21.39 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.22 111.154 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -113.02 145.28 41.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 65.54 110.912 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.612 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.23 -177.04 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 53.13 110.902 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.32 142.46 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 71.31 111.126 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.24 68.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 61.53 112.542 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.4 mt -133.68 169.6 16.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 64.32 110.951 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.58 145.7 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.4 110.932 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.63 111.77 24.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.856 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HB2' HD11 ' A' ' 31' ' ' LEU . 37.5 mmt180 -149.05 147.51 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.851 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.58 35.74 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 64.11 110.928 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.83 56.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 63.42 112.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -143.84 166.8 23.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 70.04 110.908 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.562 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.37 145.38 26.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.888 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.22 176.46 9.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.21 110.931 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.89 116.34 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 65.44 111.103 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 71.11 110.899 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.0 p . . . . . 0 CA--C 1.526 0.027 0 CA-C-O 120.905 0.383 . . . . 41.45 110.851 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.5 -167.47 28.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 61.21 112.439 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 62.5 110.865 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.26 -49.92 31.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.926 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.69 23.72 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 70.14 110.845 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 155.39 57.91 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.592 0.711 . . . . 62.54 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 158.72 56.01 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.236 . . . . 64.05 112.375 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.1 p -145.39 65.73 11.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 70.22 110.864 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.89 17.73 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.71 2.273 . . . . 61.23 112.329 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -95.22 31.22 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 41.44 110.943 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -68.43 117.94 10.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 65.12 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.59 159.49 70.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.585 0.707 . . . . 74.4 110.899 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 75.02 112.329 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.96 29.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 71.15 112.504 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -158.18 84.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.769 0.319 . . . . 64.2 110.894 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -96.14 162.46 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.843 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.41 21.62 6.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 60.14 111.079 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.6 m -113.21 145.26 41.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 73.41 110.885 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.615 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.2 -177.43 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 65.52 110.915 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.19 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 71.22 111.148 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.18 31.04 66.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.736 . . . . 30.03 112.491 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.615 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.8 mt -133.68 169.72 16.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 74.55 110.919 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -150.56 145.63 26.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 52.21 110.905 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.6 111.75 24.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.04 110.872 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' HD11 ' A' ' 31' ' ' LEU . 21.4 mmt180 -148.96 147.58 28.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 73.23 110.867 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.47 35.81 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.22 110.93 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.09 12.84 56.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 63.24 112.486 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -143.85 166.85 23.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.332 . . . . 74.11 110.919 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.565 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.38 145.42 26.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.875 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.26 176.46 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 71.5 110.915 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.95 116.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 75.21 111.121 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.12 110.831 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.939 0.4 . . . . 51.54 110.837 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.42 -167.48 28.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 54.53 112.479 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.15 -176.75 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 73.33 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.3 -49.93 30.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 63.02 110.927 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.6 23.67 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.888 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.03 155.43 58.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 72.44 110.878 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.69 2.26 . . . . 73.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -145.41 65.75 11.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 70.3 110.842 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.87 17.72 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.721 2.281 . . . . 71.53 112.312 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.27 31.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.25 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.51 117.92 10.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 45.23 110.838 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -136.57 159.48 70.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 71.42 110.893 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.261 . . . . 51.24 112.338 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.01 -8.94 29.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.74 . . . . 65.41 112.451 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -158.22 84.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 73.13 110.853 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -96.05 162.35 13.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 75.24 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.32 21.46 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.33 111.152 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -113.13 145.22 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 71.4 110.876 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.61 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.11 -177.23 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 33.5 110.889 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 tt -61.29 142.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.31 111.171 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.9 31.03 67.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 53.0 112.511 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.0 mt -133.62 169.74 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.29 . . . . 62.41 110.907 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.59 145.72 26.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.41 110.905 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.68 111.73 24.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.52 110.897 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HB2' HD11 ' A' ' 31' ' ' LEU . 26.2 mmt180 -148.97 147.59 28.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 71.44 110.883 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.48 35.82 11.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.953 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.78 56.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 63.54 112.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -143.86 166.97 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.794 0.331 . . . . 70.44 110.939 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.51 145.44 26.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.04 110.91 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.29 176.45 9.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.887 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.93 116.4 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 60.44 111.161 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.22 110.882 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.837 0.351 . . . . 61.44 110.863 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.99 -167.96 29.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 74.35 112.468 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.61 5.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 62.01 110.861 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.452 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.25 -50.1 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 53.43 110.915 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.52 23.69 9.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.41 110.838 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 155.39 57.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.721 . . . . 73.51 110.855 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 159.05 54.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.276 . . . . 64.22 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.76 65.62 11.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.737 . . . . 75.31 110.879 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -32.73 17.68 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 63.41 112.331 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -95.25 31.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 74.32 110.878 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 117.93 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.872 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -136.31 159.5 70.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 64.14 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 105.56 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.712 2.274 . . . . 61.53 112.396 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.01 29.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 73.53 112.507 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -158.19 84.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.44 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -96.16 162.58 13.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.876 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.44 21.73 6.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 62.15 111.186 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.2 m -113.18 145.33 41.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.35 110.908 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.605 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.01 -175.57 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 63.23 110.873 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.49 143.17 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 54.04 111.161 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 31.3 70.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.475 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.2 mt -133.14 169.64 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 73.35 110.921 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.68 145.77 26.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.901 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.8 111.77 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' HD11 ' A' ' 31' ' ' LEU . 16.0 mmt180 -149.0 147.65 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 54.13 110.867 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.47 35.79 11.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 70.32 110.933 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.76 56.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 32.21 112.489 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -143.79 167.0 23.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.15 110.882 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.54 145.84 25.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.857 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.53 176.45 10.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 70.41 110.892 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -76.12 116.39 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.3 111.142 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.04 110.894 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.6 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.909 0.385 . . . . 71.01 110.867 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.24 -167.47 29.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 54.05 112.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.81 5.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 64.31 110.856 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.25 -49.86 31.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 45.55 110.917 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.71 23.68 9.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.2 110.837 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.97 155.25 58.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.56 0.695 . . . . 75.11 110.879 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 158.55 56.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 70.51 112.325 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.27 65.63 11.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.573 0.702 . . . . 72.44 110.866 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.8 17.87 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.634 2.223 . . . . 64.12 112.36 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -95.3 31.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.51 117.96 10.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 61.24 110.828 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 8.8 ptm180 -135.76 159.5 71.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.57 0.7 . . . . 64.03 110.896 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.622 2.215 . . . . 62.15 112.339 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.5 29.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 63.22 112.503 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.09 84.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 72.54 110.869 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -96.1 162.5 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 p -94.41 21.69 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.149 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.5 m -113.14 145.86 40.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 63.52 110.858 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.627 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.8 -175.52 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 73.52 110.858 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.0 143.66 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 65.53 111.149 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.83 31.77 73.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.728 . . . . 64.31 112.432 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 20' ' ' CYS . 93.7 mt -133.78 169.14 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.746 0.308 . . . . 73.14 110.907 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.57 145.93 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 70.43 110.937 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -100.6 111.74 24.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HB2' HD11 ' A' ' 31' ' ' LEU . 10.5 mmt180 -148.95 147.44 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.42 110.837 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 63.53 35.81 11.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.904 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.85 56.44 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 73.15 112.45 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -143.85 166.7 24.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 73.42 110.867 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.559 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.8 t -97.25 145.34 26.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 73.21 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.08 176.5 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.939 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.91 116.33 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 62.34 111.14 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 53.43 110.893 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p . . . . . 0 N--CA 1.458 -0.044 0 CA-C-O 120.882 0.372 . . . . 61.21 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.45 -167.46 28.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 70.11 112.506 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.3 -176.76 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 72.11 110.853 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.2 tp -72.35 -49.76 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.916 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -99.67 23.7 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.878 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.2 155.55 57.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.577 0.703 . . . . 73.12 110.915 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 159.79 52.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.681 2.254 . . . . 70.31 112.328 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.82 65.65 10.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 64.23 110.863 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.9 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.71 2.274 . . . . 61.03 112.374 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.32 31.24 2.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 75.33 110.929 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.39 117.95 10.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.853 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -135.08 159.37 72.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.732 . . . . 71.3 110.842 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.77 105.49 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.737 2.291 . . . . 53.24 112.32 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.33 29.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.694 -0.765 . . . . 71.54 112.483 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -157.3 84.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 74.15 110.885 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.1 mtm-85 -96.47 164.16 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 72.54 110.895 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.54 21.92 6.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 70.31 111.118 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -112.98 145.43 40.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 73.21 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.625 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.51 -174.49 3.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.23 110.858 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.66 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.3 111.168 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 32.07 76.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 32.04 112.461 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.625 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.8 mt -133.51 169.11 17.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.754 0.311 . . . . 62.41 110.902 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.52 146.04 26.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 71.04 110.936 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.6 t -100.87 111.69 23.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.35 110.861 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.469 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.6 mmt180 -149.06 147.72 28.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 70.31 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.52 35.8 11.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 74.44 110.931 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.63 55.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 72.11 112.515 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 167.56 22.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 72.43 110.933 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.618 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.91 145.87 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 64.35 110.888 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.81 176.46 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.927 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -75.75 116.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 75.41 111.171 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.892 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.859 0.361 . . . . 63.31 110.862 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.29 -168.72 30.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 64.1 112.51 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.65 5.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 73.04 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.5 tp -72.3 -49.99 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 62.11 110.873 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.26 23.67 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.833 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.92 155.93 55.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 62.24 110.816 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 163.94 36.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 70.14 112.298 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 p -151.13 64.93 6.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.73 . . . . 74.43 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.39 18.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 65.42 112.385 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -95.0 31.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 65.23 110.896 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.98 117.93 11.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 53.01 110.879 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -135.45 159.51 71.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.646 0.736 . . . . 74.01 110.858 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 105.58 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 60.45 112.31 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.02 29.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.769 . . . . 52.41 112.504 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -158.17 84.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 71.21 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -96.04 162.86 13.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 64.45 110.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.45 21.83 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 73.23 111.166 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.2 m -112.84 145.07 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.14 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.583 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.17 -171.94 1.89 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 62.33 110.876 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -64.73 145.52 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.33 111.12 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.65 84.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 72.13 112.482 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.583 HD12 ' H ' ' A' ' 20' ' ' CYS . 77.0 mt -132.64 169.62 16.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.705 0.288 . . . . 62.34 110.93 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -150.5 147.25 27.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.884 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.99 112.06 24.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 53.02 110.899 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.543 ' HB2' HD11 ' A' ' 31' ' ' LEU . 25.8 mmt180 -148.56 147.45 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 65.23 110.877 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 63.54 36.29 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 61.33 110.952 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.5 12.33 55.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 74.42 112.487 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.98 178.52 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 73.54 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.643 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.5 t -107.1 147.49 29.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.873 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.643 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.38 176.49 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 72.24 110.914 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.27 116.39 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.54 111.107 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 61.45 110.875 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.2 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.91 0.386 . . . . 75.12 110.857 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.56 -168.65 30.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 52.25 112.487 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.61 5.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.383 . . . . 71.43 110.817 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.4 tp -72.3 -50.02 30.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 73.32 110.92 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -99.25 23.72 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 62.35 110.902 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.88 155.74 55.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.634 0.731 . . . . 61.3 110.823 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 164.32 34.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 75.03 112.32 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 p -152.06 64.83 5.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 64.03 110.879 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -32.31 18.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.271 . . . . 61.01 112.373 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -94.99 31.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.86 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.05 117.95 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.899 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 4.5 ptt-85 -134.14 159.54 71.97 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 64.01 110.859 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.8 105.32 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 62.15 112.308 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.96 -8.56 29.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 53.32 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -158.09 84.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 72.21 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.06 163.06 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.834 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.51 22.19 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 75.42 111.117 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.9 m -112.93 145.55 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 71.4 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.584 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.64 -171.93 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.31 110.876 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.64 145.51 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.14 111.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.14 33.0 85.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 72.13 112.487 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.584 HD12 ' H ' ' A' ' 20' ' ' CYS . 76.6 mt -133.03 169.57 16.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 64.35 110.917 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -150.45 147.3 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.43 110.897 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -101.07 112.1 24.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.538 ' HB2' HD11 ' A' ' 31' ' ' LEU . 35.3 mmt180 -148.54 147.5 29.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.848 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 63.5 36.32 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 71.4 110.954 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.46 12.34 55.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 63.1 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -141.87 178.54 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 74.4 110.932 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.643 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.6 t -107.21 147.5 30.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 43.15 110.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.643 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.35 176.39 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.91 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.17 116.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 72.3 111.114 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 70.21 110.872 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.906 0.384 . . . . 70.0 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.15 -168.84 30.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 71.35 112.539 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.41 -176.63 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 54.43 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.443 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.6 tp -72.2 -50.18 29.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 74.31 110.927 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.06 23.6 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.2 110.882 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.02 156.28 54.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.568 0.699 . . . . 73.21 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 164.86 33.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.644 2.229 . . . . 74.02 112.351 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.2 p -151.97 65.07 6.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.657 0.742 . . . . 61.05 110.938 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.52 18.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.723 2.282 . . . . 74.15 112.344 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -95.19 31.35 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 65.3 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.04 110.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 159.76 68.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.645 0.736 . . . . 64.55 110.901 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 106.53 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 72.11 112.377 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.12 29.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 53.34 112.531 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -158.21 84.76 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 71.14 110.866 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -96.6 162.62 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 75.32 110.913 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.4 21.53 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 62.35 111.086 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.3 m -112.96 144.67 42.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 51.03 110.871 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.579 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.91 -171.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 64.41 110.867 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.07 145.89 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 71.32 111.152 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 32.78 85.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 64.54 112.43 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.579 HD12 ' H ' ' A' ' 20' ' ' CYS . 73.7 mt -132.35 169.42 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 74.31 110.882 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -150.61 147.09 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 72.11 110.91 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -100.71 112.13 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.44 110.865 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.548 ' HB2' HD11 ' A' ' 31' ' ' LEU . 19.4 mmt180 -148.67 147.48 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 62.33 110.874 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.5 36.34 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 73.2 110.94 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.52 12.36 55.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.495 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.07 178.52 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 73.21 110.917 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.64 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.3 t -107.04 147.67 29.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 72.3 110.851 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.48 176.46 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.51 110.881 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.7 p -77.31 116.48 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 62.22 111.134 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 64.44 110.866 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.846 0.355 . . . . 65.12 110.896 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.97 -170.86 41.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 43.42 112.484 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -89.41 -172.94 3.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 71.32 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 23' ' ' LEU . 7.3 tp -72.72 -56.07 5.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.884 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.28 23.64 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 60.33 110.893 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.97 154.43 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 73.5 110.836 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 156.31 63.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 62.31 112.343 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.64 65.57 14.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.649 0.737 . . . . 61.32 110.903 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -31.94 19.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.683 2.256 . . . . 64.43 112.324 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -94.97 31.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 71.45 110.846 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.21 117.91 11.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -134.62 159.35 72.54 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.613 0.721 . . . . 71.22 110.893 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 105.16 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 71.32 112.35 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.1 29.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 51.15 112.531 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -158.2 84.54 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 60.43 110.837 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 -93.95 162.3 13.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.31 110.873 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -94.73 23.18 5.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.54 111.152 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 91.0 m -113.6 148.11 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 55.03 110.892 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.1 -178.95 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.877 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.85 139.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 52.24 111.148 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.69 32.28 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 62.33 112.48 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.575 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.5 mt -135.05 170.81 15.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 60.23 110.928 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.77 145.06 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.02 110.924 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -100.8 112.05 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.918 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HB2' HD11 ' A' ' 31' ' ' LEU . 32.2 mmt180 -148.23 147.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.885 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 63.33 35.73 12.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.904 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.05 56.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 73.33 112.501 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -143.45 165.61 27.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 72.22 110.873 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.537 ' C ' HD23 ' A' ' 31' ' ' LEU . 12.1 t -96.71 145.21 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 65.23 110.907 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.85 176.45 9.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.01 110.952 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -74.92 116.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 71.11 111.169 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 71.45 110.811 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.5 p . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.877 0.37 . . . . 72.21 110.895 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.87 -167.47 29.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 14.02 112.468 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -89.25 -176.92 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 71.44 110.843 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.471 HD13 ' CD2' ' A' ' 23' ' ' LEU . 5.9 tp -72.24 -49.82 32.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.927 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -99.87 23.77 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.02 110.829 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.49 154.36 59.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 72.13 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 158.67 56.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.229 . . . . 71.12 112.368 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -146.41 65.15 10.19 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.621 0.724 . . . . 74.23 110.87 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.647 2.231 . . . . 72.2 112.352 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -94.96 31.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 64.42 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.26 117.85 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.03 110.855 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 12.0 ptt180 -130.33 159.77 68.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 72.24 110.87 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 104.01 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 70.23 112.332 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -6.28 29.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 61.22 112.461 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.24 87.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 61.22 110.849 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -97.93 162.78 13.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.3 110.908 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 p -94.7 23.54 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.44 111.15 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.0 m -112.95 146.67 38.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 70.42 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.614 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.36 -177.15 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.2 110.869 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 22' ' ' GLY . 6.6 tp -60.87 142.48 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.2 111.143 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' H ' HD12 ' A' ' 21' ' ' ILE . . . 70.39 31.81 68.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 60.44 112.489 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.614 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.9 mt -134.79 169.51 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 42.44 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -150.47 146.44 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 64.43 110.957 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.7 t -101.21 111.69 23.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 74.2 110.905 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.7 mmt-85 -149.17 147.84 28.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.838 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.46 35.81 11.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 73.23 110.938 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.66 55.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 62.4 112.49 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -143.78 167.56 22.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 64.22 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.621 ' C ' HD23 ' A' ' 31' ' ' LEU . 6.0 t -98.12 145.19 26.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.33 110.912 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.64 176.43 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.904 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -76.66 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 64.13 111.106 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 54.1 110.882 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.1 p . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.904 0.383 . . . . 73.54 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.99 -170.05 32.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 32.24 112.525 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.57 -175.61 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 72.34 110.838 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.88 -53.98 11.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.927 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.78 23.41 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.832 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.8 154.96 58.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 73.31 110.862 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 161.64 45.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.709 2.273 . . . . 65.31 112.354 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.13 65.65 8.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.626 0.727 . . . . 61.1 110.9 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.69 17.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 74.31 112.347 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.2 31.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 72.32 110.855 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.36 117.95 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.35 110.852 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -136.71 159.43 70.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 73.43 110.904 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 105.41 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 70.33 112.351 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.27 29.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.717 . . . . 73.44 112.528 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 72.22 110.842 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -95.51 162.46 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.14 110.844 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.6 22.35 6.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 72.31 111.137 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.0 m -113.71 148.85 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.567 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.65 -171.59 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 51.12 110.891 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 tt -64.8 145.34 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 71.22 111.128 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.8 32.93 84.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.711 -0.756 . . . . 60.43 112.481 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.567 HD12 ' H ' ' A' ' 20' ' ' CYS . 68.7 mt -133.75 168.51 18.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 72.21 110.955 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.8 tt0 -150.88 146.18 26.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 63.43 110.932 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.23 112.02 24.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.869 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HB2' HD11 ' A' ' 31' ' ' LEU . 20.9 mmt85 -148.76 148.02 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.44 110.835 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.33 35.84 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 71.54 110.919 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.58 55.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 53.1 112.504 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -143.32 167.61 21.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.371 . . . . 73.42 110.858 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.611 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.6 t -97.6 146.65 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 44.41 110.887 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.611 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.21 175.09 11.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.923 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.498 HG23 HD11 ' A' ' 5' ' ' LEU . 84.9 t -72.36 116.9 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 71.12 111.127 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.885 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.87 0.367 . . . . 72.32 110.859 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.19 -169.96 32.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 61.43 112.526 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -89.65 -175.6 4.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 72.2 110.844 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.86 -54.07 11.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 72.14 110.945 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.72 23.42 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 71.4 110.838 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 154.9 58.86 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.572 0.701 . . . . 74.25 110.898 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 161.64 45.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.693 2.262 . . . . 52.44 112.285 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.24 65.58 8.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.723 . . . . 71.04 110.909 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.75 18.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.69 2.26 . . . . 73.21 112.359 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.13 31.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.32 117.96 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 70.21 110.875 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -136.46 159.44 70.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 70.01 110.857 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 105.37 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 72.1 112.318 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.3 29.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 53.22 112.488 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -158.17 84.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 72.25 110.899 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -95.47 162.6 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.881 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -94.52 22.28 6.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.154 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.0 m -113.62 148.95 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 61.13 110.899 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.75 -171.74 2.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 73.04 110.862 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.72 145.13 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 73.12 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.0 84.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 71.42 112.499 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.573 HD12 ' H ' ' A' ' 20' ' ' CYS . 69.0 mt -133.89 168.59 18.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 74.02 110.894 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.9 tt0 -150.85 146.23 26.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 63.41 110.947 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -100.31 112.09 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.42 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' A' ' 31' ' ' LEU . 29.3 mmt180 -148.72 148.09 29.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 64.14 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.35 35.79 12.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 63.4 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.51 55.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 70.34 112.474 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -143.32 167.64 21.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 62.35 110.88 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.616 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.7 t -97.6 146.62 25.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 64.55 110.861 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.22 175.14 11.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.4 110.916 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 5' ' ' LEU . 85.4 t -72.5 116.89 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 72.15 111.151 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.853 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.845 0.355 . . . . 72.21 110.927 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.66 -170.18 32.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 73.33 112.455 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.55 -175.5 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 71.43 110.887 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.94 -54.11 10.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 74.24 110.911 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -95.69 23.43 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.827 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.68 154.89 59.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.562 0.696 . . . . 72.52 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.91 47.94 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.656 2.237 . . . . 74.43 112.339 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -147.32 65.54 9.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 61.11 110.882 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -32.71 17.95 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 62.31 112.332 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.21 110.886 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.57 117.99 11.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 64.2 110.85 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -136.83 159.48 70.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.635 0.731 . . . . 72.31 110.86 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 105.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.633 2.222 . . . . 74.22 112.318 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.94 -8.43 29.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 62.53 112.472 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 75.41 110.813 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -95.62 162.26 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.846 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.59 22.29 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 65.14 111.132 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.8 m -113.63 148.65 35.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 72.11 110.901 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.49 -171.34 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 72.03 110.884 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.98 145.63 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 74.12 111.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.51 32.78 84.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 35.53 112.466 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD12 ' H ' ' A' ' 20' ' ' CYS . 68.9 mt -133.46 168.31 18.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 64.03 110.919 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.8 tt0 -150.92 146.05 26.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 72.42 110.923 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.3 t -99.89 112.06 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HB2' HD11 ' A' ' 31' ' ' LEU . 10.8 mmt180 -148.62 147.9 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 55.24 110.874 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.3 35.77 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 71.31 110.925 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.66 55.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.13 112.444 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -143.35 167.32 22.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.35 . . . . 72.35 110.873 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.601 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.5 t -97.36 146.53 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 74.21 110.876 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.06 175.44 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.89 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 5' ' ' LEU . 84.9 t -72.68 116.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 71.54 111.099 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.31 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.852 0.358 . . . . 53.21 110.91 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.38 -171.23 37.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 74.51 112.49 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.23 -172.89 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 72.3 110.838 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.8 tp -72.62 -56.14 5.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 63.44 110.944 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -95.24 23.58 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 72.54 110.854 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.77 154.24 61.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.32 110.865 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 156.18 64.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.697 2.265 . . . . 74.11 112.325 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.58 65.56 14.69 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 63.33 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.1 19.16 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 75.03 112.367 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -94.93 31.3 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 72.43 110.895 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.99 117.89 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.11 110.887 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -133.23 159.3 73.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.582 0.706 . . . . 74.44 110.857 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 104.85 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.51 112.354 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.77 -7.45 29.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.788 -0.72 . . . . 61.35 112.472 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -158.14 84.7 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 75.35 110.839 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -93.21 162.29 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 71.02 110.894 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.1 p -94.83 24.31 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 51.44 111.138 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.8 m -113.42 151.26 31.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.1 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.613 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -81.05 -179.9 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.889 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -59.36 138.29 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 64.52 111.088 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.63 35.64 55.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 71.13 112.448 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 20' ' ' CYS . 92.5 mt -138.01 170.61 15.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.793 0.33 . . . . 71.34 110.876 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -150.85 144.12 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.911 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.72 112.18 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.41 110.925 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HB2' HD11 ' A' ' 31' ' ' LEU . 3.0 mmt180 -148.06 147.74 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 74.24 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.41 35.84 11.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 75.52 110.923 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.14 13.05 57.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 72.11 112.486 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -143.75 165.44 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 63.34 110.884 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.528 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.0 t -96.32 145.02 25.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 55.51 110.848 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.63 176.41 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.23 110.931 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.4 p -74.88 116.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 64.2 110.847 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.458 -0.048 0 CA-C-O 120.91 0.386 . . . . 71.41 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.99 -169.88 39.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 44.35 112.482 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.47 -173.51 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 65.11 110.864 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 23' ' ' LEU . 7.1 tp -72.81 -54.99 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 65.3 110.921 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.95 23.63 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 75.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.16 154.58 60.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.602 0.715 . . . . 73.13 110.855 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.26 63.89 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 2.23 . . . . 75.3 112.308 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -143.22 65.41 15.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 73.35 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -32.16 19.07 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.673 2.249 . . . . 73.42 112.344 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -94.93 31.38 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.41 110.864 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 63.32 110.845 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -135.28 159.34 72.16 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 74.54 110.849 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 54.3 112.346 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 -8.28 29.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 71.32 112.498 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -158.15 84.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 74.34 110.87 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -94.27 162.18 13.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 70.12 110.875 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.85 23.39 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 54.52 111.134 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.0 m -114.13 147.73 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.24 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.588 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.54 -178.56 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.888 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.2 tt -60.55 140.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 63.33 111.13 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.65 32.61 61.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.75 . . . . 72.3 112.535 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.588 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.0 mt -135.44 170.14 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 63.31 110.912 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.79 144.99 25.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.2 110.936 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -100.1 112.05 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.884 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.3 mmt-85 -148.63 147.92 29.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.45 110.886 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 63.45 35.79 11.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.942 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.06 12.87 56.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 51.13 112.531 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -143.64 166.96 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 71.04 110.853 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.59 ' C ' HD23 ' A' ' 31' ' ' LEU . 10.8 t -97.48 144.96 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 72.23 110.86 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.46 176.43 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 72.01 110.898 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.24 115.94 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 72.23 111.154 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.23 110.872 -179.925 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.846 0.355 . . . . 73.54 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p -140.12 165.33 27.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 73.22 110.871 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.91 29.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.741 . . . . 70.2 112.492 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.61 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 74.45 110.826 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.2 tp -72.29 -50.0 30.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 61.31 110.958 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.54 23.69 9.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.01 110.845 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.18 155.43 57.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.561 0.696 . . . . 71.35 110.894 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 159.79 52.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.679 2.252 . . . . 75.05 112.351 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.5 65.67 10.44 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.622 0.725 . . . . 71.42 110.888 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -32.8 17.96 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 74.24 112.363 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -95.19 31.2 1.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 71.21 110.881 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.55 117.93 10.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 70.14 110.888 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -136.35 159.55 70.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 75.32 110.892 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 105.61 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.716 2.278 . . . . 64.2 112.257 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.0 29.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.715 -0.755 . . . . 12.53 112.477 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -158.21 84.55 0.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 75.42 110.847 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.2 mtm-85 -96.18 162.6 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 61.34 110.848 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.4 21.73 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 61.51 111.145 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.3 m -113.17 145.22 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.899 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.6 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.85 -175.63 3.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.21 110.848 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 tt -62.45 142.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 72.33 111.117 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.65 31.41 70.61 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 34.53 112.471 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.6 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.5 mt -133.28 169.65 16.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.854 0.359 . . . . 52.43 110.873 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.63 145.78 26.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 63.54 110.93 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.82 111.76 24.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.33 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.46 ' HB2' HD11 ' A' ' 31' ' ' LEU . 27.6 mmt180 -149.16 147.84 28.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 64.11 110.875 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.51 35.77 11.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 55.52 110.923 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.76 56.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 43.34 112.517 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -143.89 167.52 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 65.03 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.619 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.95 145.95 25.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 71.44 110.887 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.619 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.72 176.45 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 71.22 110.875 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.98 116.46 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 61.32 111.136 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 54.53 110.931 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.886 0.374 . . . . 74.23 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.0 p -133.14 165.24 25.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.15 110.895 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.97 -167.86 29.4 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.702 -0.761 . . . . 74.41 112.566 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.24 -176.6 5.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 74.22 110.842 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.29 -50.14 29.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 50.54 110.9 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.5 23.76 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 74.23 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.11 155.29 57.89 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.581 0.705 . . . . 75.42 110.855 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 159.76 52.2 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.654 2.236 . . . . 64.33 112.343 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -146.6 65.64 10.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.592 0.711 . . . . 53.4 110.883 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.72 17.75 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 64.42 112.301 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -95.14 31.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.257 -0.429 . . . . 75.22 110.875 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -68.57 117.96 10.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 62.13 110.885 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -135.58 159.49 71.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.73 . . . . 73.5 110.886 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 73.25 112.347 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.93 -8.52 29.51 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 32.04 112.508 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -158.05 84.52 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 72.32 110.866 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.7 mtm180 -96.13 162.49 13.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 75.45 110.898 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.9 p -94.48 22.11 6.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.02 111.136 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.5 m -113.15 145.6 40.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 64.32 110.854 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.606 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.26 -175.88 3.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 44.45 110.902 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.6 tt -62.19 142.84 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 72.13 111.158 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.79 31.61 70.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.737 . . . . 73.33 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.606 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.5 mt -133.62 169.56 16.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.746 0.308 . . . . 75.51 110.937 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.62 145.82 26.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.203 -0.453 . . . . 62.34 110.904 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.77 111.69 23.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.51 110.877 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' HD11 ' A' ' 31' ' ' LEU . 12.5 mmt180 -149.08 147.81 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 71.4 110.885 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.53 35.78 11.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.89 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.74 56.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.761 -0.733 . . . . 54.33 112.498 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 167.39 22.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 63.55 110.937 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.615 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.89 145.86 26.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 73.42 110.862 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.64 176.46 10.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 75.13 110.865 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.96 116.46 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 42.34 111.16 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.863 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 t0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.854 0.359 . . . . 71.11 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.5 p -139.78 165.21 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 60.02 110.861 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.4 -167.39 28.83 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.704 -0.76 . . . . 74.24 112.464 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.28 -176.78 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 73.31 110.832 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.0 tp -72.31 -49.92 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.2 110.927 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -99.56 23.69 9.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.897 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.07 155.29 58.0 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.621 0.724 . . . . 61.04 110.833 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 159.14 54.49 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.666 2.244 . . . . 73.43 112.33 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.91 65.64 11.11 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.664 0.745 . . . . 50.33 110.915 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -32.79 17.89 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 71.44 112.363 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -95.2 31.2 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.42 117.92 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.914 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 10.9 ptm180 -135.75 159.55 70.92 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.701 . . . . 72.45 110.841 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.5 Cg_endo -69.78 105.31 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.664 2.242 . . . . 74.41 112.344 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.56 29.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.75 -0.738 . . . . 65.23 112.424 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -158.05 84.59 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 73.11 110.885 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -96.21 162.48 13.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.21 110.842 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 p -94.4 21.77 6.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.156 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -112.98 145.38 40.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 72.34 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.612 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.34 -177.29 4.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 75.41 110.879 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.8 tt -61.16 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 62.03 111.087 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.94 31.36 67.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.731 -0.747 . . . . 43.22 112.481 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 20' ' ' CYS . 94.7 mt -133.92 169.74 16.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 70.04 110.877 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.6 145.79 26.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.89 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -100.76 111.72 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 65.21 110.882 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' HD11 ' A' ' 31' ' ' LEU . 39.2 mmt180 -149.05 147.74 28.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 70.02 110.902 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.51 35.77 11.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 65.42 110.934 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.71 56.18 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.41 112.481 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.9 167.23 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 61.12 110.9 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.607 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.8 145.52 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 75.4 110.896 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.607 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.47 176.45 10.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 70.35 110.92 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.75 116.49 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 63.23 111.078 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.48 . . . . 61.41 110.897 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 53.12 110.859 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.1 p -138.97 165.33 27.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 62.02 110.89 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.06 -167.99 29.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.78 -0.724 . . . . 55.44 112.497 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.19 -176.71 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 54.24 110.87 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.24 -50.14 29.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.9 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.48 23.73 9.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 72.22 110.885 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.06 155.31 58.02 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.572 0.701 . . . . 73.24 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 159.74 52.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 61.25 112.357 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.59 65.67 10.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.65 0.738 . . . . 64.13 110.879 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.75 17.85 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.733 2.288 . . . . 75.45 112.319 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.21 31.27 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.907 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.65 117.95 11.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 64.11 110.86 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 1.2 ptt180 -135.73 159.49 71.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.598 0.713 . . . . 74.43 110.909 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.1 Cg_endo -69.78 105.31 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.244 . . . . 60.24 112.348 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.02 -8.63 29.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.4 112.487 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -158.04 84.49 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.807 0.337 . . . . 65.43 110.881 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -96.19 162.51 13.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 63.53 110.886 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -94.45 21.95 6.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.183 -0.462 . . . . 71.41 111.139 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -113.08 145.59 40.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 74.42 110.92 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.604 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.17 -175.73 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.915 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.34 142.89 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 65.13 111.139 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.67 31.56 70.58 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 75.31 112.519 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.604 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.1 mt -133.46 169.59 16.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 65.21 110.886 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.6 145.81 26.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 64.41 110.9 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -100.81 111.72 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 71.3 110.857 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HB2' HD11 ' A' ' 31' ' ' LEU . 19.2 mmt180 -149.08 147.84 28.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.51 110.895 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.47 35.85 11.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.935 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.07 12.73 55.95 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.741 -0.742 . . . . 71.12 112.553 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -143.9 167.41 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 74.23 110.893 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.615 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.92 145.95 25.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.865 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.66 176.42 10.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 74.03 110.882 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.97 116.46 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 54.24 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.01 110.9 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.844 0.354 . . . . 60.13 110.865 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.2 p -140.39 165.26 27.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.14 110.896 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.44 -167.36 28.77 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.487 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.843 0.354 . . . . 75.21 110.814 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.26 -49.89 31.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 71.43 110.907 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.73 23.72 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.1 110.863 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.05 155.51 57.96 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.612 0.72 . . . . 74.14 110.857 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 158.7 56.03 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.691 2.261 . . . . 74.23 112.341 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.43 65.67 11.7 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 74.43 110.859 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -32.79 17.66 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 71.1 112.338 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 60.25 110.879 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -68.53 117.98 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 61.23 110.819 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -136.58 159.52 70.15 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.606 0.717 . . . . 73.13 110.883 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 105.66 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.646 2.231 . . . . 74.55 112.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.1 -9.08 29.22 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 51.4 112.483 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -158.17 84.61 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 74.23 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -96.19 162.47 13.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 73.35 110.862 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.35 21.39 7.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.22 111.154 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.8 m -113.02 145.28 41.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 65.54 110.912 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.612 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.23 -177.04 4.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 53.13 110.902 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.32 142.46 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 71.31 111.126 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.58 31.24 68.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 61.53 112.542 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.4 mt -133.68 169.6 16.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.719 0.295 . . . . 64.32 110.951 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.58 145.7 26.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 62.4 110.932 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.63 111.77 24.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.856 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HB2' HD11 ' A' ' 31' ' ' LEU . 37.5 mmt180 -149.05 147.51 28.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.851 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.58 35.74 11.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 64.11 110.928 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.83 56.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.78 -0.724 . . . . 63.42 112.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -143.84 166.8 23.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 70.04 110.908 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.562 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.37 145.38 26.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.888 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.22 176.46 9.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 71.21 110.931 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.89 116.34 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 65.44 111.103 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 71.11 110.899 -179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.837 0.351 . . . . 63.43 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.82 165.25 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 41.45 110.851 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.5 -167.47 28.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.691 -0.766 . . . . 61.21 112.439 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -89.26 -176.76 5.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 62.5 110.865 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.26 -49.92 31.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.926 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.69 23.72 9.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 70.14 110.845 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 155.39 57.91 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.592 0.711 . . . . 62.54 110.871 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 158.72 56.01 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.655 2.236 . . . . 64.05 112.375 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.1 p -145.39 65.73 11.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.628 0.728 . . . . 70.22 110.864 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.89 17.73 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.71 2.273 . . . . 61.23 112.329 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -95.22 31.22 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 41.44 110.943 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -68.43 117.94 10.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 65.12 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.59 159.49 70.25 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.585 0.707 . . . . 74.4 110.899 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.717 2.278 . . . . 75.02 112.329 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.96 29.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.806 -0.711 . . . . 71.15 112.504 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -158.18 84.52 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.769 0.319 . . . . 64.2 110.894 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.8 mtm-85 -96.14 162.46 13.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 73.44 110.843 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -94.41 21.62 6.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.147 -0.479 . . . . 60.14 111.079 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.6 m -113.21 145.26 41.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 73.41 110.885 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.615 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.2 -177.43 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 65.52 110.915 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.19 142.12 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 71.22 111.148 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.18 31.04 66.68 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.736 . . . . 30.03 112.491 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.615 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.8 mt -133.68 169.72 16.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.76 0.314 . . . . 74.55 110.919 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -150.56 145.63 26.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 52.21 110.905 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.6 111.75 24.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.04 110.872 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' HD11 ' A' ' 31' ' ' LEU . 21.4 mmt180 -148.96 147.58 28.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 73.23 110.867 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.47 35.81 11.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.22 110.93 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.09 12.84 56.37 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 63.24 112.486 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -143.85 166.85 23.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.796 0.332 . . . . 74.11 110.919 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.565 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.38 145.42 26.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.875 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.26 176.46 9.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 71.5 110.915 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.95 116.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 75.21 111.121 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 75.12 110.831 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.888 0.375 . . . . 64.15 110.905 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p -139.81 165.21 27.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 51.54 110.837 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.42 -167.48 28.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.695 -0.764 . . . . 54.53 112.479 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.15 -176.75 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 73.33 110.895 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.3 -49.93 30.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 63.02 110.927 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -99.6 23.67 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.33 110.888 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.03 155.43 58.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.585 0.707 . . . . 72.44 110.878 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.78 55.76 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.69 2.26 . . . . 73.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.3 p -145.41 65.75 11.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 70.3 110.842 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.87 17.72 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.721 2.281 . . . . 71.53 112.312 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.27 31.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 73.25 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -68.51 117.92 10.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 45.23 110.838 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -136.57 159.48 70.34 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.606 0.717 . . . . 71.42 110.893 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 105.64 1.51 Allowed 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.692 2.261 . . . . 51.24 112.338 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.01 -8.94 29.39 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.747 -0.74 . . . . 65.41 112.451 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -158.22 84.53 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 73.13 110.853 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -96.05 162.35 13.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 75.24 110.878 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -94.32 21.46 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.33 111.152 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.2 m -113.13 145.22 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 71.4 110.876 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.61 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.11 -177.23 4.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 33.5 110.889 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 tt -61.29 142.28 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.31 111.171 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.9 31.03 67.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 53.0 112.511 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.61 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.0 mt -133.62 169.74 16.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.71 0.29 . . . . 62.41 110.907 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.59 145.72 26.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.41 110.905 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -100.68 111.73 24.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.52 110.897 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.452 ' HB2' HD11 ' A' ' 31' ' ' LEU . 26.2 mmt180 -148.97 147.59 28.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 71.44 110.883 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.48 35.82 11.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 72.42 110.953 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.78 56.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.689 -0.767 . . . . 63.54 112.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mtmt -143.86 166.97 23.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.794 0.331 . . . . 70.44 110.939 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.51 145.44 26.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 74.04 110.91 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.29 176.45 9.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 75.33 110.887 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.93 116.4 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 60.44 111.161 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.22 110.882 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.826 0.346 . . . . 70.21 110.885 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.51 165.31 19.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 61.44 110.863 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.99 -167.96 29.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.767 -0.73 . . . . 74.35 112.468 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.61 5.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 62.01 110.861 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.452 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.25 -50.1 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 53.43 110.915 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.52 23.69 9.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.41 110.838 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.1 155.39 57.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.613 0.721 . . . . 73.51 110.855 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 159.05 54.78 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.713 2.276 . . . . 64.22 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -145.76 65.62 11.27 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.649 0.737 . . . . 75.31 110.879 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -32.73 17.68 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.648 2.232 . . . . 63.41 112.331 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -95.25 31.3 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 74.32 110.878 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.59 117.93 10.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.872 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -136.31 159.5 70.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 64.14 110.885 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 105.56 1.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.712 2.274 . . . . 61.53 112.396 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.01 29.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 73.53 112.507 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -158.19 84.56 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.44 110.9 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.3 mtm-85 -96.16 162.58 13.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.3 110.876 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.44 21.73 6.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 62.15 111.186 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.2 m -113.18 145.33 41.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.35 110.908 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.605 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.01 -175.57 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 63.23 110.873 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.49 143.17 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 54.04 111.161 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.53 31.3 70.88 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 72.33 112.475 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.605 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.2 mt -133.14 169.64 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.746 0.308 . . . . 73.35 110.921 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.68 145.77 26.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.901 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -100.8 111.77 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.874 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HB2' HD11 ' A' ' 31' ' ' LEU . 16.0 mmt180 -149.0 147.65 28.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 54.13 110.867 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 63.47 35.79 11.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 70.32 110.933 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.12 12.76 56.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 32.21 112.489 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -143.79 167.0 23.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.865 0.364 . . . . 74.15 110.882 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.54 145.84 25.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 71.32 110.857 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.53 176.45 10.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 70.41 110.892 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -76.12 116.39 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.3 111.142 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.4 ttm-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.04 110.894 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.82 0.343 . . . . 64.13 110.872 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.6 p -139.87 165.1 28.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 71.01 110.867 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.24 -167.47 29.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 54.05 112.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.21 -176.81 5.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.866 0.365 . . . . 64.31 110.856 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.1 tp -72.25 -49.86 31.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 45.55 110.917 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -99.71 23.68 9.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.2 110.837 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.97 155.25 58.29 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.56 0.695 . . . . 75.11 110.879 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 158.55 56.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 70.51 112.325 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.4 p -145.27 65.63 11.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.573 0.702 . . . . 72.44 110.866 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.8 17.87 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.634 2.223 . . . . 64.12 112.36 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -95.3 31.37 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.51 117.96 10.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 61.24 110.828 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 8.8 ptm180 -135.76 159.5 71.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.57 0.7 . . . . 64.03 110.896 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 105.27 1.45 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.622 2.215 . . . . 62.15 112.339 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.97 -8.5 29.43 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.745 -0.74 . . . . 63.22 112.503 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -158.09 84.46 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.81 0.338 . . . . 72.54 110.869 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -96.1 162.5 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.869 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.0 p -94.41 21.69 6.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.149 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.5 m -113.14 145.86 40.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 63.52 110.858 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.627 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.8 -175.52 3.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 73.52 110.858 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.9 tt -62.0 143.66 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 65.53 111.149 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.83 31.77 73.25 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.728 . . . . 64.31 112.432 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.627 HD12 ' H ' ' A' ' 20' ' ' CYS . 93.7 mt -133.78 169.14 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.746 0.308 . . . . 73.14 110.907 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -150.57 145.93 26.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 70.43 110.937 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -100.6 111.74 24.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.911 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' HB2' HD11 ' A' ' 31' ' ' LEU . 10.5 mmt180 -148.95 147.44 28.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 63.42 110.837 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 63.53 35.81 11.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.904 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.1 12.85 56.44 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.749 -0.738 . . . . 73.15 112.45 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mtmm -143.85 166.7 24.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 73.42 110.867 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.559 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.8 t -97.25 145.34 26.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 73.21 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.08 176.5 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.939 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -75.91 116.33 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 62.34 111.14 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 53.43 110.893 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.849 0.357 . . . . 74.24 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 25.3 p -135.65 165.38 25.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 61.21 110.902 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -100.45 -167.46 28.78 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 70.11 112.506 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -89.3 -176.76 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 72.11 110.853 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.2 tp -72.35 -49.76 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.916 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -99.67 23.7 9.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.32 110.878 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.2 155.55 57.55 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.577 0.703 . . . . 73.12 110.915 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 159.79 52.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.681 2.254 . . . . 70.31 112.328 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.2 p -146.82 65.65 10.06 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 64.23 110.863 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -32.9 17.85 Favored 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.71 2.274 . . . . 61.03 112.374 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.32 31.24 2.0 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 75.33 110.929 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -68.39 117.95 10.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 72.21 110.853 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -135.08 159.37 72.26 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.636 0.732 . . . . 71.3 110.842 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.77 105.49 1.5 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.737 2.291 . . . . 53.24 112.32 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.33 29.29 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.694 -0.765 . . . . 71.54 112.483 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -157.3 84.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.755 0.312 . . . . 74.15 110.885 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.1 mtm-85 -96.47 164.16 12.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 72.54 110.895 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.54 21.92 6.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 70.31 111.118 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -112.98 145.43 40.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 73.21 110.864 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.625 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -77.51 -174.49 3.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 73.23 110.858 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 tt -62.66 144.16 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 73.3 111.168 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.83 32.07 76.95 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 32.04 112.461 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.625 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.8 mt -133.51 169.11 17.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.754 0.311 . . . . 62.41 110.902 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -150.52 146.04 26.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 71.04 110.936 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.6 t -100.87 111.69 23.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.35 110.861 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.469 ' HB2' HD11 ' A' ' 31' ' ' LEU . 9.6 mmt180 -149.06 147.72 28.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 70.31 110.89 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.52 35.8 11.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 74.44 110.931 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.19 12.63 55.91 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 72.11 112.515 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -143.81 167.56 22.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.333 . . . . 72.43 110.933 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.618 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.7 t -97.91 145.87 26.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 64.35 110.888 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -147.81 176.46 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.927 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -75.75 116.53 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 75.41 111.171 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 73.31 110.892 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.834 0.35 . . . . 62.12 110.898 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.9 p -123.25 165.5 16.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 63.31 110.862 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.29 -168.72 30.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 64.1 112.51 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.65 5.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 73.04 110.872 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.5 tp -72.3 -49.99 30.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 62.11 110.873 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -99.26 23.67 8.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.833 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.92 155.93 55.37 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.631 0.729 . . . . 62.24 110.816 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 163.94 36.45 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 70.14 112.298 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.3 p -151.13 64.93 6.46 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.73 . . . . 74.43 110.839 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -32.39 18.65 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 65.42 112.385 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -95.0 31.34 1.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 65.23 110.896 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -68.98 117.93 11.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 53.01 110.879 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -135.45 159.51 71.38 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.646 0.736 . . . . 74.01 110.858 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 105.58 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 60.45 112.31 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.04 -9.02 29.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.769 . . . . 52.41 112.504 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -158.17 84.54 0.86 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.317 . . . . 71.21 110.858 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -96.04 162.86 13.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 64.45 110.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.45 21.83 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 73.23 111.166 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.2 m -112.84 145.07 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.14 110.884 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.17 -171.94 1.89 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 62.33 110.876 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 tp -64.73 145.52 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 71.33 111.12 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 32.65 84.51 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 72.13 112.482 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.583 HD12 ' H ' ' A' ' 20' ' ' CYS . 77.0 mt -132.64 169.62 16.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.705 0.288 . . . . 62.34 110.93 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -150.5 147.25 27.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.884 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.7 t -100.99 112.06 24.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 53.02 110.899 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.543 ' HB2' HD11 ' A' ' 31' ' ' LEU . 25.8 mmt180 -148.56 147.45 29.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 65.23 110.877 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 63.54 36.29 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 61.33 110.952 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.5 12.33 55.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 74.42 112.487 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.98 178.52 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 73.54 110.875 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.643 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.5 t -107.1 147.49 29.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.873 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.643 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.38 176.49 10.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 72.24 110.914 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.27 116.39 20.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.54 111.107 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 61.45 110.875 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.813 0.34 . . . . 65.32 110.878 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.2 p -136.47 165.61 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 75.12 110.857 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.56 -168.65 30.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 52.25 112.487 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.37 -176.61 5.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.903 0.383 . . . . 71.43 110.817 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.4 tp -72.3 -50.02 30.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 73.32 110.92 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -99.25 23.72 8.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 62.35 110.902 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.88 155.74 55.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.634 0.731 . . . . 61.3 110.823 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 164.32 34.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 75.03 112.32 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.4 p -152.06 64.83 5.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.625 0.726 . . . . 64.03 110.879 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -32.31 18.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.707 2.271 . . . . 61.01 112.373 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -94.99 31.39 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.86 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -69.05 117.95 11.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 72.44 110.899 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 4.5 ptt-85 -134.14 159.54 71.97 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 64.01 110.859 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.8 105.32 1.47 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.7 2.267 . . . . 62.15 112.308 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.96 -8.56 29.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 53.32 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -158.09 84.56 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.798 0.332 . . . . 72.21 110.81 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.06 163.06 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.834 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.51 22.19 6.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 75.42 111.117 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 92.9 m -112.93 145.55 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 71.4 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.584 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.64 -171.93 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.31 110.876 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.7 tt -64.64 145.51 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 73.14 111.086 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.14 33.0 85.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.732 . . . . 72.13 112.487 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.584 HD12 ' H ' ' A' ' 20' ' ' CYS . 76.6 mt -133.03 169.57 16.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 64.35 110.917 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -150.45 147.3 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.43 110.897 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 47.0 t -101.07 112.1 24.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.874 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' HB2' HD11 ' A' ' 31' ' ' LEU . 35.3 mmt180 -148.54 147.5 29.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.848 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 63.5 36.32 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 71.4 110.954 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.46 12.34 55.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 63.1 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -141.87 178.54 7.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.807 0.337 . . . . 74.4 110.932 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.643 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.6 t -107.21 147.5 30.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 43.15 110.895 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.643 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.35 176.39 10.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.91 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.17 116.43 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 72.3 111.114 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.448 . . . . 70.21 110.872 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.851 0.358 . . . . 74.54 110.881 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.0 165.44 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.15 -168.84 30.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 71.35 112.539 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -89.41 -176.63 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 54.43 110.849 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.443 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.6 tp -72.2 -50.18 29.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 74.31 110.927 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -99.06 23.6 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.2 110.882 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.02 156.28 54.97 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.568 0.699 . . . . 73.21 110.862 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 164.86 33.04 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.644 2.229 . . . . 74.02 112.351 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.2 p -151.97 65.07 6.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.657 0.742 . . . . 61.05 110.938 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.52 18.5 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.723 2.282 . . . . 74.15 112.344 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -95.19 31.35 1.94 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 65.3 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 63.04 110.858 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.26 159.76 68.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.645 0.736 . . . . 64.55 110.901 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 106.53 1.69 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.654 2.236 . . . . 72.11 112.377 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.06 -10.12 29.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 53.34 112.531 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -158.21 84.76 0.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.807 0.336 . . . . 71.14 110.866 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -96.6 162.62 13.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 75.32 110.913 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.4 21.53 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 62.35 111.086 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.3 m -112.96 144.67 42.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 51.03 110.871 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.579 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.91 -171.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 64.41 110.867 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.6 tt -65.07 145.89 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 71.32 111.152 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.63 32.78 85.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 64.54 112.43 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.579 HD12 ' H ' ' A' ' 20' ' ' CYS . 73.7 mt -132.35 169.42 16.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.781 0.324 . . . . 74.31 110.882 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -150.61 147.09 26.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 72.11 110.91 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.1 t -100.71 112.13 24.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.44 110.865 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.548 ' HB2' HD11 ' A' ' 31' ' ' LEU . 19.4 mmt180 -148.67 147.48 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 62.33 110.874 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 63.5 36.34 11.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 73.2 110.94 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.52 12.36 55.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.495 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -142.07 178.52 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 73.21 110.917 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.64 ' C ' HD23 ' A' ' 31' ' ' LEU . 5.3 t -107.04 147.67 29.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 72.3 110.851 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.64 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -148.48 176.46 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.51 110.881 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.7 p -77.31 116.48 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 62.22 111.134 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 64.44 110.866 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.862 0.363 . . . . 70.52 110.888 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.7 p -126.91 168.33 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 65.12 110.896 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.97 -170.86 41.64 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 43.42 112.484 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -89.41 -172.94 3.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.824 0.345 . . . . 71.32 110.868 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 23' ' ' LEU . 7.3 tp -72.72 -56.07 5.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 72.25 110.884 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.28 23.64 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 60.33 110.893 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.97 154.43 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.637 0.732 . . . . 73.5 110.836 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 156.31 63.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 62.31 112.343 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.64 65.57 14.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.649 0.737 . . . . 61.32 110.903 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -31.94 19.44 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.683 2.256 . . . . 64.43 112.324 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -94.97 31.29 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 71.45 110.846 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.21 117.91 11.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.897 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -134.62 159.35 72.54 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.613 0.721 . . . . 71.22 110.893 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 105.16 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 71.32 112.35 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.1 29.61 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 51.15 112.531 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -158.2 84.54 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.782 0.325 . . . . 60.43 110.837 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 -93.95 162.3 13.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 74.31 110.873 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.0 p -94.73 23.18 5.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 71.54 111.152 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 91.0 m -113.6 148.11 36.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 55.03 110.892 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.1 -178.95 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.877 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -60.85 139.58 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 52.24 111.148 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.69 32.28 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.735 -0.745 . . . . 62.33 112.48 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.575 HD12 ' H ' ' A' ' 20' ' ' CYS . 90.5 mt -135.05 170.81 15.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 60.23 110.928 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.77 145.06 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 74.02 110.924 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.9 t -100.8 112.05 24.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.25 110.918 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HB2' HD11 ' A' ' 31' ' ' LEU . 32.2 mmt180 -148.23 147.83 29.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.885 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 63.33 35.73 12.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 74.22 110.904 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.05 56.88 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 73.33 112.501 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -143.45 165.61 27.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.788 0.328 . . . . 72.22 110.873 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.537 ' C ' HD23 ' A' ' 31' ' ' LEU . 12.1 t -96.71 145.21 26.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 65.23 110.907 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.85 176.45 9.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.01 110.952 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.5 p -74.92 116.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 71.11 111.169 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 71.45 110.811 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.832 0.349 . . . . 63.15 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.52 164.85 29.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.895 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.87 -167.47 29.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 14.02 112.468 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -89.25 -176.92 5.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 71.44 110.843 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.471 HD13 ' CD2' ' A' ' 23' ' ' LEU . 5.9 tp -72.24 -49.82 32.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.927 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -99.87 23.77 9.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.02 110.829 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.49 154.36 59.29 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 72.13 110.903 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 158.67 56.11 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.229 . . . . 71.12 112.368 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -146.41 65.15 10.19 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.621 0.724 . . . . 74.23 110.87 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.25 18.79 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.647 2.231 . . . . 72.2 112.352 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -94.96 31.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 64.42 110.889 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -69.26 117.85 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.03 110.855 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . 12.0 ptt180 -130.33 159.77 68.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.6 0.714 . . . . 72.24 110.87 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.75 104.01 1.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.71 2.274 . . . . 70.23 112.332 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.72 -6.28 29.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 61.22 112.461 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.24 87.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 61.22 110.849 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -97.93 162.78 13.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.3 110.908 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.1 p -94.7 23.54 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 75.44 111.15 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.0 m -112.95 146.67 38.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 70.42 110.904 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.614 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.36 -177.15 5.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 72.2 110.869 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 22' ' ' GLY . 6.6 tp -60.87 142.48 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 62.2 111.143 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' H ' HD12 ' A' ' 21' ' ' ILE . . . 70.39 31.81 68.43 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.734 -0.746 . . . . 60.44 112.489 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.614 HD12 ' H ' ' A' ' 20' ' ' CYS . 95.9 mt -134.79 169.51 17.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 42.44 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -150.47 146.44 26.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 64.43 110.957 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.7 t -101.21 111.69 23.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 74.2 110.905 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.7 mmt-85 -149.17 147.84 28.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.838 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 63.46 35.81 11.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 73.23 110.938 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.13 12.66 55.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.735 -0.745 . . . . 62.4 112.49 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -143.78 167.56 22.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 64.22 110.903 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.621 ' C ' HD23 ' A' ' 31' ' ' LEU . 6.0 t -98.12 145.19 26.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.33 110.912 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.621 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.64 176.43 9.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.904 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -76.66 116.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 64.13 111.106 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 54.1 110.882 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.88 0.372 . . . . 63.31 110.917 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.1 p -134.65 164.82 26.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 73.54 110.879 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.99 -170.05 32.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 32.24 112.525 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.57 -175.61 4.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 72.34 110.838 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.88 -53.98 11.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.927 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.78 23.41 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.832 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.8 154.96 58.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.602 0.715 . . . . 73.31 110.862 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 161.64 45.15 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.709 2.273 . . . . 65.31 112.354 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.13 65.65 8.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.626 0.727 . . . . 61.1 110.9 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.69 17.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.259 . . . . 74.31 112.347 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -95.2 31.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 72.32 110.855 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -68.36 117.95 10.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.35 110.852 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -136.71 159.43 70.39 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.596 0.712 . . . . 73.43 110.904 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 105.41 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.713 2.275 . . . . 70.33 112.351 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -8.27 29.63 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.793 -0.717 . . . . 73.44 112.528 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 72.22 110.842 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -95.51 162.46 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 74.14 110.844 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.4 p -94.6 22.35 6.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 72.31 111.137 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.0 m -113.71 148.85 35.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.857 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.567 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.65 -171.59 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 51.12 110.891 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.5 tt -64.8 145.34 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 71.22 111.128 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.8 32.93 84.4 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.711 -0.756 . . . . 60.43 112.481 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.567 HD12 ' H ' ' A' ' 20' ' ' CYS . 68.7 mt -133.75 168.51 18.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 72.21 110.955 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.8 tt0 -150.88 146.18 26.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 63.43 110.932 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -100.23 112.02 24.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.869 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HB2' HD11 ' A' ' 31' ' ' LEU . 20.9 mmt85 -148.76 148.02 29.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.44 110.835 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 63.33 35.84 12.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 71.54 110.919 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.11 12.58 55.53 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.754 -0.736 . . . . 53.1 112.504 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -143.32 167.61 21.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.878 0.371 . . . . 73.42 110.858 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.611 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.6 t -97.6 146.65 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 44.41 110.887 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.611 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.21 175.09 11.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.25 110.923 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.498 HG23 HD11 ' A' ' 5' ' ' LEU . 84.9 t -72.36 116.9 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 71.12 111.127 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.885 -179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.837 0.351 . . . . 74.22 110.873 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -123.45 164.97 17.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.32 110.859 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.19 -169.96 32.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.712 -0.756 . . . . 61.43 112.526 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -89.65 -175.6 4.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 72.2 110.844 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.86 -54.07 11.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 72.14 110.945 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -95.72 23.42 6.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 71.4 110.838 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.77 154.9 58.86 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.572 0.701 . . . . 74.25 110.898 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 161.64 45.16 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.693 2.262 . . . . 52.44 112.285 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -148.24 65.58 8.82 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.723 . . . . 71.04 110.909 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.75 18.02 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.69 2.26 . . . . 73.21 112.359 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -95.13 31.21 1.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.92 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -68.32 117.96 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 70.21 110.875 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -136.46 159.44 70.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 70.01 110.857 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 105.37 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.69 2.26 . . . . 72.1 112.318 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -8.3 29.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.778 -0.725 . . . . 53.22 112.488 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -158.17 84.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 72.25 110.899 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -95.47 162.6 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.881 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -94.52 22.28 6.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.154 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.0 m -113.62 148.95 35.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 61.13 110.899 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.75 -171.74 2.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 73.04 110.862 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.72 145.13 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 73.12 111.114 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.98 33.0 84.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 71.42 112.499 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.573 HD12 ' H ' ' A' ' 20' ' ' CYS . 69.0 mt -133.89 168.59 18.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.787 0.327 . . . . 74.02 110.894 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.9 tt0 -150.85 146.23 26.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 63.41 110.947 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -100.31 112.09 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 71.42 110.883 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' A' ' 31' ' ' LEU . 29.3 mmt180 -148.72 148.09 29.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 64.14 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.35 35.79 12.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 63.4 110.914 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.51 55.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.748 . . . . 70.34 112.474 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 mtmm -143.32 167.64 21.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 62.35 110.88 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.616 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.7 t -97.6 146.62 25.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 64.55 110.861 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.22 175.14 11.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.4 110.916 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 5' ' ' LEU . 85.4 t -72.5 116.89 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 72.15 111.151 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.853 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.876 0.37 . . . . 74.4 110.895 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p -125.56 164.7 19.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.927 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.66 -170.18 32.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 73.33 112.455 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -89.55 -175.5 4.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.808 0.337 . . . . 71.43 110.887 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.496 HD11 HG23 ' A' ' 32' ' ' VAL . 5.7 tp -71.94 -54.11 10.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 74.24 110.911 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -95.69 23.43 6.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 74.32 110.827 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.68 154.89 59.12 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.562 0.696 . . . . 72.52 110.873 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 160.91 47.94 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.656 2.237 . . . . 74.43 112.339 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.9 p -147.32 65.54 9.52 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.615 0.721 . . . . 61.11 110.882 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -32.71 17.95 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.67 2.247 . . . . 62.31 112.332 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -95.3 31.3 1.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 71.21 110.886 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.57 117.99 11.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 64.2 110.85 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -136.83 159.48 70.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.635 0.731 . . . . 72.31 110.86 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 105.5 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.633 2.222 . . . . 74.22 112.318 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.94 -8.43 29.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 62.53 112.472 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -158.2 84.59 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 75.41 110.813 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -95.62 162.26 13.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.846 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -94.59 22.29 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 65.14 111.132 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.8 m -113.63 148.65 35.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 72.11 110.901 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -78.49 -171.34 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 72.03 110.884 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 19.2 tt -64.98 145.63 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 74.12 111.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.51 32.78 84.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 35.53 112.466 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD12 ' H ' ' A' ' 20' ' ' CYS . 68.9 mt -133.46 168.31 18.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.767 0.317 . . . . 64.03 110.919 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.404 ' HG2' ' HG2' ' A' ' 26' ' ' ARG . 5.8 tt0 -150.92 146.05 26.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 72.42 110.923 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.3 t -99.89 112.06 24.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 73.45 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' HB2' HD11 ' A' ' 31' ' ' LEU . 10.8 mmt180 -148.62 147.9 29.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 55.24 110.874 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 63.3 35.77 12.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 71.31 110.925 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.18 12.66 55.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.13 112.444 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -143.35 167.32 22.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.834 0.35 . . . . 72.35 110.873 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.601 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.5 t -97.36 146.53 25.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 74.21 110.876 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -149.06 175.44 11.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.89 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 5' ' ' LEU . 84.9 t -72.68 116.87 15.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 71.54 111.099 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 74.31 110.9 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.85 0.357 . . . . 72.13 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p -135.54 170.32 16.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 53.21 110.91 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.38 -171.23 37.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 74.51 112.49 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.23 -172.89 3.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.359 . . . . 72.3 110.838 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 23' ' ' LEU . 6.8 tp -72.62 -56.14 5.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 63.44 110.944 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -95.24 23.58 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 72.54 110.854 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.77 154.24 61.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.583 0.706 . . . . 72.32 110.865 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 156.18 64.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.697 2.265 . . . . 74.11 112.325 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.5 p -143.58 65.56 14.69 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.622 0.725 . . . . 63.33 110.857 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -32.1 19.16 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.242 . . . . 75.03 112.367 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -94.93 31.3 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 72.43 110.895 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -68.99 117.89 11.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.11 110.887 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -133.23 159.3 73.15 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.582 0.706 . . . . 74.44 110.857 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 104.85 1.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.679 2.253 . . . . 73.51 112.354 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.77 -7.45 29.68 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.788 -0.72 . . . . 61.35 112.472 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -158.14 84.7 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 75.35 110.839 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -93.21 162.29 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 71.02 110.894 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.1 p -94.83 24.31 4.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 51.44 111.138 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.8 m -113.42 151.26 31.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 74.1 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.613 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -81.05 -179.9 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 74.12 110.889 -179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.8 tt -59.36 138.29 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 64.52 111.088 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.63 35.64 55.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 71.13 112.448 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 20' ' ' CYS . 92.5 mt -138.01 170.61 15.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.793 0.33 . . . . 71.34 110.876 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -150.85 144.12 24.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.911 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.7 t -99.72 112.18 24.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.41 110.925 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.468 ' HB2' HD11 ' A' ' 31' ' ' LEU . 3.0 mmt180 -148.06 147.74 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 74.24 110.858 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 63.41 35.84 11.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 75.52 110.923 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.14 13.05 57.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 72.11 112.486 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -143.75 165.44 27.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 63.34 110.884 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.528 ' C ' HD23 ' A' ' 31' ' ' LEU . 13.0 t -96.32 145.02 25.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 55.51 110.848 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.63 176.41 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.23 110.931 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.4 p -74.88 116.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 64.2 110.847 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.88 0.372 . . . . 71.2 110.845 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 4.4 p -134.31 168.87 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 71.41 110.862 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.99 -169.88 39.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 44.35 112.482 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -89.47 -173.51 4.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 65.11 110.864 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 23' ' ' LEU . 7.1 tp -72.81 -54.99 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 65.3 110.921 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -95.95 23.63 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 75.0 110.845 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.16 154.58 60.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.602 0.715 . . . . 73.13 110.855 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.26 63.89 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 2.23 . . . . 75.3 112.308 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.8 p -143.22 65.41 15.2 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.601 0.715 . . . . 73.35 110.871 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -32.16 19.07 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.673 2.249 . . . . 73.42 112.344 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -94.93 31.38 1.87 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 74.41 110.864 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -69.11 117.95 11.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 63.32 110.845 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -135.28 159.34 72.16 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 74.54 110.849 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 105.3 1.46 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 54.3 112.346 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.92 -8.28 29.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.731 -0.747 . . . . 71.32 112.498 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -158.15 84.66 0.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 74.34 110.87 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -94.27 162.18 13.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 70.12 110.875 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.9 p -94.85 23.39 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 54.52 111.134 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.0 m -114.13 147.73 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 72.24 110.891 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.588 ' H ' HD12 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -78.54 -178.56 5.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 71.23 110.888 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.2 tt -60.55 140.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 63.33 111.13 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.65 32.61 61.45 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.75 . . . . 72.3 112.535 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.588 HD12 ' H ' ' A' ' 20' ' ' CYS . 91.0 mt -135.44 170.14 16.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.781 0.324 . . . . 63.31 110.912 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -150.79 144.99 25.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.2 110.936 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.0 t -100.1 112.05 24.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.884 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.3 mmt-85 -148.63 147.92 29.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 74.45 110.886 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 63.45 35.79 11.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 73.31 110.942 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.06 12.87 56.39 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.708 -0.758 . . . . 51.13 112.531 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -143.64 166.96 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.814 0.34 . . . . 71.04 110.853 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.59 ' C ' HD23 ' A' ' 31' ' ' LEU . 10.8 t -97.48 144.96 26.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 72.23 110.86 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.59 HD23 ' C ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -146.46 176.43 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 72.01 110.898 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.6 p -77.24 115.94 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 72.23 111.154 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 64.23 110.872 -179.925 . . . . . . . . 0 0 . 1 stop_ save_